WorldWideScience

Sample records for advia centaur hiv

  1. Measurement of amino terminal propeptide of type III procollagen (PIIINP) employing the ADVIA Centaur platform. Validation, reference interval and comparison to UniQ RIA

    DEFF Research Database (Denmark)

    Knudsen, Cindy Soendersoe; Heickendorff, Lene; Nexo, Ebba

    2014-01-01

    Background: Recently, measurement of amino terminal propeptide of type III procollagen (PIIINP) was introduced as a part of the hepatic cirrhotic marker enhanced liver fibrosis™ test on the automated ADVIA Centaur® immunoassay platform (Siemens Healthcare Diagnostics Inc., Tarrytown, NY, USA). In...

  2. HIRENASD Unstructured Grids - Centaur software

    Data.gov (United States)

    National Aeronautics and Space Administration — These grids were constructed using Centaur software at DLR in Germany. The grids designed for node based (labeled 'cv') and cell-centered solvers (labeled 'cc') are...

  3. Seroprevalences of HBV, HCV and HIV among Children who examined Before Elective Surgery in Mardin province

    Directory of Open Access Journals (Sweden)

    Tekin A et al.

    2011-10-01

    Full Text Available Objectives: The aim of this study was to investigate the seroprevalence of hepatitis B virus (HBV, hepatitis C virus (HCV and human immunodeficiency virus (HIV among children who examined before elective surgery in Mardin province. Materials and Methods: Between 01 November 2008 and 30 April 2010, a total of 556 patients aged 0–16 years, who planned to be operated, were investigated for viral hepatitis seroprevalences in the Mardin Women and Pediatrics Hospital. Children’s blood samples were tested for hepatitis B surface antigen (HBsAg, hepatitis B surface antibody (anti-HBs, HCV antibody (anti-HCV and HIV antibody (anti-HIV markers by chemiluminescent immunoassay with Advia Centaur (Siemens autoanalyser. Results: A total of 556 children (441 boys, 115 girls age under 16 years who planned to be underwent elective surgery were included. We found positive HBsAg and negative anti-HBs in 3 patients (0.5%; Negative HBsAg and positive anti-HBs were found in 473 children (85.1%; Negative HBsAg and negative anti-HBs were observed in 80 children (14.4%. None of the patients had positive HCV and HIV antibody. Conclusion: HBsAg positivity rate was lower and anti-HBs positivity rate was higher than expected levels. This study indicated that vaccination was successful in our region.

  4. Atlas SOHO Booster and Centaur Erection

    Science.gov (United States)

    1995-01-01

    The launch vehicle for the Solar Heliospheric Observatory (SOHO) mission is a two stage Atlas-IIAS (Atlas/Centaur). The Atlas, consists of a solid rocket booster stage powered by four Thiokol Castor IVA solid rocket boosters (SRB) and a core vehicle stage (booster and sustainer) powered by Rocketdyne MA-5A liquid propellant engines (RP-1 fuel and liquid oxygen). The multiple firing Centaur is powered by two Pratt and Whitney (RL10A-4) liquid hydrogen and liquid oxygen engines with extendible nozzles. This video shows the erection of the Atlas booster and transportation (to 36-B launching pad) and erection of the Centaur.

  5. Shuttle/Centaur Upper Stage Capability

    Science.gov (United States)

    Clark, H. J.

    1984-01-01

    A joint project to design, develop, procure, and produce Centaur upper stages for use with the Space Shuttle is discussed. A common Centaur G stage 6 meters (19.5 feet) in length is being jointly developed. A longer version designated Centaur G Prime is being developed by NASA to accomplish the Galileo and International Solar-Polar Mission flights in 1986. The Centaur G and G Prime will have the capability to place, respectively, approximately 4540 kilograms (10,000 pounds) and 5910 kilograms (13,000 pounds) into geosynchronous orbit from a standard Shuttle parking orbit of 278 kilometers (150 nautical miles) and Shuttle performance (lift) capability 29,500 kilograms (65,000 pounds). The advent of high energy upper stage capability in 1986 will permit space users and spacecraft developers to utilize spacecraft growth, stage combination concepts with storage modules, teleoperator systems, and other mission peculiar devices to satisfy complex mission demands. These capabilities should greatly enhance the usefulness of the space environment and stimulate mission planners toward conception of innovative means to meet ever increasing mission requirements.

  6. Centaurs as a hazard to civilization

    Science.gov (United States)

    Napier, Bill; Asher, David; Bailey, Mark; Steel, Duncan

    2015-12-01

    Assessments of the risk posed by near-Earth objects ignore the possibility of a giant comet entering the inner solar system. Bill Napier, David Asher, Mark Bailey and Duncan Steel examine the likelihood and potential consequences of the appearance of such a centaur.

  7. Taming Liquid Hydrogen: The Centaur Upper Stage Rocket

    Science.gov (United States)

    2004-01-01

    The Centaur is one of the most powerful rockets in the world. As an upper-stage rocket for the Atlas and Titan boosters it has been a reliable workhorse for NASA for over forty years and has played an essential role in many of NASA's adventures into space. In this CD-ROM you will be able to explore the Centaur's history in various rooms to this virtual museum. Visit the "Movie Theater" to enjoy several video documentaries on the Centaur. Enter the "Interview Booth" to hear and read interviews with scientists and engineers closely responsible for building and operating the rocket. Go to the "Photo Gallery" to look at numerous photos of the rocket throughout its history. Wander into the "Centaur Library" to read various primary documents of the Centaur program. Finally, stop by the "Observation Deck" to watch a virtual Centaur in flight.

  8. Centaure: an heterogeneous parallel architecture for computer vision

    International Nuclear Information System (INIS)

    This dissertation deals with the architecture of parallel computers dedicated to computer vision. In the first chapter, the problem to be solved is presented, as well as the architecture of the Sympati and Symphonie computers, on which this work is based. The second chapter is about the state of the art of computers and integrated processors that can execute computer vision and image processing codes. The third chapter contains a description of the architecture of Centaure. It has an heterogeneous structure: it is composed of a multiprocessor system based on Analog Devices ADSP21060 Sharc digital signal processor, and of a set of Symphonie computers working in a multi-SIMD fashion. Centaure also has a modular structure. Its basic node is composed of one Symphonie computer, tightly coupled to a Sharc thanks to a dual ported memory. The nodes of Centaure are linked together by the Sharc communication links. The last chapter deals with a performance validation of Centaure. The execution times on Symphonie and on Centaure of a benchmark which is typical of industrial vision, are presented and compared. In the first place, these results show that the basic node of Centaure allows a faster execution than Symphonie, and that increasing the size of the tested computer leads to a better speed-up with Centaure than with Symphonie. In the second place, these results validate the choice of running the low level structure of Centaure in a multi- SIMD fashion. (author)

  9. Thermal Properties of Centaurs Asbolus and Chiron

    CERN Document Server

    Fernández, Y R; Sheppard, S S

    2002-01-01

    We have measured the mid-infrared thermal continua from two Centaurs, inactive (8405) Asbolus and active 95P=(2060) Chiron, and have constrained their geometric albedos, p, and effective radii, R, with the Standard Thermal Model for slow rotators. These are the first such measurements of Asbolus; we find R=33 km +/- 2 km and p=0.12 +/- 0.03. This albedo is higher than all of those confidently known for active cometary nuclei. The thermal inertia is comparable to or lower than those of main belt asteroids, the Moon, and Chiron; lower than those of the icy Galilean satellites; and much lower than those of near-Earth asteroids. For Chiron, we find R=74 km +/- 4 km and p=0.17 +/- 0.02. While this albedo is consistent with the established value, previous radiometry by others implied a larger radius. This effect may be partially due to a varying infrared dust coma but all datasets have too low signal to be sure. Four Centaur albedos (out of about 30 objects) are now known. They show a diversity greater than that of...

  10. Shuttle Centaur engine cooldown evaluation and effects of expanded inlets on start transient

    Science.gov (United States)

    1987-01-01

    As part of the integration of the RL10 engine into the Shuttle Centaur vehicle, a satisfactory method of conditioning the engine to operating temperatures had to be established. This procedure, known as cooldown, is different from the existing Atlas Centaur due to vehicle configuration and mission profile differenced. The program is described, and the results of a Shuttle Centaur cooldown program are reported. Mission peculiarities cause substantial variation in propellant inlet conditions between the substantiated Atlas Centaur and Shuttle Centaur with the Shuttle Centaur having much larger variation in conditions. A test program was conducted to demonstrate operation of the RL10 engine over the expanded inlet conditions. As a result of this program, the Shuttle Centaur requirements were proven satisfactory. Minor configuration changes incorporated as a result of this program provide substantial reduction in cooldown propellant consumption.

  11. Assessing the contribution of Centaur impacts to ice giant luminosities

    OpenAIRE

    Dodson-Robinson, Sarah E.

    2015-01-01

    Voyager 2 observations revealed that the internal luminosity of Neptune is an order of magnitude higher than that of Uranus. If the two planets have similar interior structures and cooling histories, the luminosity of Neptune can only be explained by invoking some energy source beyond gravitational contraction. This paper investigates whether Centaur impacts could provide the energy necessary to produce the luminosity of Neptune. The major findings are (1) that impacts on both Uranus and Nept...

  12. Large retrograde Centaurs: visitors from the Oort cloud?

    CERN Document Server

    Marcos, C de la Fuente

    2014-01-01

    Among all the asteroid dynamical groups, Centaurs have the highest fraction of objects moving in retrograde orbits. The distribution in absolute magnitude, H, of known retrograde Centaurs with semi-major axes in the range 6-34 AU exhibits a remarkable trend: 10% have H 12 mag. The largest objects, namely (342842) 2008 YB3, 2011 MM4 and 2013 LU28, move in almost polar, very eccentric paths; their nodal points are currently located near perihelion and aphelion. In the group of retrograde Centaurs, they are obvious outliers both in terms of dynamics and size. Here, we show that these objects are also trapped in retrograde resonances that make them unstable. Asteroid 2013 LU28, the largest, is a candidate transient co-orbital to Uranus and it may be a recent visitor from the trans-Neptunian region. Asteroids 342842 and 2011 MM4 are temporarily submitted to various high-order retrograde resonances with the Jovian planets but 342842 may be ejected towards the trans-Neptunian region within the next few hundred kyr....

  13. The design and fabrication of the Centaur neutral buoyancy trainer and related hardware

    Science.gov (United States)

    Ware, Alan S.; Hollingsworth, Michael

    1986-01-01

    Two full scale mockups of the Centaur upper stage were designed, fabricated and delivered to NASA. One was the Centaur Weightless Environment Training Facility (WETF) trainer and the other was the Centaur 1-G mockup. The Centaur upper stage booster is designed to carry the spacecraft Galileo to Jupiter, and the spacecraft Ulysses to an orbit around the Sun after launch from the Space Shuttle. The flight vehicle has several Extravehicular Activity (EVA) contingency tasks that require crew training. This need for crew training generated the requirement for the Centaur WETF crew trainer, which is high fidelity in areas of expected crew interface. During the production of the Centaur WETF crew trainer, the need for a jumper cable from Centaur to the Orbiter was identified. This EVA contingency task would be the installation of a cable from the Orbiter cargo bay sill to various command data boxes on Centaur to allow crew control deployment should a failure occur. This task required the upgrading of volumetric boxes on the trainer to a high fidelity configuration including electrical connector installation and cable routing.

  14. RL10 Engine Ability to Transition from Atlas to Shuttle/Centaur Program

    Science.gov (United States)

    Baumeister, Joseph F.

    2015-01-01

    A key launch vehicle design feature is the ability to take advantage of new technologies while minimizing expensive and time consuming development and test programs. With successful space launch experiences and the unique features of both the National Aeronautics and Space Administration (NASA) Space Transportation System (Space Shuttle) and Atlas/Centaur programs, it became attractive to leverage these capabilities. The Shuttle/Centaur Program was created to transition the existing Centaur vehicle to be launched from the Space Shuttle cargo bay. This provided the ability to launch heaver and larger payloads, and take advantage of new unique launch operational capabilities. A successful Shuttle/Centaur Program required the Centaur main propulsion system to quickly accommodate the new operating conditions for two new Shuttle/Centaur configurations and evolve to function in the human Space Shuttle environment. This paper describes the transition of the Atlas/Centaur RL10 engine to the Shuttle/Centaur configurations; shows the unique versatility and capability of the engine; and highlights the importance of ground testing. Propulsion testing outcomes emphasize the value added benefits of testing heritage hardware and the significant impact to existing and future programs.

  15. A photometric search for activity among asteroids and Centaurs

    Science.gov (United States)

    Sosa Oyarzabal, A.; Mammana, L.; Fernández, J. A.

    2014-07-01

    We present the first results of a long-term observational campaign focused on the detection of activity in selected asteroids and centaurs. Our observational targets are near-Earth asteroids in cometary orbits (cf. [2]), the so called ''main-belt comets'' or ''active asteroids'' (well-known objects as well as potential candidates), and bright centaurs with good orbits, all close to their perihelion passages. In those objects with a former detection of activity, our aim is to contribute to a better physical knowledge of them, and determine, for instance, if the observed activity is transient or permanent. To achieve our goals, we analyzed CCD-filtered images of each observable target acquired with the 2.15-m telescope ''Jorge Sahade'' at CASLEO (San Juan, Argentina), during two runs of three consecutive nights each (during August 2013 and January 2014, respectively). Our study will be completed by future runs with the same instrumentation already assigned to our campaign. As preliminary results, we observed activity in the main-belt comets P/2013 P5 (PANSTARRS) and 133P/(7968) Elst-Pizarro. We also observed the main-belt comet (596) Scheila, which showed an unequivocally stellar appearance. We observed the main-belt comet candidate (3646) Aduatiques (cf. [1]), and noticed in this object a curious feature whose connection to some kind of activity is not well determined yet. We also observed the near-Earth asteroid in cometary orbit 2006 XL_5 (cf. [3]), and the centaurs (281371) 2008 FC_{76}, (332685) 2009 HH_{36}), (382004) 2010 RM_{64}, 2010 XZ_{78}, and 2011 UR_{402}. We have not detected activity in these objects, but an improved analysis is still in progress. %Corresponding author: Andrea Sosa (asosa@fisica.edu.uy)

  16. Assessing the contribution of Centaur impacts to ice giant luminosities

    CERN Document Server

    Dodson-Robinson, Sarah E

    2015-01-01

    Voyager 2 observations revealed that the internal luminosity of Neptune is an order of magnitude higher than that of Uranus. If the two planets have similar interior structures and cooling histories, the luminosity of Neptune can only be explained by invoking some energy source beyond gravitational contraction. This paper investigates whether Centaur impacts could provide the energy necessary to produce the luminosity of Neptune. The major findings are (1) that impacts on both Uranus and Neptune are too infrequent to provide luminosities of order the observed value for Neptune, even for optimistic impact-rate estimates, and (2) that Uranus and Neptune rarely have significantly different impact-generated luminosities at any given time. Uranus and Neptune most likely have structural differences that force them to cool and contract at different rates.

  17. Assessing the contribution of centaur impacts to ice giant luminosities

    Science.gov (United States)

    Dodson-Robinson, Sarah E.

    2016-01-01

    Voyager 2 observations revealed that Neptune's internal luminosity is an order of magnitude higher than that of Uranus. If the two planets have similar interior structures and cooling histories, Neptune's luminosity can only be explained by invoking some energy source beyond gravitational contraction. This paper investigates whether centaur impacts could provide the energy necessary to produce Neptune's luminosity. The major findings are (1) that impacts on both Uranus and Neptune are too infrequent to provide luminosities of order Neptune's observed value, even for optimistic impact-rate estimates and (2) that Uranus and Neptune rarely have significantly different impact-generated luminosities at any given time. Uranus and Neptune most likely have structural differences that force them to cool and contract at different rates.

  18. Size determination of the Centaur Chariklo from millimeter-wavelength bolometer observations

    OpenAIRE

    Altenhoff, W.J.; Menten, K. M.; Bertoldi, F.

    2000-01-01

    Using the Max-Planck Millimeter Bolometer Array (MAMBO) at the IRAM 30m telescope we detected emission at 250 GHz from the Centaur Chariklo (1997 CU26). The observed continuum flux density implies a photometric diameter of 273 km. The resulting geometric albedo is 0.055, somewhat higher than expected from a comparison with most of the other few Centaurs and cometary nuclei for which such data are available.

  19. A long term study of Centaur 174P/Echeclus

    Science.gov (United States)

    Rousselot, Philippe; Korsun, Pavlo; Kulyk, Irina; Petit, Jean-Marc; Guilbert-Lepoutre, Aurélie

    2015-11-01

    Centaur 174P/Echeclus was discovered by the Spacewatch program on March 3, 2000 and initially labelled (60558) 2000 EC 98 . On December 30, 2005, a surprising cometary outburst was discovered with the 5-m Mount Palomar Observatory telescope. This outburst corresponded to a change in the overall visual magnitude from about 21 to about 14. At that time (60558) 2000 EC 98 was located at 13.07 au to the Sun and was subsequently renamed with a cometary designation. This outburst lasted a few months and, one year later, no coma could be detected. Another secondary outburst happened in 2011 and lasted also a few months. This target was at its perihelion (5.82 au) on April 22, 2015.We present new observational data obtained with the 2.5-m Nordic Optical Telescope during the 2011 outburst and in July 2013, and with the robotic 2-m Liverpool telescope on April 27, 2014, August 13, 2014 and June 1, 2015. We also found archive observational data obtained on December 22, 2005.These archive images point out the extremely high level of the 174P/Echeclus activity during the first outburst. The R-magnitude and Afrho parameter of the target were estimated to 14.8 and 56000±3000 cm respectively. During the second outburst, in 2011, the activity level of the Centaur was lower, the R-Afrho parameters were 1200±100 cm and 480±70 cm in June and July respectively. The dust production rates needed to produce the observed comae were approximately 700 kg.s-1 in 2005 and between 10 and 20 kg.s-1 in 2011 assuming the average grain geometric albedo of 0.1 and low outflow velocities of the dust, less than 10 m.s-1. A possible scenario of the dust coma formation for the first outburst will also be proposed using a Monte Carlo modeling.Before the outburst the lightcurve amplitude was 0.24 magnitude in the R-band with a rotation period of 26.80 h (if a double-peaked lightcurve is assumed). The observational data obtained after the outburst with the NOT do not permit to detect any clear variation

  20. When Lulu met the Centaur: Photographic traces of creaturely love

    Directory of Open Access Journals (Sweden)

    Dominic Pettman

    2015-04-01

    Full Text Available The brief triangular love between Nietzche, Salomé, and Rée – as crystallised in the famous photograph of kitsch (literal horse-play, where the woman is depicted as treating the two men as beasts of burden – allows us to consider the role of ‘creaturely love’ in our more general understanding of the lover’s discourse. That is to say, through such images we can explore the role and figure of the animal within ‘the anthropological machine’, itself designed to produce a sense of the human from the inhuman (especially through mediated forms of intimacy. Further, in the different intermedial relationships between photography, poetry, and philosophy, the Centaur – in the letters and texts circulated by this group (later including Rilke – provides a charged specific totem for a libidinal ecology of souls, striving to understand themselves as simultaneously creaturely and spiritual. Such a figure allowed both a recognition and a disavowal of the nonhuman basis (and telos of human affections.

  1. Reflections on Centaur Upper Stage Integration by the NASA Lewis (Glenn) Research Center

    Science.gov (United States)

    Graham, Scott R.

    2014-01-01

    The NASA Glenn (then Lewis) Research Center (GRC) led several expendable launch vehicle (ELV) projects from 1963 to 1998, most notably the Centaur upper stage. These major, comprehensive projects included system management, system development, integration (both payload and stage), and launch operations. The integration role that GRC pioneered was truly unique and highly successful. Its philosophy, scope, and content were not just invaluable to the missions and vehicles it supported, but also had significant Agencywide benefits. An overview of the NASA Lewis Research Center (now the NASA Glenn Research Center) philosophy on ELV integration is provided, focusing on Atlas/Centaur, Titan/Centaur, and Shuttle/Centaur vehicles and programs. The necessity of having a stable, highly technically competent in-house staff is discussed. Significant depth of technical penetration of contractor work is another critical component. Functioning as a cohesive team was more than a concept: GRC senior management, NASA Headquarters, contractors, payload users, and all staff worked together. The scope, content, and history of launch vehicle integration at GRC are broadly discussed. Payload integration is compared to stage development integration in terms of engineering and organization. Finally, the transition from buying launch vehicles to buying launch services is discussed, and thoughts on future possibilities of employing the successful GRC experience in integrating ELV systems like Centaur are explored.

  2. Autonomous rendezvous and docking operations of unmanned expendable cargo transfer vehicles (e.g. Centaur) with Space Station Freedom

    Science.gov (United States)

    Emmet, Brian R.

    1991-01-01

    This paper describes the results of the feasibility study using Centaur or other CTV's to deliver payloads to the Space Station Freedom (SSF). During this study was examined the requirements upon unmanned cargo transfer stages (including Centaur) for phasing, rendezvous, proximity operations and docking/berthing (capture).

  3. The evolution of computer monitoring of real time data during the Atlas Centaur launch countdown

    Science.gov (United States)

    Thomas, W. F.

    1981-01-01

    In the last decade, improvements in computer technology have provided new 'tools' for controlling and monitoring critical missile systems. In this connection, computers have gradually taken a large role in monitoring all flights and ground systems on the Atlas Centaur. The wide body Centaur which will be launched in the Space Shuttle Cargo Bay will use computers to an even greater extent. It is planned to use the wide body Centaur to boost the Galileo spacecraft toward Jupiter in 1985. The critical systems which must be monitored prior to liftoff are examined. Computers have now been programmed to monitor all critical parameters continuously. At this time, there are two separate computer systems used to monitor these parameters.

  4. TNOs are Cool: A Survey of the Transneptunian Region: A Herschel-PACSview of 16 Centaurs

    CERN Document Server

    Duffard, R; Santos-Sanz, P; Vilenius, E; Ortiz, J L; Mueller, Th; Fornasier, S; Lellouch, E; Mommert, M; Pal, A; Kiss, C; Mueller, M; Stansberry, J; Delsanti, A; Peixinho, N; Trilling, D

    2013-01-01

    The goal of this work is to characterize a set of 16 Centaurs in terms of their size, albedo, and thermal properties. We study the correlations for a more extended sample, obtained from the literature, of diameter, albedo, orbital parameters and spectral slopes. We have done three-band photometric observations using Herschel/PACS and we use a consistent method for data reduction and aperture photometry of this sample to obtain monochromatic flux densities at 70, 100 and 160 $\\mu$m. Additionally, we use Spitzer/MIPS flux densities at 24 and 70 $\\mu$m when available. We also include the Centaurs sample observed only with Spitzer/MIPS and Scattered Disk Objects, a dynamical family of TNOs, presented in a previous work of the team. We have determined new radiometric sizes and albedos of 16 Centaurs. The first conclusion is that the albedo of the Centaurs is not determined by their orbit. Similarly we do not find any correlation between diameter and orbital parameters. We also find that most of the objects in our ...

  5. VizieR Online Data Catalog: Observations of 50 TNOs and Centaurs (Desmars+, 2015)

    Science.gov (United States)

    Desmars, J.; Camargo, J. I. B.; Braga-Ribas, F.; Vieira-Martins, R.; Assafin, M.; Vachier, F.; Colas, F.; Ortiz, J. L.; Duffard, R.; Morales, N.; Sicardy, B.; Gomes-Junior, A. R.; Benedetti-Rossi, G.

    2015-10-01

    The table provides 2895 ground-based observations of 50 trans-Neptunian objects and Centaurs performed between 2007 and 2014. The table contains the name of the observed TNO, the date of the observation, the topocentric ICRS coordinates of the object and the IAU observatory code. (1 data file).

  6. Orbit determination of Transneptunian objects and Centaurs for the prediction of stellar occultations

    CERN Document Server

    Desmars, J; Braga-Ribas, F; Vieira-Martins, R; Assafin, M; Vachier, F; Colas, F; Ortiz, J L; Duffard, R; Morales, N; Sicardy, B; Gomes-Júnior, A R; Benedetti-Rossi, G

    2015-01-01

    The prediction of stellar occultations by Transneptunian objects and Centaurs is a difficult challenge that requires accuracy both in the occulted star position as for the object ephemeris. Until now, the most used method of prediction involving tens of TNOs/Centaurs was to consider a constant offset for the right ascension and for the declination with respect to a reference ephemeris. This offset is determined as the difference between the most recent observations of the TNO and the reference ephemeris. This method can be successfully applied when the offset remains constant with time. This paper presents an alternative method of prediction based on a new accurate orbit determination procedure, which uses all the available positions of the TNO from the Minor Planet Center database plus sets of new astrometric positions from unpublished observations. The orbit determination is performed through a numerical integration procedure (NIMA), in which we develop a specific weighting scheme. The NIMA method was appli...

  7. Solar Panel Integration as an Alternate Power Source on Centaur 2 (SPIAPS)

    Science.gov (United States)

    Gebara, Christine A.; Schuetze, Nich A.; Knochel, Aviana M.; Magruder, Darby F.

    2011-01-01

    The dream of exploration has inspired thousands throughout time. Space exploration, in particular, has taken the past century by storm and caused a great advance in technology. In this project, a retractable solar panel array will be developed for use on the Centaur 2 Rover. Energy generated by the solar panels will go to power the Centaur 2 Robot (C2) or Regolith & Environment Science & Oxygen & Lunar Volatile Extraction (RESOLVE) payload, an in-situ resource utilization project. Such payload is designed to drill into lunar and Martian terrain as well as be able to conduct other geological testing; RESOLVE is slated for testing in 2012. Ultimately, this project will fit into NASA s larger goal of deep space exploration as well as long term presence outside Earth s orbit.

  8. Dynamical studies of Centaurs and their sources: interactions with the Main Belt

    Science.gov (United States)

    Galiazzo, Mattia; Carruba, Valerio; Wiegert, Paul

    2015-08-01

    Centaurs are objects whose orbits are found between those of the giant planets. Their main source is presumed to be the Trans-Neptunian objects (TNOs), and they are among the sources of Near-Earth Objects. Their dynamical evolution is heavily influenced by close encounters with giant planets and some of them were most likely scattered into their current orbits. After experiencing close encounters with the giant planets, Centaurs may have their eccentricity increased to values large enough to reach the main belt (aplan to investigate if close encounters with large (diameters larger than 100 km) outer Solar System bodies could have been responsible for the scattering of V-type asteroids from the Vesta family beyond the 3J:1 mean motion resonance, into the central and outer main belt.

  9. Carbonization in Titan Tholins: implication for low albedo on surfaces of Centaurs and trans-Neptunian objects

    Science.gov (United States)

    Giri, Chaitanya; McKay, Christopher P.; Goesmann, Fred; Schäfer, Nadine; Li, Xiang; Steininger, Harald; Brinckerhoff, William B.; Gautier, Thomas; Reitner, Joachim; Meierhenrich, Uwe J.

    2016-07-01

    Astronomical observations of Centaurs and trans-Neptunian objects (TNOs) yield two characteristic features - near-infrared (NIR) reflectance and low geometric albedo. The first feature apparently originates due to complex organic material on their surfaces, but the origin of the material contributing to low albedo is not well understood. Titan tholins synthesized to simulate aerosols in the atmosphere of Saturn's moon Titan have also been used for simulating the NIR reflectances of several Centaurs and TNOs. Here, we report novel detections of large polycyclic aromatic hydrocarbons, nanoscopic soot aggregates and cauliflower-like graphite within Titan tholins. We put forth a proof of concept stating the surfaces of Centaurs and TNOs may perhaps comprise of highly `carbonized' complex organic material, analogous to the tholins we investigated. Such material would apparently be capable of contributing to the NIR reflectances and to the low geometric albedos simultaneously.

  10. Orbit determination of trans-Neptunian objects and Centaurs for the prediction of stellar occultations

    Science.gov (United States)

    Desmars, J.; Camargo, J. I. B.; Braga-Ribas, F.; Vieira-Martins, R.; Assafin, M.; Vachier, F.; Colas, F.; Ortiz, J. L.; Duffard, R.; Morales, N.; Sicardy, B.; Gomes-Júnior, A. R.; Benedetti-Rossi, G.

    2015-12-01

    Context. The prediction of stellar occultations by trans-Neptunian objects (TNOs) and Centaurs is a difficult challenge that requires accuracy both in the occulted star position and in the object ephemeris. Until now, the most used method of prediction, involving dozens of TNOs/Centaurs, has been to consider a constant offset for the right ascension and for the declination with respect to a reference ephemeris, usually the latest public version. This offset is determined as the difference between the most recent observations of the TNO/Centaur and the reference ephemeris. This method can be successfully applied when the offset remains constant with time, i.e. when the orbit is stable enough. In this case, the prediction even holds for occultations that occur several days after the last observations. Aims: This paper presents an alternative method of prediction, based on a new accurate orbit determination procedure, which uses all the available positions of the TNO from the Minor Planet Center database, as well as sets of new astrometric positions from unpublished observations. Methods: Orbits were determined through a numerical integration procedure called NIMA, in which we developed a specific weighting scheme that considers the individual precision of the observation, the number of observations performed during one night by the same observatory, and the presence of systematic errors in the positions. Results: The NIMA method was applied to 51 selected TNOs and Centaurs. For this purpose, we performed about 2900 new observations in several observatories (European South Observatory, Observatório Pico dos Dias, Pic du Midi, etc.) during the 2007-2014 period. Using NIMA, we succeed in predicting the stellar occultations of 10 TNOs and 3 Centaurs between July 2013 and February 2015. By comparing the NIMA and Jet Propulsion Laboratory (JPL) ephemerides, we highlight the variation in the offset between them with time, by showing that, generally, the constant offset

  11. Pan-STARRS 1 observations of the unusual active Centaur P/2011 S1(Gibbs)

    International Nuclear Information System (INIS)

    P/2011 S1 (Gibbs) is an outer solar system comet or active Centaur with a similar orbit to that of the famous 29P/Schwassmann-Wachmann 1. P/2011 S1 (Gibbs) has been observed by the Pan-STARRS 1 (PS1) sky survey from 2010 to 2012. The resulting data allow us to perform multi-color studies of the nucleus and coma of the comet. Analysis of PS1 images reveals that P/2011 S1 (Gibbs) has a small nucleus <4 km radius, with colors g P1 – r P1 = 0.5 ± 0.02, r P1 – i P1 = 0.12 ± 0.02, and i P1 – z P1 = 0.46 ± 0.03. The comet remained active from 2010 to 2012, with a model-dependent mass-loss rate of ∼100 kg s–1. The mass-loss rate per unit surface area of P/2011 S1 (Gibbs) is as high as that of 29P/Schwassmann-Wachmann 1, making it one of the most active Centaurs. The mass-loss rate also varies with time from ∼40 kg s–1 to 150 kg s–1. Due to its rather circular orbit, we propose that P/2011 S1 (Gibbs) has 29P/Schwassmann-Wachmann 1-like outbursts that control the outgassing rate. The results indicate that it may have a similar surface composition to that of 29P/Schwassmann-Wachmann 1. Our numerical simulations show that the future orbital evolution of P/2011 S1 (Gibbs) is more similar to that of the main population of Centaurs than to that of 29P/Schwassmann-Wachmann 1. The results also demonstrate that P/2011 S1 (Gibbs) is dynamically unstable and can only remain near its current orbit for roughly a thousand years.

  12. Pan-STARRS 1 observations of the unusual active Centaur P/2011 S1(Gibbs)

    CERN Document Server

    Lin, H W; Lacerda, P; Ip, W H; Holman, M; Protopapas, P; Chen, W P; Burgett, W S; Chambers, K C; Flewelling, H; Huber, M E; Jedicke, R; Kaiser, N; Magnier, E A; Metcalfe, N; Price, P A

    2014-01-01

    P/2011 S1 (Gibbs) is an outer solar system comet or active Centaur with a similar orbit to that of the famous 29P/Schwassmann-Wachmann 1. P/2011 S1 (Gibbs) has been observed by the Pan-STARRS 1 (PS1) sky survey from 2010 to 2012. The resulting data allow us to perform multi-color studies of the nucleus and coma of the comet. Analysis of PS1 images reveals that P/2011 S1 (Gibbs) has a small nucleus $< 4$ km radius, with colors $g_{P1}-r_{P1} = 0.5 \\pm 0.02$, $r_{P1}-i_{P1} = 0.12 \\pm 0.02$ and $i_{P1}-z_{P1} = 0.46 \\pm 0.03$. The comet remained active from 2010 to 2012, with a model-dependent mass-loss rate of $\\sim100$ kg s$^{-1}$. The mass-loss rate per unit surface area of P/2011 S1 (Gibbs) is as high as that of 29P/Schwassmann-Wachmann 1, making it one of the most active Centaurs. The mass-loss rate also varies with time from $\\sim 40$ kg s$^{-1}$ to 150 kg s$^{-1}$. Due to its rather circular orbit, we propose that P/2011 S1 (Gibbs) has 29P/Schwassmann-Wachmann 1-like outbursts that control the outgass...

  13. Extra-red transneptunian objects and Centaurs: Composition and chemical history

    Science.gov (United States)

    Dalle Ore, C. M.; Barucci, M. A.; Cruikshank, D. P.; Emery, J. P.

    2014-07-01

    We present the results of a systematic analysis of the surface composition of ten of the reddest transneptunian objects (TNOs). The goal of the analysis is to determine the current chemical compositions of these extra-red objects and investigate possible paths of chemical evolution since formation. The sample consists of six objects from the classical and resonant populations, one detached object, and three Centaurs. The classical and resonant objects are expected to be similar to each other in composition, while the surfaces of the three Centaurs could have been significantly modified as their orbits evolved. Furthermore, Brown et al. (Brown, M.E., Schaller, E.L., & Fraser, W.C., 2011. A Hypothesis for the Color Diversity of the Kuiper Belt. ApJL, 739, L60) propose that objects with red color are rich in methanol. The available data consist of broad-band photometric measurements in the wavelength range between 0.3 and 4.5 μ m. The photometric measurements are scaled to the albedo at 0.55 μ m to yield an approximation of the spectral shape of each object that is then compared to a library of synthetic spectra of mixtures of materials known to be present on the surfaces of TNOs. Errors as well as phase-angle differences are taken into account as part of the fitting uncertainty. For each object, we obtain a range of compositions that match their spectral distribution within the estimated errors. This yields the likelihood for the various materials to be present on the surface as well as a rough measure of the uncertainty of the estimate. All objects show presence of methanol and/or methane on their surface, supporting the Brown et al. (2011) hypothesis. To further analyze our results, ices are grouped into 'stable' (H_2O), 'partially stable' (CH_3OH, CO_2), and 'volatile' (CH_4, CO, N_2). Our results show some difference in the amount of 'volatile' and 'partially stable' ices among the classical and resonant objects. A trend in the sense of less ice present on

  14. "TNOs are Cool": A survey of the trans-Neptunian region. XI. A Herschel-PACS view of 16 Centaurs

    Science.gov (United States)

    Duffard, R.; Pinilla-Alonso, N.; Santos-Sanz, P.; Vilenius, E.; Ortiz, J. L.; Mueller, T.; Fornasier, S.; Lellouch, E.; Mommert, M.; Pal, A.; Kiss, C.; Mueller, M.; Stansberry, J.; Delsanti, A.; Peixinho, N.; Trilling, D.

    2014-04-01

    Context. Centaurs are the transitional population between trans-Neptunian objects (TNOs) and Jupiter-family comets. Their physical properties provide an insight into TNO properties, but only under restricted conditions since Centaurs are closer to the Sun and Earth. For this reason it is possible to access the smaller ones, which is more difficult to do with the TNO population. Aims: The goal of this work is to characterize a set of 16 Centaurs in terms of their size, albedo, and thermal properties. We study the correlations, for a more extended sample obtained from the literature, of diameter, albedo, orbital parameters, and spectral slopes. Methods: We performed three-band photometric observations using Herschel-PACS and used a consistent method for the data reduction and aperture photometry of this sample to obtain monochromatic flux densities at 70, 100, and 160 μm. Additionally, we used Spitzer-MIPS flux densities at 24 and 70 μm when available. We also included in our Centaur sample scattered disk objects, a dynamical family of TNOs, using results previously published by our team, and some Centaurs observed only with the Spitzer-MIPS instrument. Results: We have determined new radiometric sizes and albedos of 16 Centaurs. The first conclusion is that the albedos of Centaur objects are not correlated with their orbital parameters. Similarly, there is no correlation between diameter and orbital parameters. Most of the objects in our sample are dark (pv< 7%) and most of them are small (D< 120 km). However, there is no correlation between albedo and diameter, in particular for the group of small objects as albedo values are homogeneously distributed between 4 to 16%. The correlation with the color of the objects showed that red objects are all small (mean diameter 65 km), while the gray ones span a wide range of sizes (mean diameter 120 km). Moreover, the gray objects tend to be darker, with a mean albedo of 5.6%, compared with a mean of 8.5% (ranging from 5 to

  15. Three Orbital Burns to Molniya Orbit Via Shuttle_Centaur G Upper Stage

    Science.gov (United States)

    Williams, Craig H.

    2015-01-01

    An unclassified analytical trajectory design, performance, and mission study was done for the 1982 to 1986 joint National Aeronautics and Space Administration (NASA)-United States Air Force (USAF) Shuttle/Centaur G upper stage development program to send performance-demanding payloads to high orbits such as Molniya using an unconventional orbit transfer. This optimized three orbital burn transfer to Molniya orbit was compared to the then-baselined two burn transfer. The results of the three dimensional trajectory optimization performed include powered phase steering data and coast phase orbital element data. Time derivatives of the orbital elements as functions of thrust components were evaluated and used to explain the optimization's solution. Vehicle performance as a function of parking orbit inclination was given. Performance and orbital element data was provided for launch windows as functions of launch time. Ground track data was given for all burns and coasts including variation within the launch window. It was found that a Centaur with fully loaded propellant tanks could be flown from a 37 deg inclination low Earth parking orbit and achieve Molniya orbit with comparable performance to the baselined transfer which started from a 57 deg inclined orbit: 9,545 versus 9,552 lb of separated spacecraft weight, respectively. There was a significant reduction in the need for propellant launch time reserve for a 1 hr window: only 78 lb for the three burn transfer versus 320 lb for the two burn transfer. Conversely, this also meant that longer launch windows over more orbital revolutions could be done for the same amount of propellant reserve. There was no practical difference in ground tracking station or airborne assets needed to secure telemetric data, even though the geometric locations of the burns varied considerably. There was a significant adverse increase in total mission elapsed time for the three versus two burn transfer (12 vs. 1-1/4 hr), but could be

  16. Three Orbital Burns to Molniya Orbit via Shuttle Centaur G Upper Stage

    Science.gov (United States)

    Williams, Craig H.

    2014-01-01

    An unclassified analytical trajectory design, performance, and mission study was done for the 1982-86 joint NASA-USAF Shuttle/Centaur G upper stage development program to send performance-demanding payloads to high orbits such as Molniya using an unconventional orbit transfer. This optimized three orbital burn transfer to Molniya orbit was compared to the then-baselined two burn transfer. The results of the three dimensional trajectory optimization performed include powered phase steering data and coast phase orbital element data. Time derivatives of the orbital elements as functions of thrust components were evaluated and used to explain the optimization's solution. Vehicle performance as a function of parking orbit inclination was given. Performance and orbital element data was provided for launch windows as functions of launch time. Ground track data was given for all burns and coasts including variation within the launch window. It was found that a Centaur with fully loaded propellant tanks could be flown from a 37deg inclination low Earth parking orbit and achieve Molniya orbit with comparable performance to the baselined transfer which started from a 57deg inclined orbit: 9,545 lb vs. 9,552 lb of separated spacecraft weight respectively. There was a significant reduction in the need for propellant launch time reserve for a one hour window: only 78 lb for the three burn transfer vs. 320 lb for the two burn transfer. Conversely, this also meant that longer launch windows over more orbital revolutions could be done for the same amount of propellant reserve. There was no practical difference in ground tracking station or airborne assets needed to secure telemetric data, even though the geometric locations of the burns varied considerably. There was a significant adverse increase in total mission elapsed time for the three vs. two burn transfer (12 vs. 11/4 hrs), but could be accommodated by modest modifications to Centaur systems. Future applications were

  17. Pan-STARRS 1 observations of the unusual active Centaur P/2011 S1(Gibbs)

    Energy Technology Data Exchange (ETDEWEB)

    Lin, H. W.; Ip, W. H.; Chen, W. P. [Institute of Astronomy, National Central University, Taoyuan 32001, Taiwan (China); Chen, Y. T. [Institute of Astronomy and Astrophysics, Academia Sinica, P.O. Box 23-141, Taipei 106, Taiwan (China); Lacerda, P. [Astrophysics Research Centre, School of Mathematics and Physics, Queens University Belfast, Belfast BT7 1NN (United Kingdom); Holman, M.; Protopapas, P. [Harvard-Smithsonian Center for Astrophysics, 60 Garden Street, Cambridge, MA 02138 (United States); Burgett, W. S.; Chambers, K. C.; Flewelling, H.; Huber, M. E.; Jedicke, R.; Kaiser, N.; Magnier, E. A.; Metcalfe, N. [Institute for Astronomy, University of Hawaii, 2680 Woodlawn Drive, Honolulu, HI 96822 (United States); Price, P. A., E-mail: edlin@gm.astro.ncu.edu.tw [Department of Astrophysical Sciences, Princeton University, Princeton, NJ 08544 (United States)

    2014-05-01

    P/2011 S1 (Gibbs) is an outer solar system comet or active Centaur with a similar orbit to that of the famous 29P/Schwassmann-Wachmann 1. P/2011 S1 (Gibbs) has been observed by the Pan-STARRS 1 (PS1) sky survey from 2010 to 2012. The resulting data allow us to perform multi-color studies of the nucleus and coma of the comet. Analysis of PS1 images reveals that P/2011 S1 (Gibbs) has a small nucleus <4 km radius, with colors g {sub P1} – r {sub P1} = 0.5 ± 0.02, r {sub P1} – i {sub P1} = 0.12 ± 0.02, and i {sub P1} – z {sub P1} = 0.46 ± 0.03. The comet remained active from 2010 to 2012, with a model-dependent mass-loss rate of ∼100 kg s{sup –1}. The mass-loss rate per unit surface area of P/2011 S1 (Gibbs) is as high as that of 29P/Schwassmann-Wachmann 1, making it one of the most active Centaurs. The mass-loss rate also varies with time from ∼40 kg s{sup –1} to 150 kg s{sup –1}. Due to its rather circular orbit, we propose that P/2011 S1 (Gibbs) has 29P/Schwassmann-Wachmann 1-like outbursts that control the outgassing rate. The results indicate that it may have a similar surface composition to that of 29P/Schwassmann-Wachmann 1. Our numerical simulations show that the future orbital evolution of P/2011 S1 (Gibbs) is more similar to that of the main population of Centaurs than to that of 29P/Schwassmann-Wachmann 1. The results also demonstrate that P/2011 S1 (Gibbs) is dynamically unstable and can only remain near its current orbit for roughly a thousand years.

  18. Solid rocket motor integration on the Atlas/Centaur launch vehicle

    Science.gov (United States)

    Arnett, Stephen E.

    1993-06-01

    The structural design, development, and verification testing required to integrate solid rocket motors (SRM) on the Atlas IIAS launch vehicle is described. It is concluded that the next generation Atlas Centaur based on four strap-on Castor IVA SRMs and capable of lifting 7700 pounds to geosynchronous orbit has undergone a rigorous development program. A new system intended to mount and jettison the SRMs from the core vehicle is characterized by robustness and ease of installation. To insulate the aft end of the vehicle against increased SRM-induced heat fluxes and to seal against ingress of potentially hazardous base gases extensive measures were undertaken. They include nonporous engine boots and a thrust section compartment passive pressurization system.

  19. The CENTAUR network contribution to the gene-based technology: Dissemination of information, international collaboration and training

    International Nuclear Information System (INIS)

    The CENTAUR Network (FAO Established Veterinary Biotechnology/Epidemiology Network for Central and Eastern Europe) is designed for cooperation and information of workers in state and regional veterinary directorates, veterinary practitioners, teachers from veterinary schools, advanced students, politicians specialized in agriculture, economy, science management, workers from diagnostic and research laboratories, breeders and other interested parties. It contributes to the use of the Internet, to the improvement of communication in English, to deepening of co-operation between workers with similar interests and to the better link with international organizations and internationally recognized centres of excellence. Formally, 23 countries officially belong to the CENTAUR network. However, in reality nearly one thousand CENTAUR network members are from the all continents. The membership is free and everybody can profit from all information offered. The CENTAUR is creating a protective belt for Central and Eastern European Countries especially those with the 'economies in transition' regarding the devastating Transboundary Animal Diseases such as bluetongue, foot and mouth disease and other vesicular diseases, rinderpest, peste des petits ruminants, contagious bovine pleuropneumonia, sheep and goat pox, classical swine fever, African swine fever, BSE/TSE, as well as other priority diseases and supports the prevention of a possible risk of biological terrorism. CENTAUR is based on the voluntary cooperation of countries concerned. The main task is to achieve compatibility of the disease control standards namely for better disease and contamination diagnosis and vaccine production, the modern computerized veterinary epidemiology and food safety and consumer protection with the OIE and EU international requirements. It is contributing to the accession of 8 Eastern European countries to the EU in 2004 and some other countries at a later stage. CENTAUR maintains in

  20. First ultraviolet reflectance measurements of several Kuiper Belt objects, Kuiper Belt object satellites, and new ultraviolet measurements of A Centaur

    Energy Technology Data Exchange (ETDEWEB)

    Stern, S. A.; Schindhelm, E. [Southwest Research Institute, 1050 Walnut Street, Boulder, CO 80302 (United States); Cunningham, N. J., E-mail: astern@swri.edu [Nebraska Wesleyan University, 5000 Saint Paul Avenue, Lincoln, NE 68504 (United States)

    2014-05-01

    We observed the 2600-3200 Å (hereafter, mid-UV) reflectance of two Kuiper Belt Objects (KBOs), two KBO satellites, and a Centaur, using the Hubble Space Telescope (HST) Cosmic Origins Spectrograph (COS). Other than measurements of the Pluto system, these constitute the first UV measurements obtained of KBOs, and KBO satellites, and new HST UV measurements of the Centaur 2060 Chiron. We find significant differences among these objects, constrain the sizes and densities of Haumea's satellites, and report the detection of a possible spectral absorption band in Haumea's spectrum near 3050 Å. Comparisons of these objects to previously published UV reflectance measurements of Pluto and Charon are also made here.

  1. HIV Transmission

    Science.gov (United States)

    ... Abroad Treatment Basic Statistics Get Tested Find an HIV testing site near you. Enter ZIP code or city Follow HIV/AIDS CDC HIV CDC HIV/AIDS See RSS | ... on HIV Syndicated Content Website Feedback HIV/AIDS HIV Transmission Language: English Español (Spanish) Recommend on Facebook ...

  2. Dense and narrow rings discovered around the Centaur object (10199) Chariklo

    Science.gov (United States)

    Sicardy, B.; Braga-Ribas, F.; Benedetti-Rossi, G.; Ligier, N.; Maquet, L.; Roques, F.; Leiva Espinoza, R.; El Moutamid, M.; Duffard, R.; Morales, N.; Ortiz, J. L.; Snodgrass, C.; Skottfelt, J.; Harpsøe, K.; Jørgensen, U. G.; Jehin, E.; Pollock, J.; Assafin, M.; Camargo, J.; Desmars, J.; Vieira-Martins, R.; Dumas, C.; Ivanov, V.; Maury, A.; Korhonen, H.; Leitzinger, M.

    2014-07-01

    A stellar occultation observed on June 3, 2013 revealed the unexpected presence of two dense rings around (10199) Chariklo [1], the largest Centaur object known to date with a radius of 124±9 km [2]. The two rings have respective orbital radii, widths, and normal optical depths of a_1= 391 km, W_1= 7 km, τ_1= 0.4 and a_2= 405 km, W_2= 3 km, τ_2= 0.06 [1]. They are separated by a gap of about 9 km with an optical depth less than 0.004 (1-sigma limit). The presence of those rings has been confirmed during another stellar occultation observed from ESO/NTT La Silla, ESO/VLT Paranal and San Pedro de Atacama on February 16, 2014. More results on the azimuthal variations of the rings and mass estimations of their putative shepherding satellites will be presented. This is the first ring system ever observed that does not pertain to a giant planet. The existence of such a system raises several questions as to the origin and evolution of rings around such a small object. This discovery also suggests that rings may be a more frequent feature than previously thought, in particular, around small bodies. Possible models for the ring formation will be proposed. They can be classified into collisional scenarios that disrupted an impactor or a pre-existing satellite, tidal disruption of an inward-migrating satellite, or material produced by a cometary activity of the central body.

  3. Physical properties of the extreme centaur and super-comet candidate 2013 AZ60

    CERN Document Server

    Pál, A; Horner, J; Szakáts, R; Vilenius, E; Müller, Th G; Acosta-Pulido, J; Licandro, J; Cabrera-Lavers, A; Sárneczky, K; Szabó, Gy M; Thirouin, A; Sipőcz, B; Dózsa, Á; Duffard, R

    2015-01-01

    We present estimates of the basic physical properties -- including size and albedo -- of the extreme Centaur 2013 AZ60. These properties have been derived from optical and thermal infrared measurements. Our optical measurements revealed a likely full period of ~9.4 h with a shallow amplitude of 4.5%. By combining optical brightness information and thermal emission data, we are able to derive a diameter of 62.3 +/- 5.3 km and a geometric albedo of 2.9% -- corresponding to an extremely dark surface. Additionally, our finding of ~> 50 Jm^{-2}K^{-1}s^{-1/2} for the thermal inertia is also noticeably for objects in such a distance. The results of dynamical simulations yield an unstable orbit, with a 50% probability that the target will be ejected from the Solar System within 700,000 years. The current orbit of this object as well as its instability could imply a pristine cometary surface. This possibility is in agreement with the observed low geometric albedo and red photometric colour indices for the object, whic...

  4. Capillary acquisition devices for high-performance vehicles: Executive summary. [evaluation of cryogenic propellant management techniques using the centaur launch vehicle

    Science.gov (United States)

    Blatt, M. H.; Bradshaw, R. D.; Risberg, J. A.

    1980-01-01

    Technology areas critical to the development of cryogenic capillary devices were studied. Passive cooling of capillary devices was investigated with an analytical and experimental study of wicking flow. Capillary device refilling with settled fluid was studied using an analytical and experimental program that resulted in successful correlation of a versatile computer program with test data. The program was used to predict Centaur D-1S LO2 and LH2 start basket refilling. Comparisons were made between the baseline Centaur D-1S propellant feed system and feed system alternatives including systems using capillary devices. The preferred concepts from the Centaur D-1S study were examined for APOTV and POTV vehicles for delivery and round trip transfer of payloads between LEO and GEO. Mission profiles were determined to provide propellant usage timelines and the payload partials were defined.

  5. The Self And Beyond: A Reading of The Fixer, The Centaur, And Henderson The Rain King The Self And Beyond: A Reading of The Fixer, The Centaur, And Henderson The Rain King

    Directory of Open Access Journals (Sweden)

    Susana Bornéo Funck

    2009-09-01

    Full Text Available Toward the end of the three novels I'm going to discuss, the protagonists make the following statements. Eugene penderson, in Bellow's Henderson the Rain Xing, days: "Whatever gains I ever made were always due to love and nothing else." In Updike's The Centaur, George Caldwell realizes that "Only goodness lives. But it does live." And Yakov Bok in Malamud's The Fixer recognizes that "There's no such a thing as an unpolitical man." Isolated though they may be from the contexts in which they appear, these statements summarize appropriately enough the lessons learned by the three protagonists after periods of intense doubts and suffering. Toward the end of the three novels I'm going to discuss, the protagonists make the following statements. Eugene penderson, in Bellow's Henderson the Rain Xing, days: "Whatever gains I ever made were always due to love and nothing else." In Updike's The Centaur, George Caldwell realizes that "Only goodness lives. But it does live." And Yakov Bok in Malamud's The Fixer recognizes that "There's no such a thing as an unpolitical man." Isolated though they may be from the contexts in which they appear, these statements summarize appropriately enough the lessons learned by the three protagonists after periods of intense doubts and suffering.

  6. Formation of diverse ring-satellite systems around Centaurs through tidal disruption at close encounters with giant planet

    CERN Document Server

    Hyodo, Ryuki; Genda, Hidenori; Ohtsuki, Keiji

    2016-01-01

    Centaurs are minor planets orbiting between Jupiter and Neptune that have or had crossing orbits with one or more giant planets. Recent observations and reinterpretation of previous observations have revealed the existence of ring systems around 10199 Chariklo and 2060 Chiron. However, the origin of the ring systems around such a minor planet is still an open question. Here, we propose that the tidal disruption of a differentiated object that experiences a close encounter with a giant planet could naturally form diverse ring-satellite systems around the Centaurs. During the close encounter, the icy mantle of the passing object is preferentially ripped off by the planet's tidal force and the debris is distributed mostly within the Roche limit of the largest remnant body. Assuming the existence of $20-50$wt% silicate core below the icy mantle, a disk of particles is formed when the objects pass within $0.4-0.8$ of the planet's Roche limit with the relative velocity at infinity $3-6$km s$^{-1}$ and 8h initial sp...

  7. HIV Symptoms

    Science.gov (United States)

    ... Submit Home > HIV/AIDS > What is HIV/AIDS? HIV/AIDS This information in Spanish ( en español ) HIV symptoms Photo courtesy of AIDS.gov More information ... and brain Return to top More information on HIV symptoms Explore other publications and websites Basic Information ...

  8. HIV Testing

    Science.gov (United States)

    ... Abroad Treatment Basic Statistics Get Tested Find an HIV testing site near you. Enter ZIP code or city Follow HIV/AIDS CDC HIV CDC HIV/AIDS See RSS | ... All Collapse All Should I get tested for HIV? CDC recommends that everyone between the ages of ...

  9. Discovery of A New Retrograde Trans-Neptunian Object: Hint of A Common Orbital Plane for Low Semi-Major Axis, High Inclination TNOs and Centaurs

    CERN Document Server

    Chen, Ying-Tung; Holman, Matthew J; Payne, Matthew J; Fraser, Wesley C; Lacerda, Pedro; Ip, Wing-Huen; Chen, Wen-Ping; Kudritzki, Rolf-Peter; Jedicke, Robert; Wainscoat, Richard J; Tonry, John L; Magnier, Eugene A; Waters, Christopher; Kaiser, Nick; Wang, Shiang-Yu; Lehner, Matthew

    2016-01-01

    Although the majority of Centaurs are thought to have originated in the scattered disk, with the high-inclination members coming from the Oort cloud, the origin of the high inclination component of trans-Neptunian objects (TNOs) remains uncertain. We report the discovery of a retrograde TNO, which we nickname "Niku", detected by the Pan-STARRS 1 Outer Solar System Survey. Our numerical integrations show that the orbital dynamics of Niku are very similar to that of 2008 KV$_{42}$ (Drac), with a half-life of $\\sim 500$ Myr. Comparing similar high inclination TNOs and Centaurs ($q > 10$ AU, $a 60^\\circ$), we find that these objects exhibit a surprising clustering of ascending node, and occupy a common orbital plane. This orbital configuration has high statistical significance: 3.8-$\\sigma$. An unknown mechanism is required to explain the observed clustering. This discovery may provide a pathway to investigate a possible reservoir of high-inclination objects.

  10. The Dynamics of Centaurs in the Vicinity of the 2:1 Mean Motion Resonance of Neptune and Uranus Trojan Region

    CERN Document Server

    Wood, Jeremy

    2015-01-01

    In this work we present the results of a suite of dynamical simulations following the orbital evolution of 8,022 hypothetical Centaur objects. These Centaurs begin our integrations on orbits in the vicinity of the 2:1 mean motion resonance with Neptune, and we follow their dynamical evolution for a period of 3 Myr under the gravitational influence of a motionless Sun and the four Jovian planets. The great majority of the test particles studied rapidly escaped from the vicinity of the 2:1 mean motion resonance of Neptune and diffused throughout the Solar System. The average libration time of Centaurs in the vicinity of 2:1 mean motion resonance of Neptune was found to be just 27 kyr. Although two particles did remain near the resonance for more than 1 Myr. Upon leaving the vicinity of the 2:1 resonance, the majority of test particles evolved by a process of random walk in semi-major axis, due to repeated close encounters with the giant planets.

  11. Women and HIV

    Science.gov (United States)

    ... Consumer Information by Audience For Women Women and HIV Share Tweet Linkedin Pin it More sharing options ... HIV? What should pregnant women know about HIV? HIV Quick Facts What is HIV? HIV is the ...

  12. HIV Prevention

    Science.gov (United States)

    ... PrEP PEP Living With HIV Opportunistic Infections Travel Abroad Treatment Basic Statistics Get Tested Find an HIV ... kill or neutralize viruses and bacteria. Researchers are studying both vaginal and rectal microbicides to see if ...

  13. Photometry of Centaurs and trans-Neptunian objects: 2060 Chiron (1977 UB), 10199 Chariklo (1997 CU26), 38628 Huya (2000 EB173), 28978 Ixion (2001 KX76), and 90482 Orcus (2004 DW)

    CERN Document Server

    Galiazzo, Mattia; Marcos, Raul de la Fuente; Carraro, Giovanni; Maris, Michele; Montalto, Marco

    2016-01-01

    Both Centaurs and trans-Neptunian objects (TNOs) are minor bodies found in the outer Solar System. Centaurs are a transient population that moves between the orbits of Jupiter and Neptune, and they probably diffused out of the TNOs. TNOs move mainly beyond Neptune. Some of these objects display episodic cometary behaviour; a few percent of them are known to host binary companions. Here, we study the light-curves of two Centaurs -2060 Chiron (1977 UB) and 10199 Chariklo (1997 CU26)- and three TNOs -38628 Huya (2000 EB173), 28978 Ixion (2001 KX76), and 90482 Orcus (2004 DW)- and the colours of the Centaurs and Huya. Precise, ~1%, R-band absolute CCD photometry of these minor bodies acquired between 2006 and 2011 is presented; the new data are used to investigate the rotation rate of these objects. The colours of the Centaurs and Huya are determined using BVRI photometry. The point spread function of the five minor bodies is analysed, searching for signs of a coma or close companions. Astrometry is also discusse...

  14. HIV Treatment: The Basics

    Science.gov (United States)

    HIV Treatment HIV Treatment: The Basics (Last updated 3/1/2016; last reviewed 3/1/2016) Key Points Antiretroviral therapy (ART) ... reduces the risk of HIV transmission . How do HIV medicines work? HIV attacks and destroys the infection- ...

  15. HIV Prevention

    Centers for Disease Control (CDC) Podcasts

    2012-02-01

    Dr. Kevin Fenton, Director of CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, talks about steps people can take to protect their health from HIV.  Created: 2/1/2012 by National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP).   Date Released: 2/1/2012.

  16. Get Tested for HIV

    Science.gov (United States)

    ... Submit Home > HIV/AIDS > Get tested for HIV HIV/AIDS This information in Spanish ( en español ) Get tested for HIV When should I get tested for HIV? Types ... to top More information on Get tested for HIV Explore other publications and websites HIV Anonymous Testing, ...

  17. The Diverse Solar Phase Curves of Distant Icy Bodies. Part I: Photometric Observations of 18 Trans-Neptunian Objects, 7 Centaurs, and Nereid

    CERN Document Server

    Rabinowitz1, D L; Tourtellotte3, S W; Rabinowitz1, David L.; Schaefer2, Bradley E.; Tourtellotte3, Suzanne W.

    2006-01-01

    We have measured the solar phase curves in B, V, and I for 18 Trans-Neptunian Objects, 7 Centaurs, and Nereid and determined the rotation curves for 10 of these targets. For each body, we have made ~100 observations uniformly spread over the entire visible range. We find that all the targets except Nereid have linear phase curves at small phase angles ( 3 deg, the Centaurs (54598) Bienor and (32532) Thereus have phase curves that flatten. The recently discovered Pluto-scale bodies (2003 UB313, 2005 FY9, and 2003 EL61), like Pluto, have neutral colors compared to most TNOs and small phase coefficients (< 0.1 mag/deg). Together these two properties are a likely indication for large TNOs of high-albedo, freshly coated icy surfaces. We find several bodies with significantly wavelength-dependent phase curves. The TNOs (50000) Quaoar, (120348) 2004 TY364 (47932), and 2000 GN171 have unusually high I-band phase coefficients (0.290+/-0.038, 0.413+/-0.064, 0.281+/-0.033 mag/deg, respectively) and much lower coeffic...

  18. Discovery of a New Retrograde Trans-Neptunian Object: Hint of a Common Orbital Plane for Low Semimajor Axis, High-inclination TNOs and Centaurs

    Science.gov (United States)

    Chen, Ying-Tung; Lin, Hsing Wen; Holman, Matthew J.; Payne, Matthew J.; Fraser, Wesley C.; Lacerda, Pedro; Ip, Wing-Huen; Chen, Wen-Ping; Kudritzki, Rolf-Peter; Jedicke, Robert; Wainscoat, Richard J.; Tonry, John L.; Magnier, Eugene A.; Waters, Christopher; Kaiser, Nick; Wang, Shiang-Yu; Lehner, Matthew

    2016-08-01

    Although the majority of Centaurs are thought to have originated in the scattered disk, with the high-inclination members coming from the Oort cloud, the origin of the high-inclination component of trans-Neptunian objects (TNOs) remains uncertain. We report the discovery of a retrograde TNO, which we nickname “Niku,” detected by the Pan-STARRS 1 Outer Solar System Survey. Our numerical integrations show that the orbital dynamics of Niku are very similar to that of 2008 KV42 (Drac), with a half-life of ˜500 Myr. Comparing similar high-inclination TNOs and Centaurs (q > 10 au, a 60°), we find that these objects exhibit a surprising clustering of ascending node, and occupy a common orbital plane. This orbital configuration has high statistical significance: 3.8-σ. An unknown mechanism is required to explain the observed clustering. This discovery may provide a pathway to investigating a possible reservoir of high-inclination objects.

  19. HIV/AIDS

    Science.gov (United States)

    HIV stands for human immunodeficiency virus. It harms your immune system by destroying the white blood cells ... It is the final stage of infection with HIV. Not everyone with HIV develops AIDS. HIV most ...

  20. HIV and Pregnancy

    Science.gov (United States)

    ... Management Education & Events Advocacy For Patients About ACOG HIV and Pregnancy Home For Patients Search FAQs HIV ... HIV and Pregnancy FAQ113, December 2012 PDF Format HIV and Pregnancy Pregnancy What is human immunodeficiency virus ( ...

  1. HIV Medication Adherence

    Science.gov (United States)

    HIV Treatment HIV Medication Adherence (Last updated 3/1/2016; last reviewed 3/1/2016) Key Points Medication adherence means sticking ... exactly as prescribed. Why is adherence to an HIV regimen important? Adherence to an HIV regimen gives ...

  2. HIV and Rheumatic Disease

    Science.gov (United States)

    ... A Patient / Caregiver Diseases & Conditions HIV & Rheumatic Diseases HIV and Rheumatic Disease Fast Facts Rheumatic diseases related ... knows he or she has HIV. What are HIV-associated rheumatic diseases? Some diseases of the joints ...

  3. HIV and AIDS

    Science.gov (United States)

    ... Got Homework? Here's Help White House Lunch Recipes HIV and AIDS KidsHealth > For Kids > HIV and AIDS ... actually the virus that causes the disease AIDS. HIV Hurts the Immune System People who are HIV ...

  4. HIV Antibody Test

    Science.gov (United States)

    ... be limited. Home Visit Global Sites Search Help? HIV Antibody and HIV Antigen (p24) Share this page: Was this page helpful? Also known as: HIV Screening Tests; AIDS Test; AIDS Screen; HIV Serology; ...

  5. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... of HIV in the United States, please visit: https://www.aids.gov/hiv-aids-basics/hiv-aids- ... HIV, STD, and TB Prevention. What Is HIV? ( http://www.cdc.gov/hiv/pubs/faq/faq1.htm ). ...

  6. Screening and diagnosis for HIV

    Science.gov (United States)

    HIV testing; HIV screening; HIV screening test; HIV confirmatory test ... A positive result on a screening test does not confirm that the person has HIV infection. More tests are needed to confirm HIV infection. A negative test ...

  7. HIV among Women

    Science.gov (United States)

    ... VIH En Español Get Tested Find an HIV testing site near you. Enter ZIP code or city Follow HIV/AIDS CDC HIV CDC HIV/AIDS See RSS | ... Email Updates on HIV Syndicated Content Website Feedback HIV Among Women Language: English Español (Spanish) Format: Select ...

  8. HIV Life Cycle

    Science.gov (United States)

    HIV Overview The HIV Life Cycle (Last updated 9/22/2015; last reviewed 9/22/2015) Key Points HIV gradually destroys the immune ... life cycle. What is the connection between the HIV life cycle and HIV medicines? Antiretroviral therapy (ART) ...

  9. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... help us Send the Message . Get the Facts What are HIV and AIDS? HIV (human immunodeficiency virus) ... National Center for HIV, STD, and TB Prevention. What Is HIV? ( http://www.cdc.gov/hiv/pubs/ ...

  10. Basic HIV/AIDS Statistics

    Science.gov (United States)

    ... HIV Syndicated Content Website Feedback HIV/AIDS Basic Statistics Language: English Español (Spanish) Recommend on Facebook Tweet ... HIV. Interested in learning more about CDC's HIV statistics? Terms, Definitions, and Calculations Used in CDC HIV ...

  11. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... HIV in the United States, please visit: https://www.aids.gov/hiv-aids-basics/hiv-aids-101/ ... STD, and TB Prevention. What Is HIV? ( http://www.cdc.gov/hiv/pubs/faq/faq1.htm ). Atlanta, ...

  12. How HIV Causes AIDS

    Science.gov (United States)

    ... Share this: Main Content Area How HIV Causes AIDS HIV destroys CD4 positive (CD4+) T cells, which ... and disease, ultimately resulting in the development of AIDS. Most people who are infected with HIV can ...

  13. HIV and Immunizations

    Science.gov (United States)

    HIV Treatment HIV and Immunizations (Last updated 3/1/2016; last reviewed 3/1/2016) Key Points Vaccines are products that ... a disease outbreak. Is there a vaccine against HIV? Testing is underway on experimental vaccines to prevent ...

  14. HIV-AIDS Connection

    Science.gov (United States)

    ... Content Marketing Share this: Main Content Area The HIV-AIDS Connection AIDS was first recognized in 1981 ... cancers. Why is there overwhelming scientific consensus that HIV causes AIDS? Before HIV infection became widespread in ...

  15. Women and HIV

    Science.gov (United States)

    ... on HIV testing. Gynecological problems can be early signs of HIV infection . Ulcers in the vagina, persistent yeast infections, and severe pelvic inflammatory disease (PID) can be signs of HIV. Hormone changes, birth control pills, or antibiotics can ...

  16. HIV/AIDS

    Science.gov (United States)

    HIV stands for human immunodeficiency virus. It kills or damages the body's immune system cells. AIDS stands ... is the most advanced stage of infection with HIV. HIV most often spreads through unprotected sex with ...

  17. Preventing HIV with Medicine

    Science.gov (United States)

    ... HIV/AIDS This information in Spanish ( en español ) Preventing HIV with medicine Get medicine right after you ... during sex. Return to top More information on Preventing HIV with medicine Explore other publications and websites ...

  18. Psychotropic prescribing in HIV

    OpenAIRE

    Reid, E; Orrell, C.; K Stoloff; Joska, J.

    2012-01-01

    Psychiatric disorders frequently co-occur with HIV, as preceding conditions or consequent to HIV infection. This potentially compromises HIV diagnosis and antiretroviral (ARV) treatment adherence. We provide a brief guide to the diagnosis and treatment of common mental disorders in people living with HIV/AIDS, including: prescribing psychotropics in HIV; neuropsychiatric side-effects of ARVs and other medications commonly prescribed in HIV; and the diagnosis and treatment of depression, anxie...

  19. National HIV Testing Day

    Centers for Disease Control (CDC) Podcasts

    2011-06-09

    Dr. Kevin A. Fenton, Director of CDC's National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, discusses National HIV Testing Day, an annual observance which raises awareness of the importance of knowing one's HIV status and encourages at-risk individuals to get an HIV test.  Created: 6/9/2011 by National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP).   Date Released: 6/9/2011.

  20. Eliminating Perinatal HIV Transmission

    Centers for Disease Control (CDC) Podcasts

    2012-11-26

    In this podcast, CDC’s Dr. Steve Nesheim discusses perinatal HIV transmission, including the importance of preventing HIV among women, preconception care, and timely HIV testing of the mother. Dr. Nesheim also introduces the revised curriculum Eliminating Perinatal HIV Transmission intended for faculty of OB/GYN and pediatric residents and nurse midwifery students.  Created: 11/26/2012 by Division of HIV/AIDS Prevention.   Date Released: 11/26/2012.

  1. Side Effects of HIV Medicines: HIV and Lactic Acidosis

    Science.gov (United States)

    ... HIV medicines. All HIV medicines in the nucleoside reverse transcriptase inhibitor (NRTI) drug class may cause lactic acidosis, but ... some HIV medicines. HIV medicines in the nucleoside reverse transcriptase inhibitor (NRTI) drug class can cause the body to ...

  2. Doctors Report Groundbreaking HIV-To-HIV Organ Transplants

    Science.gov (United States)

    ... html Doctors Report Groundbreaking HIV-to-HIV Organ Transplants One donor supplied a kidney to one patient ... 30, 2016 (HealthDay News) -- Trailblazing liver and kidney transplants from an HIV-positive donor to HIV-positive ...

  3. HIV / AIDS: An Unequal Burden

    Science.gov (United States)

    Skip Navigation Bar Home Current Issue Past Issues HIV / AIDS HIV / AIDS: An Unequal Burden Past Issues / Summer 2009 ... high-risk category, emphasizes Dr. Cargill. Photo: iStock HIV and Pregnancy Are there ways to help HIV- ...

  4. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... Drugs and HIV Learn the Link - Drugs and HIV Email Facebook Twitter 2005 –Ongoing Behaviors associated with ... Send the Message . Get the Facts What are HIV and AIDS? HIV (human immunodeficiency virus) is the ...

  5. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... transmitting HIV/AIDS or other infectious diseases. Research Reports: HIV/AIDS : Explores the link between drug abuse ... access to the latest, federally approved HIV/AIDS medical practice guidelines, HIV treatment and prevention clinical trials, ...

  6. Photometry of Centaurs and trans-Neptunian objects: 2060 Chiron (1977 UB), 10199 Chariklo (1997 CU26), 38628 Huya (2000 EB173), 28978 Ixion (2001 KX76), and 90482 Orcus (2004 DW)

    Science.gov (United States)

    Galiazzo, M.; de la Fuente Marcos, C.; de la Fuente Marcos, R.; Carraro, G.; Maris, M.; Montalto, M.

    2016-07-01

    Both Centaurs and trans-Neptunian objects (TNOs) are minor bodies found in the outer Solar System. Centaurs are a transient population that moves between the orbits of Jupiter and Neptune, and they probably diffused out of the TNOs. TNOs move mainly beyond Neptune. Some of these objects display episodic cometary behaviour; a few percent of them are known to host binary companions. Here, we study the light-curves of two Centaurs—2060 Chiron (1977 UB) and 10199 Chariklo (1997 CU26)—and three TNOs—38628 Huya (2000 EB173), 28978 Ixion (2001 KX76), and 90482 Orcus (2004 DW)—and the colours of the Centaurs and Huya. Precise, ˜1~%, R-band absolute CCD photometry of these minor bodies acquired between 2006 and 2011 is presented; the new data are used to investigate the rotation rate of these objects. The colours of the Centaurs and Huya are determined using BVRI photometry. The point spread function of the five minor bodies is analysed, searching for signs of a coma or close companions. Astrometry is also discussed. A periodogram analysis of the light-curves of these objects gives the following rotational periods: 5.5±0.4~h for Chiron, 7.0± 0.6~h for Chariklo, 4.45±0.07~h for Huya, 12.4±0.3~h for Ixion, and 11.9±0.5~h for Orcus. The colour indices of Chiron are found to be B-V=0.53±0.05, V-R=0.37±0.08, and R-I=0.36±0.15. The values computed for Chariklo are V-R=0.62±0.07 and R-I=0.61±0.07. For Huya, we find V-R=0.58±0.09 and R-I=0.64±0.20. Our rotation periods are similar to and our colour values are consistent with those already published for these objects. We find very low levels of cometary activity (if any) and no sign of close or wide binary companions for these minor bodies.

  7. Psychotropic prescribing in HIV

    Directory of Open Access Journals (Sweden)

    E Reid

    2012-11-01

    Full Text Available Psychiatric disorders frequently co-occur with HIV, as preceding conditions or consequent to HIV infection. This potentially compromises HIV diagnosis and antiretroviral (ARV treatment adherence. We provide a brief guide to the diagnosis and treatment of common mental disorders in people living with HIV/AIDS, including: prescribing psychotropics in HIV; neuropsychiatric side-effects of ARVs and other medications commonly prescribed in HIV; and the diagnosis and treatment of depression, anxiety, psychosis, agitation, sleep disturbance, pain, and mania. Psychotropic treatments recommended were drawn primarily from those available in the public sector of South Africa.

  8. Therapeutic HIV Peptide Vaccine

    DEFF Research Database (Denmark)

    Fomsgaard, Anders

    2015-01-01

    Therapeutic vaccines aim to control chronic HIV infection and eliminate the need for lifelong antiretroviral therapy (ART). Therapeutic HIV vaccine is being pursued as part of a functional cure for HIV/AIDS. We have outlined a basic protocol for inducing new T cell immunity during chronic HIV-1...... infection directed to subdominant conserved HIV-1 epitopes restricted to frequent HLA supertypes. The rationale for selecting HIV peptides and adjuvants are provided. Peptide subunit vaccines are regarded as safe due to the simplicity, quality, purity, and low toxicity. The caveat is reduced immunogenicity...

  9. HIV/AIDS Basics

    Science.gov (United States)

    ... Providers Prevention Resources Newsletter Get Tested Find an HIV testing site near you. Enter ZIP code or ... AIDS Get Email Updates on AAA Anonymous Feedback HIV/AIDS Media Infographics Syndicated Content Podcasts Slide Sets ...

  10. Pregnancy and HIV

    Science.gov (United States)

    ... 17, 2014 Select a Language: Fact Sheet 611 Pregnancy and HIV HOW DO BABIES GET AIDS? HOW CAN WE ... doses due to nausea and vomiting during early pregnancy, giving HIV a chance to develop resistance The risk of ...

  11. HIV Resistance Testing

    Science.gov (United States)

    ... 14, 2016 Select a Language: Fact Sheet 126 HIV Resistance Testing WHAT IS RESISTANCE? HOW DOES RESISTANCE ... ARVs. If you miss doses of your medications, HIV will multiply more easily. More mutations will occur. ...

  12. Hepatitis B and HIV

    Science.gov (United States)

    ... Hospitalization and Palliative Care Friends & Family Dating and Marriage Family Planning Mixed-Status Couples Discrimination Legal Issues ... National HIV/AIDS and Aging Awareness Day National Gay Men's HIV/AIDS Awareness Day National Latino AIDS ...

  13. Children and HIV

    Science.gov (United States)

    ... Hospitalization and Palliative Care Friends & Family Dating and Marriage Family Planning Mixed-Status Couples Discrimination Legal Issues ... National HIV/AIDS and Aging Awareness Day National Gay Men's HIV/AIDS Awareness Day National Latino AIDS ...

  14. Hepatitis A and HIV

    Science.gov (United States)

    ... Hospitalization and Palliative Care Friends & Family Dating and Marriage Family Planning Mixed-Status Couples Discrimination Legal Issues ... National HIV/AIDS and Aging Awareness Day National Gay Men's HIV/AIDS Awareness Day National Latino AIDS ...

  15. HIV Treatment Adherence

    Science.gov (United States)

    ... Hospitalization and Palliative Care Friends & Family Dating and Marriage Family Planning Mixed-Status Couples Discrimination Legal Issues ... National HIV/AIDS and Aging Awareness Day National Gay Men's HIV/AIDS Awareness Day National Latino AIDS ...

  16. Stages of HIV Infection

    Science.gov (United States)

    ... Hospitalization and Palliative Care Friends & Family Dating and Marriage Family Planning Mixed-Status Couples Discrimination Legal Issues ... National HIV/AIDS and Aging Awareness Day National Gay Men's HIV/AIDS Awareness Day National Latino AIDS ...

  17. Hepatitis C and HIV

    Science.gov (United States)

    ... Hospitalization and Palliative Care Friends & Family Dating and Marriage Family Planning Mixed-Status Couples Discrimination Legal Issues ... National HIV/AIDS and Aging Awareness Day National Gay Men's HIV/AIDS Awareness Day National Latino AIDS ...

  18. Testing for HIV

    Science.gov (United States)

    ... Medical Devices Radiation-Emitting Products Vaccines, Blood & Biologics Animal & Veterinary Cosmetics Tobacco Products Vaccines, Blood & Biologics Home Vaccines, Blood & Biologics Safety & Availability (Biologics) HIV Home Test Kits Testing for HIV Share Tweet Linkedin Pin it More ...

  19. Smoking and HIV

    Science.gov (United States)

    ... 28, 2014 Select a Language: Fact Sheet 803 Smoking and HIV WHY IS SMOKING MORE DANGEROUS FOR ... It can also worsen liver problems like hepatitis. Smoking and Side Effects People with HIV who smoke ...

  20. Exercise and HIV

    Science.gov (United States)

    ... HIV WHY IS EXERCISE IMPORTANT? WHAT ARE THE ADVANTAGES OF EXERCISE? WHAT ARE THE RISKS OF EXERCISE? ... healthier while ageing with HIV. WHAT ARE THE ADVANTAGES OF EXERCISE? Regular, moderate exercise has many of ...

  1. Periodontitis in HIV patients

    OpenAIRE

    Oseeva А.О.; Soboleva L.A.; Bulkina N.V.; Shuldyakov A.A.

    2011-01-01

    The article presents the study of formation mechanisms and periodontitis course in patients with subclinical stage of HIV-infection. The examination of 45 patients has enabled the division of patients into three basic groups: patients with periodontitis and HIV-infection; patients with periodontitis; and HIV patients without periodontitis. It has been determined that the patients with periodontitis and subclinical HIV-infection have developed local inflammatory reaction with infection, activa...

  2. HIV and AIDS

    Science.gov (United States)

    ... are at greater risk for getting HIV during sex with infected partners. If a woman with HIV is pregnant, her newborn baby can catch the virus from her before birth, during the birthing process, or from breastfeeding. When doctors know a mom-to-be has HIV, they can do things ...

  3. Tuberculosis and HIV Coinfection.

    Science.gov (United States)

    Bruchfeld, Judith; Correia-Neves, Margarida; Källenius, Gunilla

    2015-07-01

    Tuberculosis (TB) and human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) constitute the main burden of infectious disease in resource-limited countries. In the individual host, the two pathogens, Mycobacterium tuberculosis and HIV, potentiate one another, accelerating the deterioration of immunological functions. In high-burden settings, HIV coinfection is the most important risk factor for developing active TB, which increases the susceptibility to primary infection or reinfection and also the risk of TB reactivation for patients with latent TB. M. tuberculosis infection also has a negative impact on the immune response to HIV, accelerating the progression from HIV infection to AIDS. The clinical management of HIV-associated TB includes the integration of effective anti-TB treatment, use of concurrent antiretroviral therapy (ART), prevention of HIV-related comorbidities, management of drug cytotoxicity, and prevention/treatment of immune reconstitution inflammatory syndrome (IRIS). PMID:25722472

  4. HIV Medicines and Side Effects

    Science.gov (United States)

    Side Effects of HIV Medicines HIV Medicines and Side Effects (Last updated 1/7/2016; last reviewed 1/7/2016) Key Points HIV medicines help people with ... will depend on a person’s individual needs. Can HIV medicines cause side effects? HIV medicines help people ...

  5. HIV/AIDS and Alcohol

    Science.gov (United States)

    ... Psychiatric Disorders Other Substance Abuse HIV/AIDS HIV/AIDS Human immunodeficiency virus (HIV) targets the body’s immune ... and often leads to acquired immune deficiency syndrome (AIDS). Each year in the United States, between 55, ...

  6. HIV, AIDS, and the Future

    Science.gov (United States)

    Skip Navigation Bar Home Current Issue Past Issues HIV / AIDS HIV, AIDS, and the Future Past Issues / Summer 2009 ... turn Javascript on. Photo: The NAMES Project Foundation HIV and AIDS are a global catastrophe. While advances ...

  7. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... HIV to their babies during pregnancy, delivery, and breastfeeding. HIV destroys a certain kind of white blood ... clinical trials, and other research information for health care providers, researchers, people affected by HIV/AIDS, and ...

  8. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... abuse and HIV both affect the brain. Research has shown that HIV causes greater injury to cells ... do not abuse drugs. In animal studies, methamphetamine has been shown to increase the amount of HIV ...

  9. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... and Prevention, National Center for HIV, STD, and TB Prevention. What Is HIV? ( http://www.cdc.gov/ ... of HIV in brain cells 1 . Drug abuse treatment. Since the late 1980s, research has shown that ...

  10. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... What are HIV and AIDS? HIV (human immunodeficiency virus) is the virus that causes AIDS (acquired immune deficiency syndrome). AIDS ... but no cure, at the present time. The virus (HIV) and the disease it causes (AIDS) are ...

  11. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... the Link - Drugs and HIV Learn the Link - Drugs and HIV Email Facebook Twitter 2005 –Ongoing Behaviors ... GA: CDC, DHHS. Retrieved June 2012 How are Drug Abuse and HIV Related? Drug abuse and addiction ...

  12. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... chances of unsafe behavior by altering judgment and decision-making. To learn about HIV among youth, please visit: http://www.cdc.gov/hiv/risk/age/youth/index.html​ . Resources Publications Drug Facts: HIV/ ...

  13. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... Education Projects » Learn the Link - Drugs and HIV Learn the Link - Drugs and HIV Email Facebook Twitter ... research findings and news updates. Read on to Learn the Link between drug abuse and HIV and ...

  14. HIV / AIDS: An Unequal Burden

    Science.gov (United States)

    ... Navigation Bar Home Current Issue Past Issues HIV / AIDS HIV / AIDS: An Unequal Burden Past Issues / Summer 2009 Table ... Victoria Cargill talks to students about HIV and AIDS at the opening of a National Library of ...

  15. HIV, AIDS, and the Future

    Science.gov (United States)

    ... Navigation Bar Home Current Issue Past Issues HIV / AIDS HIV, AIDS, and the Future Past Issues / Summer 2009 Table ... and your loved ones from HIV/AIDS. The AIDS Memorial Quilt In 1987, a total of 1, ...

  16. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... Global Health Hepatitis (Viral) HIV/AIDS Medical Consequences Mental Health Military Pain Prevention Treatment Trends & Statistics Women ... hiv-aids-101/statistics/ . Reference Centers for Disease Control and Prevention, National Center for HIV, STD, and ...

  17. HIV-Positive-to-HIV-Positive Liver Transplantation.

    Science.gov (United States)

    Calmy, A; van Delden, C; Giostra, E; Junet, C; Rubbia Brandt, L; Yerly, S; Chave, J-P; Samer, C; Elkrief, L; Vionnet, J; Berney, T

    2016-08-01

    Most countries exclude human immunodeficiency virus (HIV)-positive patients from organ donation because of concerns regarding donor-derived HIV transmission. The Swiss Federal Act on Transplantation has allowed organ transplantation between HIV-positive donors and recipients since 2007. We report the successful liver transplantation from an HIV-positive donor to an HIV-positive recipient. Both donor and recipient had been treated for many years with antiretroviral therapy and harbored multidrug-resistant viruses. Five months after transplantation, HIV viremia remains undetectable. This observation supports the inclusion of appropriate HIV-positive donors for transplants specifically allocated to HIV-positive recipients. PMID:27109874

  18. Travelling with HIV

    DEFF Research Database (Denmark)

    Nielsen, Ulla S; Jensen-Fangel, Søren; Pedersen, Gitte;

    2014-01-01

    BACKGROUND: We aimed to describe travel patterns, extent of professional pre-travel advice and health problems encountered during travel among HIV-infected individuals. METHODS: During a six-month period a questionnaire was handed out to 2821 adult HIV-infected individuals attending any of the...... eight Danish medical HIV care centers. RESULTS: A total of 763 individuals responded. During the previous two years 49% had travelled outside Europe; 18% had travelled less and 30% were more cautious when choosing travel destination than before the HIV diagnosis. Pre-travel advice was sought by only 38......%, and travel insurance was taken out by 86%. However, 29%/74% did not inform the advisor/the insurance company about their HIV status. Nearly all patients on highly active antiretroviral therapy (HAART) were adherent, but 58% worried about carrying HIV-medicine and 19% tried to hide it. Only 19...

  19. HIV Stigma Among Substance Abusing People Living with HIV/AIDS: Implications for HIV Treatment

    OpenAIRE

    Levi-Minzi, Maria A.; Hilary L Surratt

    2014-01-01

    HIV-related stigma has a major impact on quality of life and health among people living with HIV and AIDS (PLWHA). This study examines demographic, mental health, behavioral, contextual, and HIV care-related correlates of HIV stigma among 503 substance abusing PLWHA. Stigma was measured with the HIV Internalized Stigma Measure which has four subscales: stereotypes about HIV, self-acceptance, disclosure concerns, and social relationships. Severe substance dependence (55.3%) and depression (54....

  20. Microbiome in HIV infection

    OpenAIRE

    Salas, January T; Chang, Theresa L

    2014-01-01

    HIV primary infection occurs at mucosa tissues, suggesting an intricate interplay between microbiome and HIV infection. Recent advanced technologies of high-throughput sequencing and bioinformatics allow researchers to explore nonculturable microbes including bacteria, virus and fungi and their association with diseases. HIV/SIV infection is associated with microbiome shifts and immune activation that may affect the outcome of disease progression. Similarly, altered microbiome and inflammatio...

  1. Revisiting HIV-1 uncoating

    OpenAIRE

    Arhel Nathalie

    2010-01-01

    Abstract HIV uncoating is defined as the loss of viral capsid that occurs within the cytoplasm of infected cells before entry of the viral genome into the nucleus. It is an obligatory step of HIV-1 early infection and accompanies the transition between reverse transcription complexes (RTCs), in which reverse transcription occurs, and pre-integration complexes (PICs), which are competent to integrate into the host genome. The study of the nature and timing of HIV-1 uncoating has been paved wit...

  2. HIV and Fertility Revisited

    OpenAIRE

    Sebnem Kalemli-Ozcan; Belgi Turan

    2010-01-01

    Young (2005) argues that HIV related population declines reinforced by the fertility response to the epidemic will lead to higher capital-labor ratios and to higher per capita incomes in the affected countries of Africa. Using household level data on fertility from South Africa and relying on between cohort variation in country level HIV infection, he estimates a large negative effect of HIV prevalence on fertility. However, the studies that utilize the recent rounds of Demographic Health Sur...

  3. High correlation of specific IgE sensitization between birch pollen, soy and apple allergens indicates pollen-food allergy syndrome among birch pollen allergic patients in northern China

    OpenAIRE

    Hao, Guo-dong; Zheng, Yi-Wu; Wang, Zhi-Xiang; Kong, Xing-ai; Song, Zhi-jing; Lai, Xu-Xin; Spangfort, Michael D.

    2016-01-01

    Background: Birch pollen sensitization and associated pollen-food syndrome among Chinese allergic patients have not been investigated. Methods: Sera from 203 allergic patients from the northern part of China and collected during February to July 2014 were investigated. Specific immunoglobulin E (IgE) against birch pollen extract Bet v and major birch pollen allergen Bet v 1 were measured using the ADVIA Centaur. The presence of major apple allergen Mal d 1 and soy bean allergen Gly m 4 specif...

  4. Living with HIV/AIDS

    Science.gov (United States)

    Infection with HIV is serious. But the outlook for people with HIV/AIDS is improving. If you are infected with HIV, there are many things you can do to ... health care provider who knows how to treat HIV. You may want to join a support group. ...

  5. HIV/AIDS and Alcohol

    Science.gov (United States)

    ... Other Psychiatric Disorders Other Substance Abuse HIV/AIDS HIV/AIDS Human immunodeficiency virus (HIV) targets the body’s immune ... and abuse can contribute to the spread of HIV/AIDS and affect treatment for infected patients. Abusing alcohol ...

  6. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... Send the Message . Get the Facts What are HIV and AIDS? HIV (human immunodeficiency virus) is the virus that ... AIDS) are often linked and referred to as "HIV/AIDS." HIV can be transferred between people if an ...

  7. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... the link between drug abuse and HIV/AIDS, populations most at risk, trends in HIV/AIDS, and ... increasingly at risk for HIV infection through risky sexual behaviors. NIDA researchers have studied and continue to study the links between drug abuse and HIV/AIDS. In the early years of ...

  8. Indikatorsygdomme for hiv-infektion

    DEFF Research Database (Denmark)

    Hansen, Birgitte Rønde; Andersen, Åse Bengård; Koch, Anders; Ravn, Pernille; Larsen, Carsten Schade; Weis, Nina; Gerstoft, Jan

    2015-01-01

    guideline on indicator-based HIV testing in order to improve early HIV diagnosis. The Danish Society of Infectious Diseases wishes to highlight the importance of indicator-based HIV testing, in order to improve the possibility of early diagnosis and therapy of HIV-infection....

  9. Let's Stop HIV Together

    Centers for Disease Control (CDC) Podcasts

    2012-07-16

    This podcast features 22 individuals who encourage others in the fight against HIV.  Created: 7/16/2012 by National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP).   Date Released: 7/16/2012.

  10. HIV/AIDS

    Science.gov (United States)

    ... health days Meetings and consultations 2014 Fact sheets Features Commentaries 2014 Multimedia Contacts HIV/AIDS Fact sheet Updated July 2016 Key facts HIV continues to be a major global public health issue, having claimed more than 35 million lives so far. In 2015, 1.1 (940 000– ...

  11. Ludacris Talks About HIV

    Centers for Disease Control (CDC) Podcasts

    2012-07-24

    Ludacris, award winning singer and actor, urges everyone to talk about HIV/AIDS and its prevention.  Created: 7/24/2012 by National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP).   Date Released: 7/24/2012.

  12. Indikatorsygdomme for hiv-infektion

    DEFF Research Database (Denmark)

    Hansen, Birgitte Rønde; Andersen, Åse Bengård; Koch, Anders;

    2015-01-01

    The mortality of HIV-infected patients in Denmark approaches that of the background population. Still, half of the HIV-infected patients are diagnosed late, resulting in poorer response to therapy, larger cost and greater transmission rate. A pan-European initiative, "HIV in Europe" has published a...... guideline on indicator-based HIV testing in order to improve early HIV diagnosis. The Danish Society of Infectious Diseases wishes to highlight the importance of indicator-based HIV testing, in order to improve the possibility of early diagnosis and therapy of HIV-infection....

  13. Periodontitis in HIV patients

    Directory of Open Access Journals (Sweden)

    Oseeva А.О.

    2011-09-01

    Full Text Available The article presents the study of formation mechanisms and periodontitis course in patients with subclinical stage of HIV-infection. The examination of 45 patients has enabled the division of patients into three basic groups: patients with periodontitis and HIV-infection; patients with periodontitis; and HIV patients without periodontitis. It has been determined that the patients with periodontitis and subclinical HIV-infection have developed local inflammatory reaction with infection, activation of anti-inflammatory cytokines in parodontal recess fluid. It has been proved that the causative factor of frequent and durable relapses in parodontal pathology with clinical HIV-infection was the development of pathologic process with endotoxicosis syndrome and imbalance of lipid peroxidation and antioxidant system

  14. HIV and neurocognitive dysfunction.

    Science.gov (United States)

    Spudich, Serena

    2013-09-01

    The spectrum of HIV-associated neurocognitive disorder (HAND) has been dramatically altered in the setting of widely available effective antiretroviral therapy (ART). Once culminating in dementia in many individuals infected with HIV, HAND now typically manifests as more subtle, though still morbid, forms of cognitive impairment in persons surviving long-term with treated HIV infection. Despite the substantial improvement in severity of this disorder, the fact that neurologic injury persists despite ART remains a challenge to the community of patients, providers and investigators aiming to optimize quality of life for those living with HIV. Cognitive dysfunction in treated HIV may reflect early irreversible CNS injury accrued before ART is typically initiated, ongoing low-level CNS infection and progressive injury in the setting of ART, or comborbidities including effects of treatment which may confound the beneficial reduction in viral replication and immune activation effected by ART. PMID:23860944

  15. HIV-Associated Tuberculosis.

    Science.gov (United States)

    Naidoo, Kogieleum; Naidoo, Kasavan; Padayatchi, Nesri; Abdool Karim, Quarraisha

    2011-01-01

    The intersecting HIV and Tuberculosis epidemics in countries with a high disease burden of both infections pose many challenges and opportunities. For patients infected with HIV in high TB burden countries, the diagnosis of TB, ARV drug choices in treating HIV-TB coinfected patients, when to initiate ARV treatment in relation to TB treatment, managing immune reconstitution, minimising risk of getting infected with TB and/or managing recurrent TB, minimizing airborne transmission, and infection control are key issues. In addition, given the disproportionate burden of HIV in women in these settings, sexual reproductive health issues and particular high mortality rates associated with TB during pregnancy are important. The scaleup and resource allocation to access antiretroviral treatment in these high HIV and TB settings provide a unique opportunity to strengthen both services and impact positively in meeting Millennium Development Goal 6. PMID:20871843

  16. HIV treatment for prevention

    Directory of Open Access Journals (Sweden)

    Ambrosioni Juan

    2011-05-01

    Full Text Available Abstract "No virus, no transmission." Studies have repeatedly shown that viral load (the quantity of virus present in blood and sexual secretions is the strongest predictor of HIV transmission during unprotected sex or transmission from infected mother to child. Effective treatment lowers viral load to undetectable levels. If one could identify and treat all HIV-infected people immediately after infection, the HIV/AIDS epidemic would eventually disappear. Such a radical solution is currently unrealistic. In reality, not all people get tested, especially when they fear stigma and discrimination. Thus, not all HIV-infected individuals are known. Of those HIV-positive individuals for whom the diagnosis is known, not all of them have access to therapy, agree to be treated, or are taking therapy effectively. Some on effective treatment will stop, and in others, the development of resistance will lead to treatment failure. Furthermore, resources are limited: should we provide drugs to asymptomatic HIV-infected individuals without indication for treatment according to guidelines in order to prevent HIV transmission at the risk of diverting funding from sick patients in urgent need? In fact, the preventive potential of anti-HIV drugs is unknown. Modellers have tried to fill the gap, but models differ depending on assumptions that are strongly debated. Further, indications for antiretroviral treatments expand; in places like Vancouver and San Francisco, the majority of HIV-positive individuals are now under treatment, and the incidence of new HIV infections has recently fallen. However, correlation does not necessarily imply causation. Finally, studies in couples where one partner is HIV-infected also appear to show that treatment reduces the risk of transmission. More definite studies, where a number of communities are randomized to either receive the "test-and-treat" approach or continue as before, are now in evaluation by funding agencies. Repeated

  17. HIV treatment for prevention.

    Science.gov (United States)

    Ambrosioni, Juan; Calmy, Alexandra; Hirschel, Bernard

    2011-01-01

    "No virus, no transmission." Studies have repeatedly shown that viral load (the quantity of virus present in blood and sexual secretions) is the strongest predictor of HIV transmission during unprotected sex or transmission from infected mother to child. Effective treatment lowers viral load to undetectable levels. If one could identify and treat all HIV-infected people immediately after infection, the HIV/AIDS epidemic would eventually disappear.Such a radical solution is currently unrealistic. In reality, not all people get tested, especially when they fear stigma and discrimination. Thus, not all HIV-infected individuals are known. Of those HIV-positive individuals for whom the diagnosis is known, not all of them have access to therapy, agree to be treated, or are taking therapy effectively. Some on effective treatment will stop, and in others, the development of resistance will lead to treatment failure. Furthermore, resources are limited: should we provide drugs to asymptomatic HIV-infected individuals without indication for treatment according to guidelines in order to prevent HIV transmission at the risk of diverting funding from sick patients in urgent need? In fact, the preventive potential of anti-HIV drugs is unknown. Modellers have tried to fill the gap, but models differ depending on assumptions that are strongly debated. Further, indications for antiretroviral treatments expand; in places like Vancouver and San Francisco, the majority of HIV-positive individuals are now under treatment, and the incidence of new HIV infections has recently fallen. However, correlation does not necessarily imply causation. Finally, studies in couples where one partner is HIV-infected also appear to show that treatment reduces the risk of transmission.More definite studies, where a number of communities are randomized to either receive the "test-and-treat" approach or continue as before, are now in evaluation by funding agencies. Repeated waves of testing would precisely

  18. MedlinePlus: HIV/AIDS Medicines

    Science.gov (United States)

    ... Training Center) Also in Spanish Side Effects (New Mexico AIDS Education and Training Center) Also in Spanish Side Effects of HIV Medicines: HIV and Diabetes (AIDSinfo) Side Effects of HIV Medicines: HIV and ...

  19. HIV Molecular Immunology 2014

    Energy Technology Data Exchange (ETDEWEB)

    Yusim, Karina [Los Alamos National Lab. (LANL), Los Alamos, NM (United States); Korber, Bette Tina Marie [Los Alamos National Lab. (LANL), Los Alamos, NM (United States); Barouch, Dan [Beth Israel Deaconess Medical Center, Boston, MA (United States); Koup, Richard [Vaccine Research Center National Institutes of Health (United States); de Boer, Rob [Utrecht Univ. (Netherlands). Dept. of Biology; Moore, John P. [Cornell Univ., Ithaca, NY (United States). Weill Medical College; Brander, Christian [Institucioi Catalana de Recerca i Estudis Avancats (ICREA), Barcelona (Spain); Haynes, Barton F. [Duke Univ., Durham, NC (United States). Duke Human Vaccine Institute and Departments of Medicine, Surgery and Immunology; Walker, Bruce D. [Ragon Institute of Massachusetts General Hospital, Cambridge, MA (United States); Harvard Univ., Cambridge, MA (United States); Massachusetts Inst. of Technology (MIT), Cambridge, MA (United States)

    2015-02-03

    HIV Molecular Immunology is a companion volume to HIV Sequence Compendium. This publication, the 2014 edition, is the PDF version of the web-based HIV Immunology Database (http://www.hiv.lanl.gov/content/immunology/). The web interface for this relational database has many search options, as well as interactive tools to help immunologists design reagents and interpret their results. In the HIV Immunology Database, HIV-specific B-cell and T-cell responses are summarized and annotated. Immunological responses are divided into three parts, CTL, T helper, and antibody. Within these parts, defined epitopes are organized by protein and binding sites within each protein, moving from left to right through the coding regions spanning the HIV genome. We include human responses to natural HIV infections, as well as vaccine studies in a range of animal models and human trials. Responses that are not specifically defined, such as responses to whole proteins or monoclonal antibody responses to discontinuous epitopes, are summarized at the end of each protein section. Studies describing general HIV responses to the virus, but not to any specific protein, are included at the end of each part. The annotation includes information such as crossreactivity, escape mutations, antibody sequence, TCR usage, functional domains that overlap with an epitope, immune response associations with rates of progression and therapy, and how specific epitopes were experimentally defined. Basic information such as HLA specificities for T-cell epitopes, isotypes of monoclonal antibodies, and epitope sequences are included whenever possible. All studies that we can find that incorporate the use of a specific monoclonal antibody are included in the entry for that antibody. A single T-cell epitope can have multiple entries, generally one entry per study. Finally, maps of all defined linear epitopes relative to the HXB2 reference proteins are provided.

  20. HIV transmission biology: translation for HIV prevention.

    Science.gov (United States)

    Ronen, Keshet; Sharma, Amit; Overbaugh, Julie

    2015-11-01

    Rigorous testing of new HIV-prevention strategies is a time-consuming and expensive undertaking. Thus, making well informed decisions on which candidate-prevention approaches are most likely to provide the most benefit is critical to appropriately prioritizing clinical testing. In the case of biological interventions, the decision to test a given prevention approach in human trials rests largely on evidence of protection in preclinical studies. The ability of preclinical studies to predict efficacy in humans may depend on how well the model recapitulates key biological features of HIV transmission relevant to the question at hand. Here, we review our current understanding of the biology of HIV transmission based on data from animal models, cell culture, and viral sequence analysis from human infection. We summarize studies of the bottleneck in viral transmission; the characteristics of transmitted viruses; the establishment of infection; and the contribution of cell-free and cell-associated virus. We seek to highlight the implications of HIV-transmission biology for development of prevention interventions, and to discuss the limitations of existing preclinical models. PMID:26418086

  1. HIV among Gay and Bisexual Men

    Science.gov (United States)

    ... VIH En Español Get Tested Find an HIV testing site near you. Enter ZIP code or city Follow HIV/AIDS CDC HIV CDC HIV/AIDS See RSS | ... Email Updates on HIV Syndicated Content Website Feedback HIV Among Gay and Bisexual Men Format: Select one ...

  2. HIV among Transgender People

    Science.gov (United States)

    ... mobilization, HIV testing, and coordinated referral networks and service integration). Developing Act Against AIDS communication materials to reach transgender people, including campaigns such as: Doing It , which ... & services . San Francisco, CA: University of California, San Francisco, ...

  3. Primaer HIV-infektion

    DEFF Research Database (Denmark)

    Pedersen, C; Pedersen, B K

    1996-01-01

    Up to 70% of individuals with primary HIV infection will develop symptoms of an acute illness. The most common symptoms reported are fever, generalized lymphadenopathy, arthralgia and myalgia, headache, pharyngitis, enanthema, skin rash, diarrhoea, and mucocutaneous ulcerations. More rarely...

  4. HIV and Kidney Disease

    Science.gov (United States)

    ... Sheets Permission to Use Fact Sheets Sponsors and Advertising Privacy Policy Project ... Disease WHY SHOULD PEOPLE WITH HIV CARE ABOUT KIDNEY DISEASE? WHAT IS NORMAL KIDNEY FUNCTION? HOW DO I KNOW IF THERE ARE PROBLEMS ...

  5. HIV/AIDS

    Science.gov (United States)

    ... Casual contact, such as hugging Mosquitoes Participating in sports Touching items that were touched by a person ... 20 years. People with AIDS have had their immune system damaged by HIV. They are at very high ...

  6. HIV Genotypic Resistance Testing

    Science.gov (United States)

    ... of the disease progression and to minimize viral replication and mutation. However, a person may be initially infected with a drug-resistant HIV strain or drug resistance may develop during treatment, ...

  7. Drugs, Alcohol and HIV

    Science.gov (United States)

    ... Z) Hepatitis HIV Mental Health Mental Health Home Suicide Prevention Substance Abuse Military Sexual Trauma PTSD Research (MIRECC) Military Exposures Polytrauma Rehabilitation Spinal Cord Injury Telehealth Womens Health Issues Wellness Programs MyHealtheVet Nutrition Quitting Smoking ...

  8. Mental Health and HIV

    Science.gov (United States)

    ... Z) Hepatitis HIV Mental Health Mental Health Home Suicide Prevention Substance Abuse Military Sexual Trauma PTSD Research (MIRECC) Military Exposures Polytrauma Rehabilitation Spinal Cord Injury Telehealth Womens Health Issues Wellness Programs MyHealtheVet Nutrition Quitting Smoking ...

  9. Vaccinations and HIV

    Science.gov (United States)

    ... 23, 2014 Select a Language: Fact Sheet 207 Vaccinations and HIV WHAT ARE VACCINATIONS? WHAT’S DIFFERENT FOR ... your viral load within 4 weeks of any vaccination. Flu shots have been studied more than any ...

  10. HIV Molecular Immunology 2015

    Energy Technology Data Exchange (ETDEWEB)

    Yusim, Karina [Los Alamos National Lab. (LANL), Los Alamos, NM (United States). Theoretical Division; Korber, Bette Tina [Los Alamos National Lab. (LANL), Los Alamos, NM (United States). Theoretical Division; Brander, Christian [Institucio Catalana de Recerca i Estudis Avancats (ICREA), Barcelona (Spain); Barouch, Dan [Beth Israel Deaconess Medical Center, Boston, MA (United States). Division of Vaccine Research; de Boer, Rob [Utrecht University, Utrecht (Netherlands). Faculty of Biology; Haynes, Barton F. [Duke Univ., Durham, NC (United States). Duke Human Vaccine Institute and Departments of Medicine, Surgery and Immunology; Koup, Richard [National Inst. of Health (NIH), Bethesda, MD (United States). Vaccine Research Center; Moore, John P. [Cornell Univ., Ithaca, NY (United States). Weill Medical College; Walker, Bruce D. [Ragon Institute, Cambridge, MA (United States); Watkins, David [Wisconsin Regional Primate Research Center, Madison, WI (United States)

    2016-04-05

    The scope and purpose of the HIV molecular immunology database: HIV Molecular Immunology is a companion volume to HIV Sequence Compendium. This publication, the 2015 edition, is the PDF version of the web-based HIV Immunology Database (http://www.hiv.lanl.gov/ content/immunology/). The web interface for this relational database has many search options, as well as interactive tools to help immunologists design reagents and interpret their results. In the HIV Immunology Database, HIV-specific B-cell and T-cell responses are summarized and annotated. Immunological responses are divided into three parts, CTL, T helper, and antibody. Within these parts, defined epitopes are organized by protein and binding sites within each protein, moving from left to right through the coding regions spanning the HIV genome. We include human responses to natural HIV infections, as well as vaccine studies in a range of animal models and human trials. Responses that are not specifically defined, such as responses to whole proteins or monoclonal antibody responses to discontinuous epitopes, are summarized at the end of each protein section. Studies describing general HIV responses to the virus, but not to any specific protein, are included at the end of each part. The annotation includes information such as cross-reactivity, escape mutations, antibody sequence, TCR usage, functional domains that overlap with an epitope, immune response associations with rates of progression and therapy, and how specific epitopes were experimentally defined. Basic information such as HLA specificities for T-cell epitopes, isotypes of monoclonal antibodies, and epitope sequences are included whenever possible. All studies that we can find that incorporate the use of a specific monoclonal antibody are included in the entry for that antibody. A single T-cell epitope can have multiple entries, generally one entry per study. Finally, maps of all defined linear epitopes relative to the HXB2 reference proteins

  11. A patient carrying HIV

    OpenAIRE

    Adeela, Bashir

    2009-01-01

    A 52-year-old Caucasian man presented to hospital with confusion and was treated for a urinary tract infection. He developed new and unexpected signs and symptoms during his stay in hospital. On further questioning, the story of his social background unfolded and, following further investigation, he was diagnosed with human immunodeficiency virus (HIV). This case reminds all clinicians to think about HIV in the older patient and it also gives direction for investigation and management of simi...

  12. HIV, poverty and women.

    Science.gov (United States)

    Rodrigo, Chaturaka; Rajapakse, Senaka

    2010-03-01

    This review examines the interactions of financial status and HIV and its implications for women. MEDLINE and Google scholar were searched using the keywords 'women', 'poverty' and 'HIV' in any field of the article. The search was limited to articles published in English over the last 10 years. The first section of the article tries to establish whether poverty or wealth is a risk factor for HIV. There is credible evidence for both arguments. While wealth shows an increased risk for both sexes, poverty places women at a special disadvantage. The second section explains how the financial status interacts with other 'non biological' factors to put women at increased risk. While discrimination based on these factors disadvantage women, there are some paradoxical observations that do not fit with the traditional line of explanation (e.g. paradoxical impact of wealth and education on HIV). The final section assesses the impact of HIV in driving poverty and the role of women in interventional programmes. The specific impact of poverty on females in families living with HIV is less explored. Though microfinance initiatives to empower women are a good idea in theory, the actual outcome of such a programme is less convincing. PMID:24037044

  13. Side Effects of HIV Medicines: HIV and Lipodystrophy

    Science.gov (United States)

    ... of the following HIV medicines in the nucleoside reverse transcriptase inhibitor (NRTI) drug class . Stavudine (brand name: Zerit) Zidovudine ( ... is an HIV medicine in the non-nucleoside reverse transcriptase inhibitor (NNRTI) drug class . Efavirenz is one of the ...

  14. Frequency and Implications of HIV Superinfection

    OpenAIRE

    Redd, Andrew D.; Quinn, Thomas C; Tobian, Aaron A. R.

    2013-01-01

    HIV superinfection (HIV-SI) occurs when an HIV infected individual is infected with a new distinct HIV viral strain. HIV-SI has been reported throughout the world, and studies have reported HIV-SI incidence rates of 0% to 7.7% per year. Recent use of next-generation sequencing has improved detection of HIV-SI. Several studies have suggested that HIV-SI may occur at rates comparable to initial HIV infection. HIV-SI has been shown to be transmitted by injecting drug use, heterosexual and homose...

  15. Side Effects of HIV Medicines: HIV and Rash

    Science.gov (United States)

    Side Effects of HIV Medicines HIV and Rash (Last updated 1/7/2016; last reviewed 1/7/2016) Key Points A rash is an irritated area of ... requires immediate medical attention. Why do people with HIV develop rash? A rash is an irritated area ...

  16. Side Effects of HIV Medicines: HIV and Osteoporosis

    Science.gov (United States)

    Side Effects of HIV Medicines HIV and Osteoporosis (Last updated 1/11/2016; last reviewed 1/11/2016) Key Points Osteoporosis ... Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents: Adverse Effects of Antiretroviral Agents From the National Institutes of ...

  17. Research Report: HIV/AIDS

    Science.gov (United States)

    ... Reports » HIV/AIDS » Letter from the Director HIV/AIDS Email Facebook Twitter Letter from the Director Human ... the virus that causes acquired immune deficiency syndrome (AIDS) — has been with us for three decades now. ...

  18. Women and HIV/AIDS

    Science.gov (United States)

    ... About Us Contact Us Text size | Print | HIV/AIDS This information in Spanish ( en español ) The human ... HIV, is a sexually transmitted infection and causes acquired immunodeficiency syndrome, or AIDS. Today, about one in four Americans ...

  19. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... HIV destroys a certain kind of white blood cell that is crucial to the normal function of the human immune system. Loss of these CD4+ cells in people with HIV is a key predictor ...

  20. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... risky choices that ultimately led to an HIV-positive diagnosis. The "After the Party" PSA tells the story of the girl who is HIV-positive (from the "Text Message" spot) from her own ...

  1. HIV/AIDS in Women

    Science.gov (United States)

    HIV, the human immunodeficiency virus, kills or damages cells of the body's immune system. The most advanced stage of infection with HIV is AIDS, which stands for acquired immunodeficiency syndrome. ...

  2. HIV/AIDS Clinical Trials

    Science.gov (United States)

    ... Home Apps APIs Widgets Order Publications Skip Nav HIV/AIDS Clinical Trials Home > Clinical Trials Español small ... Renal (Kidney) Complications/Damage Skin Diseases FDA-Approved HIV Drugs Abacavir Atazanavir Atripla Cobicistat Combivir Complera Darunavir ...

  3. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... about the link between drug abuse and HIV. We have produced a set of multicultural public service ... many of us think about HIV/AIDS when we’re at parties or hanging out with friends? ...

  4. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... 1 Some hopeful news is that, in recent years, HIV is no longer a death sentence, as ... contracting HIV. In general, middle and late teen years are when young people engage in risk-taking ...

  5. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... HIV patients who do not abuse drugs. In animal studies, methamphetamine has been shown to increase the ... risky choices that ultimately led to an HIV-positive diagnosis. The "After the Party" PSA tells the ...

  6. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... HIV (human immunodeficiency virus) is the virus that causes AIDS (acquired immune deficiency syndrome). AIDS is a ... time. The virus (HIV) and the disease it causes (AIDS) are often linked and referred to as " ...

  7. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... HIV to their babies during pregnancy, delivery, and breastfeeding. HIV destroys a certain kind of white blood ... It provides them with useful information on the science behind drug abuse. NIDA’s Easy-to-Read Drug ...

  8. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... the Facts What are HIV and AIDS? HIV (human immunodeficiency virus) is the virus that causes AIDS ( ... is crucial to the normal function of the human immune system. Loss of these CD4+ cells in ...

  9. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... to raise awareness among this generation of the real risks of drug use for transmitting HIV, and ... Visual AIDS Bus Boys and Poets Sistahs Getting Real About HIV Conference Radio Stations: WTOP Radio WPFW ...

  10. HIV, AIDS, and Older People

    Science.gov (United States)

    ... symptoms to appear, or any time in between. Signs of HIV include flu-like symptoms such as headache, cough, diarrhea, fevers, and/or sweats. Additional signs of HIV include swollen glands, lack of energy, loss of ...

  11. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... Related Topics Addiction Science Adolescent Brain Comorbidity College-Age & Young Adults Criminal Justice Drugged Driving Drug Testing ... please visit: http://www.cdc.gov/hiv/risk/age/youth/index.html​ . Resources Publications Drug Facts: HIV/ ...

  12. HIV/AIDS: Women's Health

    Science.gov (United States)

    ... Hospitalization and Palliative Care Friends & Family Dating and Marriage Family Planning Mixed-Status Couples Discrimination Legal Issues ... National HIV/AIDS and Aging Awareness Day National Gay Men's HIV/AIDS Awareness Day National Latino AIDS ...

  13. What Is HIV/AIDS?

    Science.gov (United States)

    ... Hospitalization and Palliative Care Friends & Family Dating and Marriage Family Planning Mixed-Status Couples Discrimination Legal Issues ... National HIV/AIDS and Aging Awareness Day National Gay Men's HIV/AIDS Awareness Day National Latino AIDS ...

  14. HIV/AIDS and Vaccines

    Science.gov (United States)

    ... Hospitalization and Palliative Care Friends & Family Dating and Marriage Family Planning Mixed-Status Couples Discrimination Legal Issues ... National HIV/AIDS and Aging Awareness Day National Gay Men's HIV/AIDS Awareness Day National Latino AIDS ...

  15. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... learn-link-drugs-hiv . 120x90 460x80 486x60 Social Media Send the message to young people and to parents, teachers, and the media about the link between drug abuse and HIV. ...

  16. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... function of the human immune system. Loss of these CD4+ cells in people with HIV is a ... HIV/AIDS, and what to do to counter these trends. Online Resources NIDA for Teens Web site : ...

  17. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... abuse and HIV infection. It contains information for young people, parents and teachers, and the media with links ... 177(1):355-361. How are Teens Affected? Young people are at risk for contracting HIV. In general, ...

  18. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... made risky choices that ultimately led to an HIV-positive diagnosis. The "After the Party" PSA tells the story of the girl who is HIV-positive (from the "Text Message" spot) from her ...

  19. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... Post-Award Concerns General Information Grant & Contract Application Process Funding Priorities Research Training News & Events News Nora's ... hiv-aids-101/statistics/ . Reference Centers for Disease Control and Prevention, National Center for HIV, STD, and ...

  20. Diagnostik af HIV-1 infektionen

    DEFF Research Database (Denmark)

    Christiansen, C B; Dickmeiss, E; Bygbjerg, Ib Christian

    1991-01-01

    Different methods have been developed for the diagnosis of HIV infection, i.e. detection of antibodies, antigen and proviral DNA. ELISA methods for detecting HIV-1 antibodies are widely used as screening assays. A sample which is repeatedly positive with ELISA is re-tested with a confirmatory test......, e.g. western blot. Antibodies to HIV-1 are not detectable until 2-3 months after infection, but antigens may be detectable during the last weeks of this initial period, though they disappear with the appearance of the antibodies. In the later stages of HIV infection, HIV antigen is again detectable...... in a proportion of patients. Detection and quantitation of HIV antigen are used as indicators of disease progression and for monitoring the antiviral efficacy of therapeutic interventions. When no antibodies or antigens can be detected in persons suspected of having HIV infection, culture of HIV can...

  1. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... influence of drugs and alcohol engaged in risky sexual behavior that resulted in HIV infection. Watch the "After ... poor decision making, which can result in risky sexual behaviors and HIV infection. Although the characters are fictional, ...

  2. Pyoderma gangrenosum in HIV patient

    Directory of Open Access Journals (Sweden)

    Sayal S

    1997-01-01

    Full Text Available Pyoderma gangrenosum (PG has previously been reported in very few patients with HIV infection. We describe here a 30-year-old housewife with HIV infection having multiple ulcerations over lower limbs characteristic of PG.

  3. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... gov : This blog fosters public discussions on using new media effectively in response to HIV/AIDS, as ... as HIV/AIDS research and policies. AIDS.gov New Media Tools : These new media tools offer new ...

  4. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... causes AIDS (acquired immune deficiency syndrome). AIDS is a disease of the immune system for which there ... causes (AIDS) are often linked and referred to as "HIV/AIDS." HIV can be transferred between people ...

  5. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... or decrease symptoms of illness. To learn about current statistics of HIV in the United States, please ... programs also serve an important role in providing current information on HIV/AIDS and related diseases, counseling ...

  6. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... the link between drug abuse and HIV infection. It contains information for young people, parents and teachers, ... present time. The virus (HIV) and the disease it causes (AIDS) are often linked and referred to ...

  7. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... cdc.gov/hiv/risk/age/youth/index.html​ . Resources Publications Drug Facts: HIV/AIDS and Drug Abuse: ... what to do to counter these trends. Online Resources NIDA for Teens Web site : This Web site ...

  8. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... HIV patients who do not abuse drugs. In animal studies, methamphetamine has been shown to increase the ... on HIV/AIDS and related diseases, counseling and testing services, and referrals for medical and social services. ...

  9. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... Drugs of abuse and HIV both affect the brain. Research has shown that HIV causes greater injury to cells in the brain and cognitive impairment among methamphetamine abusers than among ...

  10. Creating a National HIV Curriculum.

    Science.gov (United States)

    Spach, David H; Wood, Brian R; Karpenko, Andrew; Unruh, Kenton T; Kinney, Rebecca G; Roscoe, Clay; Nelson, John

    2016-01-01

    In recent years, the HIV care provider workforce has not kept pace with an expanding HIV epidemic. To effectively address this HIV workforce shortage, a multipronged approach is needed that includes high-quality, easily accessible, up-to-date HIV education for trainees and practicing providers. Toward this objective, the University of Washington, in collaboration with the AIDS Education and Training Center National Coordinating Resource Center, is developing a modular, dynamic curriculum that addresses the entire spectrum of the HIV care continuum. Herein, we outline the general principles, content, organization, and features of this federally funded National HIV Curriculum, which allows for longitudinal, active, self-directed learning, as well as real-time evaluation, tracking, and feedback at the individual and group level. The online curriculum, which is in development, will provide a free, comprehensive, interactive HIV training and resource tool that can support national efforts to expand and strengthen the United States HIV clinical care workforce. PMID:27086188

  11. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... blood cell that is crucial to the normal function of the human immune system. Loss of these ... of abuse and HIV both affect the brain. Research has shown that HIV causes greater injury to ...

  12. ORAL CANDIDIASIS AND HIV INFECTION

    OpenAIRE

    Prabhu, Rachana Vishnudas

    2013-01-01

    The acquired immunodeficiency syndrome (AIDS) pandemic, caused by infection with human immunodeficiency virus (HIV) dramatically illustrates the awesome transmission capabilities of disease. Oral manifestations of HIV have been important in identification of patients harboring the HIV virus and in predicting the decline in their immune system Oral candidiasis is one of the earliest premonitory signs of HIV infection and its diagnosis may have grave prognostic implications for the eventual dev...

  13. Living with HIV: Patients Perspective

    Centers for Disease Control (CDC) Podcasts

    2009-06-04

    This podcast showcases three people who are living with HIV. The patients share their experiences of being diagnosed with HIV, of the treatments they are undergoing, and on taking responsibility for their health.  Created: 6/4/2009 by Division of HIV and AIDS Prevention (DHAP), National Center for HIV, Hepatitis, STD, and Tuberculosis Prevention ( NCHHSTP).   Date Released: 6/4/2009.

  14. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... HIV, as well as other information about the science of drug abuse is available at NIDA's home page . blog.AIDS.gov : This blog fosters public discussions on using new media effectively in response to HIV/AIDS, as well as HIV/AIDS research and policies. AIDS.gov New Media Tools : These ...

  15. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... HIV, as well as other information about the science of drug abuse is available at NIDA's home page . blog.AIDS.gov : This blog fosters public discussions on using new media effectively in response to HIV/AIDS, as well as HIV/AIDS research and policies. AIDS.gov New Media Tools : These new media ...

  16. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... CDC, DHHS. Retrieved June 2012 How are Drug Abuse and HIV Related? Drug abuse and addiction have been linked with HIV/AIDS ... this regard, the role that non-injection drug abuse plays in the spread of HIV is less ...

  17. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... transmitting HIV/AIDS or other infectious diseases. Research Reports: HIV/AIDS : Explores the link between drug abuse ... at: https://www.drugabuse.gov/news-events/public-education-projects/learn-link-drugs-hiv . 120x90 460x80 486x60 ...

  18. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... Drugs of abuse and HIV both affect the brain. Research has shown that HIV causes greater injury to ... shown to increase the amount of HIV in brain cells 1 . Drug abuse treatment. Since the late 1980s, research has shown that treating drug abuse is an ...

  19. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... Plan Search Share Print Home » News & Events » Public Education Projects » Learn the Link - Drugs and HIV Learn the Link - Drugs and HIV Email Facebook Twitter 2005 –Ongoing Behaviors associated with drug abuse are among the main factors in the spread of HIV infection in the ...

  20. Vaccination scars in HIV infected patients – does vaccinia vaccination confer protection against HIV?

    DEFF Research Database (Denmark)

    Jespersen, Sanne; Hønge, Bo Langhoff; Medina, Candida;

    Vaccination scars in HIV infected patients – does vaccinia vaccination confer protection against HIV?......Vaccination scars in HIV infected patients – does vaccinia vaccination confer protection against HIV?...

  1. Regional Differences in Prevalence of HIV-1 Discordance in Africa and Enrollment of HIV-1 Discordant Couples into an HIV-1 Prevention Trial

    OpenAIRE

    Jairam R Lingappa; Lambdin, Barrot; Bukusi, Elizabeth Ann; Ngure, Kenneth; Kavuma, Linda; Inambao, Mubiana; Kanweka, William; Allen, Susan; Kiarie, James N.; Were, Edwin; Manongi, Rachel; Coetzee, David; de Bruyn, Guy; Delany-Moretlwe, Sinead; MAGARET, Amalia

    2008-01-01

    Background: Most HIV-1 transmission in Africa occurs among HIV-1-discordant couples (one partner HIV-1 infected and one uninfected) who are unaware of their discordant HIV-1 serostatus. Given the high HIV-1 incidence among HIV-1 discordant couples and to assess efficacy of interventions for reducing HIV-1 transmission, HIV-1 discordant couples represent a critical target population for HIV-1 prevention interventions and prevention trials. Substantial regional differences exist in HIV-1 preval...

  2. HIV in Southeast Asia.

    Science.gov (United States)

    Abrams, S

    1998-01-01

    This article explores the HIV/AIDS epidemic in Southeast Asia. Prostitution and injecting drug use are two major factors in the appearance of HIV/AIDS in a country. But, it is the correct social network that assures its transmission to epidemic proportions. Heterosexual transmission in Cambodia, Myanmar, and Thailand is linked with prevalence among female sex workers and their clients. In Malaysia, the Ministry of Health responded immediately, but the number of new infections continued to increase. The failures suggest the need for more effective, intensive health education programs, outreach by nongovernmental organizations, and peer education at the grassroots level and in remote areas. Public health officials need to promote political change. International agencies could play an important role, if countries such as Myanmar, Cambodia, and Viet Nam were open to international exchanges. In Myanmar, political unrest has a priority over the need for aggressive health interventions. In Indonesia, the Islamic influence prevents recognition of the country's significant sex industry or the existence of a homosexual community. In Cambodia, health officials warned about the high number of sexual partners, high mobility rate, and low condom use, but HIV spread rapidly in the 1990s. Thailand initiated a 100% condom campaign to combat HIV prevalence in the 1990s, and HIV prevalence declined among sex workers and military recruits. Risk factors for rapid transmission include mobility, the number of sexual partners/sex worker, the proportion engaging in commercial sex, and the rate of regular condom use among sex workers. PMID:12294443

  3. HIV Sequence Compendium 2015

    Energy Technology Data Exchange (ETDEWEB)

    Foley, Brian Thomas [Los Alamos National Lab. (LANL), Los Alamos, NM (United States); Leitner, Thomas Kenneth [Los Alamos National Lab. (LANL), Los Alamos, NM (United States); Apetrei, Cristian [Univ. of Pittsburgh, PA (United States); Hahn, Beatrice [Univ. of Pennsylvania, Philadelphia, PA (United States); Mizrachi, Ilene [National Center for Biotechnology Information, Bethesda, MD (United States); Mullins, James [Univ. of Washington, Seattle, WA (United States); Rambaut, Andrew [Univ. of Edinburgh, Scotland (United Kingdom); Wolinsky, Steven [Northwestern Univ., Evanston, IL (United States); Korber, Bette Tina Marie [Los Alamos National Lab. (LANL), Los Alamos, NM (United States)

    2015-10-05

    This compendium is an annual printed summary of the data contained in the HIV sequence database. We try to present a judicious selection of the data in such a way that it is of maximum utility to HIV researchers. Each of the alignments attempts to display the genetic variability within the different species, groups and subtypes of the virus. This compendium contains sequences published before January 1, 2015. Hence, though it is published in 2015 and called the 2015 Compendium, its contents correspond to the 2014 curated alignments on our website. The number of sequences in the HIV database is still increasing. In total, at the end of 2014, there were 624,121 sequences in the HIV Sequence Database, an increase of 7% since the previous year. This is the first year that the number of new sequences added to the database has decreased compared to the previous year. The number of near complete genomes (>7000 nucleotides) increased to 5834 by end of 2014. However, as in previous years, the compendium alignments contain only a fraction of these. A more complete version of all alignments is available on our website, http://www.hiv.lanl.gov/ content/sequence/NEWALIGN/align.html As always, we are open to complaints and suggestions for improvement. Inquiries and comments regarding the compendium should be addressed to seq-info@lanl.gov.

  4. Laboratory diagnostics for HIV infection

    Directory of Open Access Journals (Sweden)

    Stefano Buttò

    2010-03-01

    Full Text Available Laboratory diagnosis of human immunodeficiency virus (HIV infection is fundamental for detecting and monitoring infection. Many diagnostic tools are available that are based on both detection of HIV-specific antibodies and virus antigen, or nucleic acid. As technology evolves, HIV testing assays are being improved providing better sensitivity and specificity. In this short review, we summarize the common and new methodologies that are being used in laboratories, from the HIV antibody-based assays to the new tests for the detection of HIV nucleic acids.

  5. Preventing HIV infection.

    Science.gov (United States)

    Coates, T J; Collins, C

    1998-07-01

    The primary way of preventing HIV infections is to change behaviors that enable transmission of the virus, specifically those behaviors relating to sex and drug injection. Realistic public health workers have focused on encouraging adoption of safer sexual practices, primarily condom use. The fundamental way to persuade people to engage in preventive practices is through targeted education aimed at particularly at-risk communities. Other effective behavioral interventions against HIV infections are: testing and follow-up counseling; comprehensive sex education; peer influence and community action; advertising and marketing; easing access to condoms; physician-patient dialogue; drug treatment; access to clean needles; and direct outreach. On the contrary, interventions that do not work are the following: one-time exposure to information; delivering a single message; abstinence-only programs; and coercive measures to identify people with HIV or their sexual partners. PMID:9648304

  6. Revisiting HIV-1 uncoating

    Directory of Open Access Journals (Sweden)

    Arhel Nathalie

    2010-11-01

    Full Text Available Abstract HIV uncoating is defined as the loss of viral capsid that occurs within the cytoplasm of infected cells before entry of the viral genome into the nucleus. It is an obligatory step of HIV-1 early infection and accompanies the transition between reverse transcription complexes (RTCs, in which reverse transcription occurs, and pre-integration complexes (PICs, which are competent to integrate into the host genome. The study of the nature and timing of HIV-1 uncoating has been paved with difficulties, particularly as a result of the vulnerability of the capsid assembly to experimental manipulation. Nevertheless, recent studies of capsid structure, retroviral restriction and mechanisms of nuclear import, as well as the recent expansion of technical advances in genome-wide studies and cell imagery approaches, have substantially changed our understanding of HIV uncoating. Although early work suggested that uncoating occurs immediately following viral entry in the cell, thus attributing a trivial role for the capsid in infected cells, recent data suggest that uncoating occurs several hours later and that capsid has an all-important role in the cell that it infects: for transport towards the nucleus, reverse transcription and nuclear import. Knowing that uncoating occurs at a later stage suggests that the viral capsid interacts extensively with the cytoskeleton and other cytoplasmic components during its transport to the nucleus, which leads to a considerable reassessment of our efforts to identify potential therapeutic targets for HIV therapy. This review discusses our current understanding of HIV uncoating, the functional interplay between infectivity and timely uncoating, as well as exposing the appropriate methods to study uncoating and addressing the many questions that remain unanswered.

  7. Revisiting HIV-1 uncoating.

    Science.gov (United States)

    Arhel, Nathalie

    2010-01-01

    HIV uncoating is defined as the loss of viral capsid that occurs within the cytoplasm of infected cells before entry of the viral genome into the nucleus. It is an obligatory step of HIV-1 early infection and accompanies the transition between reverse transcription complexes (RTCs), in which reverse transcription occurs, and pre-integration complexes (PICs), which are competent to integrate into the host genome. The study of the nature and timing of HIV-1 uncoating has been paved with difficulties, particularly as a result of the vulnerability of the capsid assembly to experimental manipulation. Nevertheless, recent studies of capsid structure, retroviral restriction and mechanisms of nuclear import, as well as the recent expansion of technical advances in genome-wide studies and cell imagery approaches, have substantially changed our understanding of HIV uncoating. Although early work suggested that uncoating occurs immediately following viral entry in the cell, thus attributing a trivial role for the capsid in infected cells, recent data suggest that uncoating occurs several hours later and that capsid has an all-important role in the cell that it infects: for transport towards the nucleus, reverse transcription and nuclear import. Knowing that uncoating occurs at a later stage suggests that the viral capsid interacts extensively with the cytoskeleton and other cytoplasmic components during its transport to the nucleus, which leads to a considerable reassessment of our efforts to identify potential therapeutic targets for HIV therapy. This review discusses our current understanding of HIV uncoating, the functional interplay between infectivity and timely uncoating, as well as exposing the appropriate methods to study uncoating and addressing the many questions that remain unanswered. PMID:21083892

  8. HIV/AIDS Clinical Trials Fact Sheet

    Science.gov (United States)

    HIV Prevention HIV/AIDS Clinical Trials (Last updated 9/15/2015; last reviewed 9/15/2015) Key Points HIV/AIDS clinical ... safe and effective in people. What is an HIV/AIDS clinical trial? HIV/AIDS clinical trials help ...

  9. Aggressive HIV-1?

    OpenAIRE

    van der Hoek Lia; de Ronde Anthony; Berkhout Ben

    2005-01-01

    Abstract New York City health officials announced on February 11, 2005 that a patient rapidly developed full-blown AIDS shortly after being diagnosed with a rare, drug-resistant strain of HIV-1. The New York City Department of Health issued an alert to all hospitals and doctors and a press conference was held to announce the emergence of an aggressive HIV-1 strain that may be difficult to treat and that appears to trigger rapid progression to AIDS. Is the panic justified?

  10. Benchmarking HIV health care

    DEFF Research Database (Denmark)

    Podlekareva, Daria; Reekie, Joanne; Mocroft, Amanda;

    2012-01-01

    ABSTRACT: BACKGROUND: State-of-the-art care involving the utilisation of multiple health care interventions is the basis for an optimal long-term clinical prognosis for HIV-patients. We evaluated health care for HIV-patients based on four key indicators. METHODS: Four indicators of health care were...... to North, patients from other regions had significantly lower odds of virological response; the difference was most pronounced for East and Argentina (adjusted OR 0.16[95%CI 0.11-0.23, p care utilization...

  11. Leishmaniasis in HIV infection.

    Directory of Open Access Journals (Sweden)

    Paredes R

    2003-01-01

    Full Text Available Herein we review the particular aspects of leishmaniasis associated with HIV infection. The data in this review are mainly from papers identified from PubMed searches and from papers in reference lists of reviewed articles and from the authors′ personal archives. Epidemiological data of HIV/Leishmania co-infection is discussed, with special focus on the influence of Highly Active Antiretroviral Therapy (HAART on incidence of leishmaniasis and transmission modalities. Microbiological characteristics, pathogenesis, clinical presentation and specific treatment of the co-infection are also presented.

  12. HIV peripheral neuropathy.

    Science.gov (United States)

    Gabbai, Alberto Alain; Castelo, Adauto; Oliveira, Acary Souza Bulle

    2013-01-01

    Peripheral neuropathies are the most common neurological manifestations occurring in HIV-infected individuals. Distal symmetrical sensory neuropathy is the most common form encountered today and is one of the few that are specific to HIV infection or its treatment. The wide variety of other neuropathies is akin to the neuropathies seen in the general population and should be managed accordingly. In the pre-ART era, neuropathies were categorized according to the CD4 count and HIV viral load. In the early stages of HIV infection when CD4 count is high, the inflammatory demyelinating neuropathies predominate and in the late stages with the decline of CD4 count opportunistic infection-related neuropathies prevail. That scenario has changed with the present almost universal use of ART (antiretroviral therapy). Hence, HIV-associated peripheral neuropathies are better classified according to their clinical presentations: distal symmetrical polyneuropathy, acute inflammatory demyelinating polyradiculoneuropathy (AIDP) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), mononeuropathies, mononeuropathies multiplex and cranial neuropathies, autonomic neuropathy, lumbosacral polyradiculomyelopathy, and amyotrophic lateral sclerosis (ALS)-like motor neuropathy. Treated with ART, HIV-infected individuals are living longer and are at a higher risk of metabolic and age-related complications; moreover they are also prone to the potentially neurotoxic effects of ART. There are no epidemiological data regarding the incidence and prevalence of the peripheral neuropathies. In the pre-ART era, most data were from case reports, series of patients, and pooled autopsy data. At that time the histopathological evidence of neuropathies in autopsy series was almost 100%. In large prospective cohorts presently being evaluated, it has been found that 57% of HIV-infected individuals have distal symmetrical sensory neuropathy and 38% have neuropathic pain. It is now clear that

  13. Incorporation of chimeric HIV-SIV-Env and modified HIV-Env proteins into HIV pseudovirions

    International Nuclear Information System (INIS)

    Low level incorporation of the viral glycoprotein (Env) into human immunodeficiency virus (HIV) particles is a major drawback for vaccine strategies against HIV/AIDS in which HIV particles are used as immunogen. Within this study, we have examined two strategies aimed at achieving higher levels of Env incorporation into non-infectious pseudovirions (PVs). First, we have generated chimeric HIV/SIV Env proteins containing the truncated C-terminal tail region of simian immunodeficiency virus (SIV)mac239-Env767stop, which mediates strongly increased incorporation of SIV-Env into SIV particles. In a second strategy, we have employed a truncated HIV-Env protein (Env-Tr752N750K) which we have previously demonstrated to be incorporated into HIV virions, generated in infected T-cells, to a higher level than that of Wt-HIV-Env. Although the chimeric HIV/SIV Env proteins were expressed at the cell surface and induced increased levels of cell-cell fusion in comparison to Wt-HIV-Env, they did not exhibit increased incorporation into either HIV-PVs or SIV-PVs. Only Env-Tr752N750K exhibited significantly higher (threefold) levels of incorporation into HIV-PVs, an improvement, which, although not dramatic, is worthwhile for the large-scale preparation of non-infectious PVs for vaccine studies aimed at inducing Env humoral responses

  14. HIV Excess Cancers JNCI

    Science.gov (United States)

    In 2010, an estimated 7,760 new cancers were diagnosed among the nearly 900,000 Americans known to be living with HIV infection. According to the first comprehensive study in the United States, approximately half of these cancers were in excess of what wo

  15. Modeling HIV Cure

    Science.gov (United States)

    Perelson, Alan; Conway, Jessica; Cao, Youfang

    A large effort is being made to find a means to cure HIV infection. I will present a dynamical model of post-treatment control (PTC) or ``functional cure'' of HIV-infection. Some patients treated with suppressive antiviral therapy have been taken off of therapy and then spontaneously control HIV infection such that the amount of virus in the circulation is maintained undetectable by clinical assays for years. The model explains PTC occurring in some patients by having a parameter regime in which the model exhibits bistability, with both a low and high steady state viral load being stable. The model makes a number of predictions about how to attain the low PTC steady state. Bistability in this model depends upon the immune response becoming exhausted when over stimulated. I will also present a generalization of the model in which immunotherapy can be used to reverse immune exhaustion and compare model predictions with experiments in SIV infected macaques given immunotherapy and then taken off of antiretroviral therapy. Lastly, if time permits, I will discuss one of the hurdles to true HIV eradication, latently infected cells, and present clinical trial data and a new model addressing pharmacological means of flushing out the latent reservoir. Supported by NIH Grants AI028433 and OD011095.

  16. Psychotropic Drugs and HIV

    Directory of Open Access Journals (Sweden)

    Ana-Lúcia Moreira

    2014-06-01

    Full Text Available Background: HIV/AIDS infection is frequently associated with psychiatric disor- ders like psychosis, depression and anxiety. Psychiatric comorbidities may interfere with adherence to antiretroviral treatment. Therefore, diagnosis and treatment of these conditions are essential. However, the administration of a psychotropic drug to HAART therapy can result in drug interactions.Objectives: This review aims to analyze the various psychotropic drugs that can be used in these patients, as well as the interactions and adverse reactions that may occur. Methods: A MEDLINE search on anglo-saxonic literature was conducted, from 1993 until 2011, using the key-words: HIV, AIDS, psychosis, depression, anxiety, secondary mania, antidepressive agents, antipsychotics, benzodiazepines, HAART. Results: We found 100 articles, of which 66 were included and 34 excluded. The articles that showed no specific data on the use of psychotropic drugs in HIV patients were excluded. Discussion: Pharmachologic interactions may occur by occupation of the same metabolic pathways. Further research is needed with indications for best practices. Psychotherapeutic interventions should be considered. Conclusion: The choice of the therapeutic intervention, namely when considering psychotropic drugs with the lowest number of interactions and adverse effects is crucial in order to achieve therapeutic success in the treatment of HIV infected patients.

  17. HIV and Pulmonary Hypertension

    Science.gov (United States)

    ... HIV AIDS.gov: www.aids.gov AIDS Healthcare Foundation: www.hivcare.org POZ Magazine: www.poz.com • Educational conferences and materials for medical professionals and patients • A wealth of information in the Survival Guide • PH patient ...

  18. HIV and development.

    Science.gov (United States)

    Decosas, J

    1996-12-01

    Global patterns of human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) are consistent with indicators of social development. The highest HIV prevalence is found in poor societies, societies in turmoil, and among the displaced, powerless, and marginalized. AIDS is an indicator of uneven or dysfunctional development, a cause of developmental delays, and a result of inadequacies in the development of health and social services. Factors such as untreated sexually transmitted diseases, the education of women and their level of autonomy to seek medical care, the availability and quality of medical services, large age differences between men and women in sexual partnerships, prostitution as a means of economic survival, and labor migration and refugee movements play key roles in the generation of AIDS epidemics. The impact of HIV on the feminization of poverty and the maldistribution of household wealth is one of the most significant developmental effects. In areas with high HIV prevalence, crop yields and soil fertility are declining, pests and plant diseases are spreading, and starchy crops of low nutritional value are replacing more labor-intensive traditional crops. Finally, AIDS exerts a major impact on the human development index, especially life expectancy at birth. PMID:8970714

  19. HIV/AIDS and the Flu

    Science.gov (United States)

    ... this? Submit What's this? Submit Button Past Newsletters HIV/AIDS and the Flu Questions & Answers Language: English ... to people with HIV/AIDS. Should people with HIV/AIDS receive the inactivated influenza vaccine? People with ...

  20. Managing Your Treatment of HIV/AIDS

    Science.gov (United States)

    ... HIV/AIDS This information in Spanish ( en español ) Managing your treatment of HIV/AIDS Related information How ... any reason. Return to top More information on Managing your treatment of HIV/AIDS Explore other publications ...

  1. HIV / AIDS: Symptoms, Diagnosis, Prevention and Treatment

    Science.gov (United States)

    Skip Navigation Bar Home Current Issue Past Issues HIV / AIDS HIV / AIDS: Symptoms , Diagnosis, Prevention and Treatment Past Issues / ... Most people who have become recently infected with HIV will not have any symptoms. They may, however, ...

  2. Infant feeding and HIV

    Directory of Open Access Journals (Sweden)

    Ameena Ebrahim Goga

    2009-12-01

    Full Text Available Recent studies on antiretroviral prophylaxis during breastfeeding show that maternal HAART (alone or with 1,4 or 24 weeks infant prophylaxis or infant prophylaxis alone (with limited maternal prophylaxis for 6, 14 or 24 weeks reduces HIV transmission through breastmilk (postnatal transmission. Maternal postnatal regimens appear to be as efficacious as infant postnatal regimens, although one study shows a trend favouring infant nevirapine over maternal HAART (both used from 1 week to 6 months post-delivery. These new findings necessitate a review of existing PMTCT interventions, and the immediate implementation of regimens that reduce postnatal transmission - where this is feasible – to save children’s lives. In the public sector, whilst stakeholders engage in discussions about which is the best regimen to minimise postnatal transmission SSSUPPORT should be given to all HIV-positive women, as explained below, to improve infant outcomes and reduce postnatal transmission: Screen all women for HIV, Send off CD4 cell counts on all HIV-positive women, Screen all HIV-positive women for AFASS using a standardised tool (e.g. Table 3; Understand the woman’s personal and socio-cultural context; Promote exclusive or predominant breastfeeding if all AFASS criteria are not met; Promote exclusive formula feeding if all AFASS criteria are met; Organise supplies of formula milk and cotrimoxazole; Review mothers and infants in the first 3 days post-delivery, in the first two weeks postnatally and monthly thereafter, and review health and feeding practices, regardless of feeding choice, at every visit; lastly Treat all pregnant women with HAART if they meet national criteria for HAART initiation.

  3. HIV Sequence Compendium 2010

    Energy Technology Data Exchange (ETDEWEB)

    Kuiken, Carla [Los Alamos National Lab. (LANL), Los Alamos, NM (United States); Foley, Brian [Los Alamos National Lab. (LANL), Los Alamos, NM (United States); Leitner, Thomas [Los Alamos National Lab. (LANL), Los Alamos, NM (United States); Apetrei, Christian [Univ. of Pittsburgh, PA (United States); Hahn, Beatrice [Univ. of Alabama, Tuscaloosa, AL (United States); Mizrachi, Ilene [National Center for Biotechnology Information, Bethesda, MD (United States); Mullins, James [Univ. of Washington, Seattle, WA (United States); Rambaut, Andrew [Univ. of Edinburgh, Scotland (United Kingdom); Wolinsky, Steven [Northwestern Univ., Evanston, IL (United States); Korber, Bette [Los Alamos National Lab. (LANL), Los Alamos, NM (United States)

    2010-12-31

    This compendium is an annual printed summary of the data contained in the HIV sequence database. In these compendia we try to present a judicious selection of the data in such a way that it is of maximum utility to HIV researchers. Each of the alignments attempts to display the genetic variability within the different species, groups and subtypes of the virus. This compendium contains sequences published before January 1, 2010. Hence, though it is called the 2010 Compendium, its contents correspond to the 2009 curated alignments on our website. The number of sequences in the HIV database is still increasing exponentially. In total, at the time of printing, there were 339,306 sequences in the HIV Sequence Database, an increase of 45% since last year. The number of near complete genomes (>7000 nucleotides) increased to 2576 by end of 2009, reflecting a smaller increase than in previous years. However, as in previous years, the compendium alignments contain only a small fraction of these. Included in the alignments are a small number of sequences representing each of the subtypes and the more prevalent circulating recombinant forms (CRFs) such as 01 and 02, as well as a few outgroup sequences (group O and N and SIV-CPZ). Of the rarer CRFs we included one representative each. A more complete version of all alignments is available on our website, http://www.hiv.lanl.gov/content/sequence/NEWALIGN/align.html. Reprints are available from our website in the form of both HTML and PDF files. As always, we are open to complaints and suggestions for improvement. Inquiries and comments regarding the compendium should be addressed to seq-info@lanl.gov.

  4. Morphine Enhances HIV Infection of Neonatal Macrophages

    OpenAIRE

    Li, Yuan; MERRILL, JEFFREY D.; Mooney, Kathy; Song, Li; Wang, Xu; GUO, CHANG-JIANG; Savani, Rashmin C; Metzger, David S.; Douglas, Steven D.; Ho, Wen-Zhe

    2003-01-01

    Perinatal transmission of HIV accounts for almost all new HIV infections in children. There is an increased risk of perinatal transmission of HIV with maternal illicit substance abuse. Little is known about neonatal immune system alteration and subsequent susceptibility to HIV infection after morphine exposure. We investigated the effects of morphine on HIV infection of neonatal monocyte-derived macrophages (MDM). Morphine significantly enhanced HIV infection of neonatal MDM. Morphine-induced...

  5. Role of HIV in Amyloid Metabolism

    OpenAIRE

    Ortega, Mario; Ances, Beau M.

    2014-01-01

    HIV infection has changed from an acute devastating disease to a more chronic illness due to combination anti-retroviral treatment (cART). In the cART era, the life expectancy of HIV-infected (HIV+) individuals has increased. More HIV+ individuals are aging with current projections suggesting that 50% of HIV+ individuals will be over 50 years old by 2015. With advancing age, HIV+ individuals may be at increased risk of developing other potential neurodegenerative disorders [especially Alzheim...

  6. Developing strategies for HIV-1 eradication

    OpenAIRE

    Durand, Christine M.; Blankson, Joel N.; Siliciano, Robert F.

    2012-01-01

    Highly active antiretroviral therapy (HAART) suppresses HIV-1 replication, transforming the outlook for infected patients. However, reservoirs of replication-competent forms of the virus persist during HAART, and when treatment is stopped, high rates of HIV-1 replication return. Recent insights into HIV-1 latency, as well as a report that HIV-1 infection was eradicated in one individual, have renewed interest in finding a cure for HIV-1 infection. Strategies for HIV-1 eradication include gene...

  7. HIV-miR-H1 evolvability during HIV pathogenesis

    OpenAIRE

    Lamers, Susanna L.; Fogel, Gary B.; Michael S McGrath

    2010-01-01

    The discovery of microRNAs (miRNAs) in viruses has generated considerable attention into their functional relevance in processes such as cell death, viral proliferation, and oncogenesis. Two early studies found no detectable miRNAs expressed within HIV; however, several studies have verified the existence and function of three HIV miRNAs, most notably HIV-miR-TAR, thus making the earlier results controversial. Although miRNAs are highly conserved within most species, HIV is known to have a hi...

  8. Implications of prioritizing HIV cure: new momentum to overcome old challenges in HIV.

    OpenAIRE

    Tucker, JD; Gilbertson, A; Lo, YR; Vitória, M

    2016-01-01

    Background Curing HIV is a new strategic priority for several major AIDS organizations. In step with this new priority, HIV cure research and related programs are advancing in low, middle, and high-income country settings. This HIV cure momentum may influence existing HIV programs and research priorities. Discussion Despite the early stage of ongoing HIV cure efforts, these changes have directly influenced HIV research funding priorities, pilot programs, and HIV messaging. The building moment...

  9. Oral Complications of HIV Disease

    OpenAIRE

    Leao, Jair C.; Camila M. B. Ribeiro; Carvalho, Alessandra A. T.; Cristina Frezzini; Stephen Porter

    2009-01-01

    Oral lesions are among the early signs of HIV infection and can predict its progression to acquired immunodeficiency syndrome (AIDS). A better understanding of the oral manifestations of AIDS in both adults and children has implications for all health care professionals. The knowledge of such alterations would allow for early recognition of HIV-infected patients. The present paper reviews epidemiology, relevant aspects of HIV infection related to the mouth in both adults and children, as well...

  10. Family Wellness, Not HIV Prevention

    OpenAIRE

    Rotheram-Borus, Mary Jane; Swendeman, Dallas; Flannery, Diane

    2009-01-01

    HIV exceptionalism (and disease-specific programs generally) garner both unbalanced funding and the most talented personnel, distorting local health priorities. In support of HIV exceptionalism, the successful mobilization of significant global health sector resources was not possible prior to HIV. Both sides of the debate have merits; rather than perpetuating polarization, we suggest that sustained improvements in global health require creating a prevention infrastructure to meet multiple he...

  11. Hyperthermia stimulates HIV-1 replication.

    OpenAIRE

    Ferdinand Roesch; Oussama Meziane; Anna Kula; Sébastien Nisole; Françoise Porrot; Ian Anderson; Fabrizio Mammano; Ariberto Fassati; Alessandro Marcello; Monsef Benkirane; Olivier Schwartz

    2012-01-01

    International audience HIV-infected individuals may experience fever episodes. Fever is an elevation of the body temperature accompanied by inflammation. It is usually beneficial for the host through enhancement of immunological defenses. In cultures, transient non-physiological heat shock (42-45°C) and Heat Shock Proteins (HSPs) modulate HIV-1 replication, through poorly defined mechanisms. The effect of physiological hyperthermia (38-40°C) on HIV-1 infection has not been extensively inve...

  12. HIV-1 Antiretroviral Drug Therapy

    OpenAIRE

    Arts, Eric J.; Hazuda, Daria J.

    2012-01-01

    The most significant advance in the medical management of HIV-1 infection has been the treatment of patients with antiviral drugs, which can suppress HIV-1 replication to undetectable levels. The discovery of HIV-1 as the causative agent of AIDS together with an ever-increasing understanding of the virus replication cycle have been instrumental in this effort by providing researchers with the knowledge and tools required to prosecute drug discovery efforts focused on targeted inhibition with ...

  13. HIV: Social and Environmental Factors

    Centers for Disease Control (CDC) Podcasts

    2012-02-01

    Dr. Kevin Fenton, Director of CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, discusses how social and environmental factors may put African Americans at greater risk for HIV.  Created: 2/1/2012 by National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP).   Date Released: 2/1/2012.

  14. National HIV/AIDS Strategy

    Centers for Disease Control (CDC) Podcasts

    2012-02-01

    Dr. Kevin Fenton, Director of CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, talks about the importance of the National HIV/AIDS Strategy and the work of CDC.  Created: 2/1/2012 by National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP).   Date Released: 2/1/2012.

  15. Ocular manifestations of HIV infection.

    OpenAIRE

    Jabs, D A

    1995-01-01

    OBJECTIVE: To evaluate the frequency of ocular complications and the clinical outcomes of these complications in patients with various stages of HIV infection. METHODS: Retrospective review of all HIV-infected patients seen in an AIDS ophthalmology clinic from November 1983 through December 31, 1992. RESULTS: Eleven-hundred sixty-three patients were seen for ophthalmologic evaluation. Of these, 781 had the acquired immune deficiency syndrome (AIDS), 226 had symptomatic HIV infection (AIDs-rel...

  16. HIV testing, staging, and evaluation.

    Science.gov (United States)

    Rodriguez, Carla V; Horberg, Michael A

    2014-09-01

    HIV testing and incidence are stable, but trends for certain populations are concerning. Primary prevention must be reinvigorated and target vulnerable populations. Science and policy have progressed to improve the accuracy, speed, privacy, and affordability of HIV testing. More potent and much better tolerated HIV treatments and a multidisciplinary approach to care have increased adherence and viral suppression. Changes to health care law in the United States seek to expand the affordability and access of improved HIV diagnostics and treatment. Continued challenges include improving long-term outcomes in people on lifetime regimens, reducing comorbidities associated with those regimens, and preventing further transmission. PMID:25151560

  17. Bromodomain Proteins in HIV Infection

    Directory of Open Access Journals (Sweden)

    Melanie Ott

    2013-06-01

    Full Text Available Bromodomains are conserved protein modules of ~110 amino acids that bind acetylated lysine residues in histone and non-histone proteins. Bromodomains are present in many chromatin-associated transcriptional regulators and have been linked to diverse aspects of the HIV life cycle, including transcription and integration. Here, we review the role of bromodomain-containing proteins in HIV infection. We begin with a focus on acetylated viral factors, followed by a discussion of structural and biological studies defining the involvement of bromodomain proteins in the HIV life cycle. We end with an overview of promising new studies of bromodomain inhibitory compounds for the treatment of HIV latency.

  18. A conditionally replicating HIV-1 vector interferes with wild-type HIV-1 replication and spread.

    OpenAIRE

    Dropulić, B; Hĕrmánková, M; Pitha, P M

    1996-01-01

    Defective-interfering viruses are known to modulate virus pathogenicity. We describe conditionally replicating HIV-1 (crHIV) vectors that interfere with wild-type HIV-1 (wt-HIV) replication and spread. crHIV vectors are defective-interfering HIV genomes that do not encode viral proteins and replicate only in the presence of wt-HIV helper virus. In cells that contain both wt-HIV and crHIV genomes, the latter are shown to have a selective advantage for packaging into progeny virions because the...

  19. HIV Behavioral Research Online

    OpenAIRE

    Chiasson, Mary Ann; Parsons, Jeffrey T.; Tesoriero, James M.; Carballo-Dieguez, Alex; Hirshfield, Sabina; Remien, Robert H.

    2006-01-01

    Internet access has caused a global revolution in the way people of all ages and genders interact. Many have turned to the Internet to seek love, companionship, and sex, prompting researchers to move behavioral studies online. The sexual behavior of men who have sex with men (MSM) has been more closely studied than that of any other group online given the abundance of gay-oriented websites and concerns about increasing transmission of HIV and other sexually transmitted infections. Not only do...

  20. Psychotropic Drugs and HIV

    OpenAIRE

    Ana-Lúcia Moreira; Melinda Carmen Godinho Pereira; Diogo Telles-Correia

    2014-01-01

    Background: HIV/AIDS infection is frequently associated with psychiatric disor- ders like psychosis, depression and anxiety. Psychiatric comorbidities may interfere with adherence to antiretroviral treatment. Therefore, diagnosis and treatment of these conditions are essential. However, the administration of a psychotropic drug to HAART therapy can result in drug interactions.Objectives: This review aims to analyze the various psychotropic drugs that can be used in these patients, as well as ...

  1. Chemokines, lymphocytes, and HIV

    Directory of Open Access Journals (Sweden)

    Farber J.M.

    1998-01-01

    Full Text Available Chemokines are members of a family of more than 30 human cytokines whose best-described activities are as chemotactic factors for leukocytes and that are presumed to be important in leukocyte recruitment and trafficking. While many chemokines can act on lymphocytes, the roles of chemokines and their receptors in lymphocyte biology are poorly understood. The recent discoveries that chemokines can suppress infection by HIV-1 and that chemokine receptors serve, along with CD4, as obligate co-receptors for HIV-1 entry have lent urgency to studies on the relationships between chemokines and lymphocytes. My laboratory has characterized Mig and Crg-2/IP-10, chemokines that are induced by IFN-g and that specifically target lymphocytes, particularly activated T cells. We have demonstrated that the genes for these chemokines are widely expressed during experimental infections in mice with protozoan and viral pathogens, but that the patterns of mig and crg-2 expression differed, suggesting non-redundant roles in vivo. Our related studies to identify new chemokine receptors from activated lymphocytes resulted in the cloning of STRL22 and STRL33. We and others have shown that STRL22 is a receptor for the CC chemokine MIP-3a, and STRL22 has been re-named CCR6. Although STRL33 remains an orphan receptor, we have shown that it can function as a co-receptor for HIV-1 envelope glycoproteins, and that it is active with a broader range of HIV-1 envelope glycoproteins than the major co-receptors described to date. The ability of STRL33 to function with a wide variety of envelope glycoproteins may become particularly important if therapies are instituted to block other specific co-receptors. We presume that investigations into the roles of chemokines and their receptors in lymphocyte biology will provide information important for understanding the pathogenesis of AIDS and for manipulating immune and inflammatory responses for clinical benefit

  2. HIV stigma among substance abusing people living with HIV/AIDS: implications for HIV treatment.

    Science.gov (United States)

    Levi-Minzi, Maria A; Surratt, Hilary L

    2014-08-01

    HIV-related stigma has a major impact on quality of life and health among people living with HIV and AIDS (PLWHA). This study examines demographic, mental health, behavioral, contextual, and HIV care-related correlates of HIV stigma among 503 substance abusing PLWHA. Stigma was measured with the HIV Internalized Stigma Measure which has four subscales: stereotypes about HIV, self-acceptance, disclosure concerns, and social relationships. Severe substance dependence (55.3%) and depression (54.7%) were associated with higher HIV stigma across all domains. 49.9% of the sample reported antiretroviral (ARV) medication diversion (the unlawful sale and trading of ARV medications); diverters endorsed significantly higher stigma related to disclosure. 54.1% of the sample reported ≥95% ARV adherence; these individuals reported significantly lower stigma for self-acceptance, disclosure, and social relationships. Multivariate linear regression showed that depression and social support demonstrated significant main effects across stigma domains. Findings suggest that interventions to decrease HIV related stigma may be an important component of initiatives to increase engagement in HIV care. PMID:24983302

  3. An HIV-Preventive Intervention for Youth Living with HIV

    Science.gov (United States)

    Lightfoot, Marguerita; Rotheram-Borus, Mary Jane; Tevendale, Heather

    2007-01-01

    As the number of youth infected with HIV rises, secondary prevention programs are needed to help youth living with HIV meet three goals: (1) increase self-care behaviors, medical adherence, and health-related interactions; (2) reduce transmission acts; and (3) enhance their quality of life. This article describes an intervention program for youth…

  4. Characteristics, Immunological Response & Treatment Outcomes of HIV-2 Compared with HIV-1 & Dual Infections (HIV 1/2) in Mumbai

    OpenAIRE

    Chiara, Montaldo; Rony, Zachariah; Homa, Mansoor; Bhanumati, Varghese; Ladomirska, Joanna; Manzi, M.; Wilson, N; Alaka, Deshpande; Harries, A. D.

    2010-01-01

    Background & objectives: Information available on HIV-2 and dual infection (HIV-1/2) is limited. This study was carried out among HIV positive individuals in an urban referral clinic in Khar, Mumbai, India, to report on relative proportions of HIV-1, HIV-2 and HIV-1/2 and baseline characteristics, response to and outcomes on antiretroviral treatment (ART). Methods: Retrospective analysis of programme data (May 2006-May 2009) at Khar HIV/AIDS clinic at Mumbai, India was done. Three test algori...

  5. How you get HIV/AIDS

    Science.gov (United States)

    How you get HIV/AIDS Which body fluids contain HIV? HIV is a virus that lives in blood and other fluids in the body. Moving ... answers to any questions you have about HIV/AIDS. Your public health department and health care provider ...

  6. Fotodegradovatelné inhibitory HIV proteasy

    Czech Academy of Sciences Publication Activity Database

    Schimer, Jiří; Pávová, Marcela; Prouzová, Hana; Weber, Jan; Cígler, Petr; Majer, Pavel; Konvalinka, Jan

    2014-01-01

    Roč. 108, č. 5 (2014), s. 549. ISSN 0009-2770. [Mezioborové setkání mladých biologů, biochemiků a chemiků /14./. 13.05.2014-16.05.2014, Milovy] Institutional support: RVO:61388963 Keywords : HIV protease * HIV PR inhibitors * Caged HIV Pr * HIV maturation Subject RIV: CE - Biochemistry

  7. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... prevention clinical trials, and other research information for health care providers, researchers, people affected by HIV/AIDS, and ... HIV/AIDS : This site provides information both for health care providers and for Veterans and the public. Past ...

  8. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... Children & Teens Search Connect with NIDA : Google Plus Facebook LinkedIn Twitter YouTube Flickr RSS Menu Home Drugs ... HIV Learn the Link - Drugs and HIV Email Facebook Twitter 2005 –Ongoing Behaviors associated with drug abuse ...

  9. HIV/AIDS and Pregnancy

    Science.gov (United States)

    If you have HIV/AIDS and find out you are pregnant or think you may be pregnant, you should let your health care provider know as soon as possible. Some HIV/AIDS medicines may harm your baby. Your health ...

  10. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... can pass HIV to their babies during pregnancy, delivery, and breastfeeding. HIV destroys a certain kind of white blood cell that is crucial to the normal function of the human immune system. Loss of these CD4+ cells in people with ...

  11. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... gov New Media Tools : These new media tools offer new ways to deliver HIV/AIDS information to ... U.S. Department of Health and Human Services (HHS), offers access to the latest, federally approved HIV/AIDS ...

  12. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... Strategic Plan Search Share Print Home » News & Events » Public Education Projects » Learn the Link - Drugs and HIV Learn the Link - Drugs and HIV Email Facebook Twitter 2005 –Ongoing Behaviors associated with drug abuse are among the main ...

  13. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... home page . blog.AIDS.gov : This blog fosters public discussions on using new media effectively in response to HIV/AIDS, as well as HIV/AIDS research and policies. AIDS.gov New Media Tools : These new media ...

  14. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... the message to young people and to parents, teachers, and the media about the link between drug abuse and HIV. We have produced a set of ... the message to young people and to parents, teachers, and the media about the link between drug abuse and HIV. Post on Facebook or Twitter ; add ...

  15. Drugs + HIV, Learn the Link

    Science.gov (United States)

    ... the message to young people and to parents, teachers, and the media about the link between drug abuse and HIV. We have produced a set of ... the message to young people and to parents, teachers, and the media about the link between drug abuse and HIV. Post on Facebook or Twitter ; add ...

  16. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... with HIV is a key predictor of the development of AIDS. Because of their compromised immune system, ... at: https://www.drugabuse.gov/news-events/public-education-projects/learn-link-drugs-hiv . 120x90 460x80 486x60 ...

  17. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... party and under the influence of drugs and alcohol engaged in risky sexual behavior that resulted in HIV infection. Watch the "After ... young adults that non-injection drug use and alcohol use can lead to poor ... behaviors and HIV infection. Although the characters are fictional, ...

  18. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... info. nih.gov : AIDSinfo, a service of the U.S. Department of Health and Human Services (HHS), offers ... affected by HIV/AIDS, and the general public. U.S. National Library of Medicine HIV/AIDS Information : Specialized ...

  19. HIV Testing among Detained Youth

    Science.gov (United States)

    Voisin, Dexter R.; Salazar, Laura F.; Crosby, Richard; DiClemente, Ralph J.; Yarber, William L.; Staples-Horne, Michelle

    2004-01-01

    Published reports have not investigated the issue of voluntary HIV testing among detained youth, a population disproportionately infected with HIV compared to other adolescent groups. Data were collected from 467 sexually active detained adolescents in Georgia on demographic, environmental, and drug and sexual history variables, to explore…

  20. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... gov/hiv-aids-basics/hiv-aids-101/statistics/ . Reference Centers for Disease Control and Prevention, National Center ... services, and referrals for medical and social services. Reference Marcondes, M.C. et al. “Methamphetamine increases brain ...

  1. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... HIV to their babies during pregnancy, delivery, and breastfeeding. HIV destroys a certain kind of white blood ... DC Department of Health AIDS Arms, Inc. National Community Center of Excellence in Women’s Health National Women’s ...

  2. Syphilis in the HIV Era

    OpenAIRE

    Kassutto, Sigall; Doweiko, John P.

    2004-01-01

    The incidence of syphilis has consistently increased from 2000 to 2002. We report a case of acquired syphilis with symptoms of Tullio phenomenon in a patient concurrently diagnosed with HIV infection. The resurgence of syphilis in HIV-positive groups at high risk has public health implications for prevention of both diseases.

  3. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... public service ads (PSA) where an HIV-positive teenager recounts the night she went to a party and under the influence of drugs and alcohol engaged in risky sexual behavior that resulted in HIV infection. Watch the "After ...

  4. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... HIV patients who do not abuse drugs. In animal studies, methamphetamine has been shown to increase the amount of HIV in brain cells 1 . Drug abuse treatment. Since the late 1980s, research has shown that treating drug abuse is an ...

  5. Jamie Foxx Talks About HIV

    Centers for Disease Control (CDC) Podcasts

    2012-07-24

    Jamie Foxx, Academy Award winning actor and singer, urges everyone to talk about HIV/AIDS and its prevention.  Created: 7/24/2012 by National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP).   Date Released: 7/24/2012.

  6. HIV/AIDS and Pregnancy

    Science.gov (United States)

    If you have HIV/AIDS and find out you are pregnant or think you may be pregnant, you should let your health care provider know as soon as possible. Some HIV/AIDS medicines may harm your baby. Your health care ...

  7. Encephalitis in primary HIV infection

    DEFF Research Database (Denmark)

    Helleberg, M; Kirk, O

    2013-01-01

    We report a case of primary HIV encephalitis, which initially presented as acute psychosis. Magnetic resonance imaging of the brain was suggestive of vasculitis and multiple infarctions, whereas a brain biopsy after six weeks of symptoms showed HIV encephalitis with microglial nodules, but no sig...

  8. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... gov/hiv/risk/age/youth/index.html​ . Resources Publications Drug Facts: HIV/AIDS and Drug Abuse: Intertwined ... Press Office Meetings & Events Media Guide Get this Publication Español View Webisodes View Videos "After the Party" " ...

  9. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... HIV/AIDS, and the general public. U.S. National Library of Medicine HIV/AIDS Information : Specialized Information Services. ... NIDA TV PEERx Drugs & Health Blog The NIDA Science Fair Award for Addiction Science USA Science & Engineering ...

  10. An ancestral HIV-2/simian immunodeficiency virus peptide with potent HIV-1 and HIV-2 fusion inhibitor activity

    OpenAIRE

    Borrego, Pedro; Calado, Rita; Marcelino, José M.; Pereira, Patrícia MR; Quintas, Alexandre; Barroso, Helena; Taveira, Nuno

    2013-01-01

    "Objectives: To produce new fusion inhibitor peptides for HIV-1 and HIV-2 based on ancestral envelope sequences. Methods: HIV-2/simian immunodeficiency virus (SIV) ancestral transmembrane protein sequences were reconstructed and ancestral peptides were derived from the helical region 2 (HR2). The activity of one ancestral peptide (named P3) was examined against a panel of HIV-1 and HIV-2 primary isolates in TZM-bl cells and peripheral blood mononuclear cells and compared to ...

  11. Impact of HIV-1, HIV-2 and HIV-1+2 dual infection on the outcome of tuberculosis

    DEFF Research Database (Denmark)

    Wejse, C; Patsche, C B; Kühle, A;

    2014-01-01

    BACKGROUND: HIV-1 infection has been shown to impact the outcome of patients with tuberculosis (TB), but data regarding the impact of HIV-2 on TB outcomes are limited. The aim of this study was to assess the impact of HIV types on mortality among TB patients in Guinea-Bissau and to examine the...... predictive ability of the TBscoreII, a clinical score used to assess disease severity. METHODS: In a prospective follow-up study, we examined the prevalence of HIV-1, HIV-2, and HIV-1+2 co-infection in TB patients in Guinea-Bissau, and the impact on outcomes at 12 months of follow-up. We included all adult...... seventy-nine patients were HIV-infected: 241 had HIV-1, 93 had HIV-2, and 45 were HIV-1+2 dual infected. The HIV type-associated risk of TB was 6-fold higher for HIV-1, 7-fold higher for HIV-1+2 dual infection, and 2-fold higher for HIV-2 compared with the HIV-uninfected. Of the patients included, 144 (11...

  12. Is an HIV vaccine possible?

    Directory of Open Access Journals (Sweden)

    Nancy A. Wilson

    2009-08-01

    Full Text Available The road to the discovery of a vaccine for HIV has been arduous and will continue to be difficult over the ensuing twenty years. Most vaccines are developed by inducing neutralizing antibodies against the target pathogen or by using attenuated strains of the particular pathogen to engender a variety of protective immune responses. Unfortunately, simple methods of generating anti-HIV antibodies have already failed in a phase III clinical trial. While attenuated SIV variants work well against homologous challenges in non-human primates, the potential for reversion to a more pathogenic virus and recombination with challenge viruses will preclude the use of attenuated HIV in the field. It has been exceedingly frustrating to vaccinate for HIV-specific neutralizing antibodies given the enormous diversity of the Envelope (Env glycoprotein and its well-developed glycan shield. However, there are several antibodies that will neutralize many different strains of HIV and inducing these types of antibodies in vaccinees remains the goal of a vigorous effort to develop a vaccine for HIV based on neutralizing antibodies. Given the difficulty in generating broadly reactive neutralizing antibodies, the HIV vaccine field has turned its attention to inducing T cell responses against the virus using a variety of vectors. Unfortunately, the results from Merck's phase IIb STEP trial proved to be disappointing. Vaccinees received Adenovirus type 5 (Ad5 expressing Gag, Pol, and Nef of HIV. This vaccine regimen failed to either prevent infection or reduce the level of HIV replication after challenge. These results mirrored those in non-human primate testing of Ad5 using rigorous SIV challenge models. This review will focus on recent developments in HIV vaccine development. We will deal largely with attempts to develop a T cell-based vaccine using the non-human primate SIV challenge model.

  13. High Feasibility of Empiric HIV Treatment for Patients With Suspected Acute HIV in an Emergency Department.

    Science.gov (United States)

    Jacobson, Kathleen R; Arora, Sanjay; Walsh, Kristin B; Lora, Meredith; Merjavy, Stephen; Livermore, Shanna; Menchine, Michael

    2016-07-01

    Earlier intervention in acute HIV infection limits HIV reservoirs and may decrease HIV transmission. We developed criteria for empiric antiretroviral therapy (ART) in an emergency department (ED) routine HIV screening program. We assessed the feasibility and willingness of patients with suspected acute HIV infection in the ED to begin ART. A suspected acute HIV infection was defined as a positive HIV antigen antibody combination immunoassay with pending HIV-antibody differentiation test results and HIV RNA viral load. During the study period, there were 16 confirmed cases of acute HIV infection: 11 met our criteria for empiric ART and agreed to treatment, 10 were prescribed ART, and 1 left the ED against medical advice without a prescription for ART. Eight patients completed at least one follow-up visit. Empiric HIV treatment in an ED is feasible, well received by patients, and offers a unique entry point into the HIV care continuum. PMID:27028498

  14. Rapid HIV Testing in Large Urban Jails

    OpenAIRE

    Beckwith, Curt G.; Nunn, Amy; Baucom, Sharon; Getachew, Asresahegn; Akinwumi, Akin; Herdman, Bruce; DiBartolo, Phil; Spencer, Susan; Brown, Devon; Lesansky, Henry; Kuo, Irene

    2012-01-01

    HIV prevalence is higher in jails than in the community, yet many jails do not conduct HIV testing. Jails in Baltimore, Maryland; Philadelphia, Pennsylvania; and the District of Columbia have implemented innovative rapid HIV testing programs. We have summarized the results of these programs, including the numbers of persons tested, rapid and confirmatory HIV test results, and numbers of persons newly diagnosed with HIV. We have described facilitators and challenges of implementation. These pr...

  15. Nutrition and HIV-Positive Pregnancy

    OpenAIRE

    Montgomery, Kristen S.

    2003-01-01

    When an HIV-positive woman becomes pregnant, additional nutritional considerations are warranted. Compared to routine prenatal nutritional assessment and intervention, pregnant HIV-positive women have increased needs to promote a healthy outcome. This column contains information on HIV and pregnancy, nutrition and infection, and nutrition for HIV-positive pregnancy. This content can be integrated into childbirth education settings to improve care to women who are HIV-positive.

  16. HIV Testing, Subjective Beliefs and Economic Behavior

    OpenAIRE

    Rebecca L. Thornton

    2012-01-01

    This paper examines the effects of learning HIV status on economic behavior among rural Malawians. According to economic life-cycle models, if learning HIV results is informative about additional years of life, being diagnosed HIV-positive or negative should predict changes in consumption, investment and savings behavior with important micro and macro-economic implications. Using an experiment that randomly assigned incentives to learn HIV results, I find that while learning HIV results had s...

  17. Persistent HIV-1 replication during antiretroviral therapy

    OpenAIRE

    Martinez-Picado, Javier; Deeks, Steven G

    2016-01-01

    Purpose of review The present review will highlight some of the recent findings regarding the capacity of HIV-1 to replicate during antiretroviral therapy (ART). Recent findings Although ART is highly effective at inhibiting HIV replication, it is not curative. Several mechanisms contribute to HIV persistence during ART, including HIV latency, immune dysfunction, and perhaps persistent low-level spread of the virus to uninfected cells (replication). The success in curing HIV will depend on ef...

  18. HIV, opiates and enteric neuron dysfunction

    OpenAIRE

    Galligan, James J.

    2015-01-01

    HIV is an immunosuppressive virus that targets CD4+ T-lymphocytes. HIV infections cause increased susceptibility to opportunistic infections and cancer. HIV infection can also alter central nervous system (CNS) function causing cognitive impairment. HIV does not infect neurons but it does infect astrocytes and microglia in the CNS. HIV can also infect enteric glia initiating an intestinal inflammatory response which causes enteric neural injury and gut dysfunction. Part of the inflammatory re...

  19. Reducing mother-to-child HIV transmission

    Institute of Scientific and Technical Information of China (English)

    2001-01-01

    In developing countries,mother-to-child trans mission of human immune deficiency virus (HIV)is responsible for 5 to 10 percen t o f all new HIV infections.Most children born to HIV-positive mothers are not HIV positive,but one quarter to one third are.The following instert looks at the p o ssibilities for reducing mother-to-child HIV transmission,and discusses some of the questions that are still unanswered.

  20. Reward, attention, and HIV-related risk in HIV+ individuals.

    Science.gov (United States)

    Anderson, Brian A; Kronemer, Sharif I; Rilee, Jessica J; Sacktor, Ned; Marvel, Cherie L

    2016-08-01

    Human immunodeficiency virus (HIV) is often contracted through engaging in risky reward-motivated behaviors such as needle sharing and unprotected sex. Understanding the factors that make an individual more vulnerable to succumbing to the temptation to engage in these risky behaviors is important to limiting the spread of HIV. One potential source of this vulnerability concerns the degree to which an individual is able to resist paying attention to irrelevant reward information. In the present study, we examine this possible link by characterizing individual differences in value-based attentional bias in a sample of HIV+ individuals with varying histories of risk-taking behavior. Participants learned associations between experimental stimuli and monetary reward outcome. The degree of attentional bias for these reward-associated stimuli, reflected in their ability to capture attention when presented as task-irrelevant distractors, was then assessed both immediately and six months following reward learning. Value-driven attentional capture was related to substance abuse history and non-planning impulsiveness during the time leading up to contraction of HIV as measured via self-report. These findings suggest a link between the ability to ignore reward-associated information and prior HIV-related risk-taking behavior. Additionally, particular aspects of HIV-associated neurocognitive disorders were related to attentional bias, including motor deficits commonly associated with HIV-induced damage to the basal ganglia. PMID:26484383

  1. Occurrence of Pregnancies among HIV Infected Indian Women: Does Knowledge about HIV Status Make a Difference?

    OpenAIRE

    Shrinivas Darak; Inge Hutter; Sanjeevani Kulkarni; Vinay Kulkarni; Fanny Janssen

    2015-01-01

    textabstractThis is the first study to examine the behavioural effect of HIV on fertility among HIV infected women in India. Retrospective calendar data from ever-married HIV infected women between 15 and 45 years of age, attending a specialized HIV clinic in Pune, Western India (N = 560), were analysed. Directly standardized overall and parity-specific pregnancy rates were compared among HIV infected women before and after coming to know about their HIV status. The age- and parity-standardiz...

  2. Interactive Effects of Morphine on HIV Infection: Role in HIV-Associated Neurocognitive Disorder

    OpenAIRE

    Nair, Madhavan P.N.; Zainulabedin Saiyed; Saxena, Shailendra K; Sudheesh Pilakka-Kanthikeel; Pichili Vijaya Bhaskar Reddy

    2012-01-01

    HIV epidemic continues to be a severe public health problem and concern within USA and across the globe with about 33 million people infected with HIV. The frequency of drug abuse among HIV infected patients is rapidly increasing and is another major issue since injection drug users are at a greater risk of developing HIV associated neurocognitive dysfunctions compared to non-drug users infected with HIV. Brain is a major target for many of the recreational drugs and HIV. Evidences suggest th...

  3. The role of enacted stigma in parental HIV disclosure among HIV-infected parents in China

    OpenAIRE

    Qiao, Shan; Li, Xiaoming; Zhou, Yuejiao; Shen, Zhiyong; Tang, Zhenzhu; Stanton, Bonita

    2015-01-01

    Existing studies have delineated that HIV-infected parents face numerous challenges in disclosing their HIV infection to the children (“parental HIV disclosure”), and practices of parental HIV disclosure vary with individual characteristics, family contexts, and social environment. Using cross-sectional data from 1254 HIV-infected parents who had children aged 5–16 years in southwest China, the current study examined the association of parental HIV disclosure with mental health and medication...

  4. Ergotismo y HIV

    OpenAIRE

    Bárbara C. Finn; Sabrina Vadalá; Ana Meraldi; Julio E. Bruetman; Jorge V. Martínez; Pablo Young

    2013-01-01

    El ergotismo es una complicación de la intoxicación aguda y/o el abuso crónico de los derivados del ergot. Se manifiesta por síndrome vasomotor con enfermedad vascular periférica que frecuentemente compromete extremidades. Presentamos cuatro casos de pacientes infectados con el virus de la inmunodeficiencia humana 1 (HIV-1), en tratamiento con antirretrovirales que incluyen inhibidores de la proteasa reforzados con ritonavir, y que habían recibido ergotamina como automedicación. Ellos desarro...

  5. Potent Intratype Neutralizing Activity Distinguishes Human Immunodeficiency Virus Type 2 (HIV-2) from HIV-1

    OpenAIRE

    Özkaya Şahin, Gülşen; Holmgren, Birgitta; da Silva, Zacarias; Nielsen, Jens; Nowroozalizadeh, Salma; Esbjörnsson, Joakim; Månsson, Fredrik; Andersson, Sören; Norrgren, Hans; Aaby, Peter; Jansson, Marianne; Fenyö, Eva Maria

    2012-01-01

    HIV-2 has a lower pathogenicity and transmission rate than HIV-1. Neutralizing antibodies could be contributing to these observations. Here we explored side by side the potency and breadth of intratype and intertype neutralizing activity (NAc) in plasma of 20 HIV-1-, 20 HIV-2-, and 11 dually HIV-1/2 (HIV-D)-seropositive individuals from Guinea-Bissau, West Africa. Panels of primary isolates, five HIV-1 and five HIV-2 isolates, were tested in a plaque reduction assay using U87.CD4-CCR5 cells a...

  6. HIV: Past, present and future

    Directory of Open Access Journals (Sweden)

    Harindra V

    2008-01-01

    Full Text Available The origin of acquired immune deficiency syndrome (AIDS and human immunodeficiency virus (HIV has puzzled scientists ever since the illness first came to light in the early 1980s. For over 25 years it has been the subject of fierce debate and the cause of countless arguments. It is now generally accepted that HIV is a descendant of a simian immunodeficiency virus and there are many theories about how this ′zoonosis′ originated and how SIV became HIV in humans. Advances in treatment have steadily reduced the morbidity and mortality associated with HIV infection. However, in the low-income, high-prevalence countries, antiretroviral medication has taken a long time to reach the people who actually need it. Access to medication must greatly improve if millions of deaths are to be avoided. HIV is a preventable disease. Unless great progress is made in prevention, the number of people living with HIV will outstrip the resources available for treatment. The search for effective vaccines and microbicides must therefore be one of the very highest priorities. HIV is a global threat. Action needs to be taken to prevent it killing many more millions than those who have already died. This action needs not only to continue, but to be speeded up considerably.

  7. Why do HIV-1 and HIV-2 use different pathways to develop AZT resistance?

    Directory of Open Access Journals (Sweden)

    2006-02-01

    Full Text Available The human immunodeficiency virus type 1 (HIV-1 develops resistance to all available drugs, including the nucleoside analog reverse transcriptase inhibitors (NRTIs such as AZT. ATP-mediated excision underlies the most common form of HIV-1 resistance to AZT. However, clinical data suggest that when HIV-2 is challenged with AZT, it usually accumulates resistance mutations that cause AZT resistance by reduced incorporation of AZTTP rather than selective excision of AZTMP. We compared the properties of HIV-1 and HIV-2 reverse transcriptase (RT in vitro. Although both RTs have similar levels of polymerase activity, HIV-1 RT more readily incorporates, and is more susceptible to, inhibition by AZTTP than is HIV-2 RT. Differences in the region around the polymerase active site could explain why HIV-2 RT incorporates AZTTP less efficiently than HIV-1 RT. HIV-1 RT is markedly more efficient at carrying out the excision reaction with ATP as the pyrophosphate donor than is HIV-2 RT. This suggests that HIV-1 RT has a better nascent ATP binding site than HIV-2 RT, making it easier for HIV-1 RT to develop a more effective ATP binding site by mutation. A comparison of HIV-1 and HIV-2 RT shows that there are numerous differences in the putative ATP binding sites that could explain why HIV-1 RT binds ATP more effectively. HIV-1 RT incorporates AZTTP more efficiently than does HIV-2 RT. However, HIV-1 RT is more efficient at ATP-mediated excision of AZTMP than is HIV-2 RT. Mutations in HIV-1 RT conferring AZT resistance tend to increase the efficiency of the ATP-mediated excision pathway, while mutations in HIV-2 RT conferring AZT resistance tend to increase the level of AZTTP exclusion from the polymerase active site. Thus, each RT usually chooses the pathway best suited to extend the properties of the respective wild-type enzymes.

  8. EFFECT OF HIV PREVENTION AND TREATMENT PROGRAM ON HIV AND HCV TRANSMISSION AND HIV MORTALITY AT AN INDONESIAN NARCOTIC PRISON.

    Science.gov (United States)

    Nelwan, Erni J; Indrati, Agnes K; Isa, Ahmad; Triani, Nurlita; Alam, Nisaa Nur; Herlan, Maria S; Husen, Wahid; Pohan, Herdiman T; Alisjahbana, Bachti; Meheus, Andre; Van Crevel, Reinout; van der Ven, Andre Jam

    2015-09-01

    Validated data regarding HIV-transmission in prisons in developing countries is scarce. We examined sexual and injecting drug use behavior and HIV and HCV transmission in an Indonesian narcotic prison during the implementation of an HIV prevention and treatment program during 2004-2007 when the Banceuy Narcotic Prison in Indonesia conducted an HIV transmission prevention program to provide 1) HIV education, 2) voluntary HIV testing and counseling, 3) condom supply, 4) prevention of rape and sexual violence, 5) antiretroviral treatment for HIV-positive prisoners and 6) methadone maintenance treatment. During a first survey that was conducted between 2007 and 2009, new prisoners entered Banceuy Narcotics Prison were voluntary tested for HIV and HCV-infection after written informed consent was obtained. Information regarding sexual and injecting risk behavior and physical status were also recorded at admission to the prison. Participants who tested negative for both HIV and HCV during the first survey were included in a second survey conducted during 2008-2011. During both surveys, data on mortality among HIV-seropositive patients were also recorded. All HIV-seropositive participants receive treatment for HIV. HIV/ AIDS-related deaths decreased: 43% in 2006, 18% in 2007, 9% in 2008 and 0% in 2009. No HIV and HCV seroconversion inside Banceuy Narcotic Prison were found after a median of 23 months imprisonment (maximum follow-up: 38 months). Total of 484.8 person-years observation was done. Participants reported HIV transmission risk-behavior in Banceuy Prison during the second survey was low. After implementation of HIV prevention and treatment program, no new HIV or HCV cases were detected and HIV-related mortality decreased. PMID:26863859

  9. Oral complications of HIV disease

    Directory of Open Access Journals (Sweden)

    Jair C. Leao

    2009-05-01

    Full Text Available Oral lesions are among the early signs of HIV infection and can predict its progression to acquired immunodeficiency syndrome (AIDS. A better understanding of the oral manifestations of AIDS in both adults and children has implications for all health care professionals. The knowledge of such alterations would allow for early recognition of HIV-infected patients. The present paper reviews epidemiology, relevant aspects of HIV infection related to the mouth in both adults and children, as well as current trends in antiretroviral therapy and its connection with orofacial manifestations related to AIDS.

  10. HIV / AIDS Network.

    Science.gov (United States)

    1995-01-01

    The HIV/AIDS Network and the Philippines Department of Health (DOH) collaborated to produce the AIDS Candlelight Memorial at the Philippine International Convention Center (PICC), May 1995, and World AIDS Day activities on December 1, 1995. After the memorial, a fashion show, "Body Shots," provided a channel for information on acquired immunodeficiency syndrome (AIDS). On World AIDS Day, at the request of DOH, the Network provided speakers who lectured on human immunodeficiency virus (HIV) and AIDS in different government offices. Prior to World AIDS Day, the Network focused on strengthening its cohesiveness and building the capabilities of its member organizations through lectures and symposia during November. Network activities were coordinated by the Remedios AIDS Foundation with support from the other members of the Coordinating Council: Health Action Information Network (HAIN); Caritas; Kabalikat, Stop Trafficking of Pilopinos Foundation, Inc. (STOP);and the Library Foundation (TLF). The Coordinating Council elected for 1996 includes the Remedios AIDS Foundation, HAIN, Caritas, TLF, STOP, the Foundation for Adolescent Development (FAD), and the Salvation Army. PMID:12291699

  11. HIV/AIDS epidemiology.

    Science.gov (United States)

    Todd, C

    2000-10-14

    In this paper, Charles Todd comments that the report of Evan Wood and colleagues illustrates the dangers of taking a narrow medical view of the HIV/AIDS epidemic in Africa. It runs the risk of reversing the growing realization that the HIV/AIDS epidemic in southern Africa is a broad, social, cultural, political, and economic issue rather than a purely medical one. Todd raises the point that Wood and colleagues did not model the costs associated with the voluntary testing and counseling that should accompany a prophylaxis program. To this effect, a more helpful approach on meeting basic health needs and eradicating poverty would be to compare the impact of such levels of expenditure. It is also emphasized that the title of the paper of Wood and colleagues is misleading, implying that the focus of the modeling was sub-Saharan Africa as a whole, when it was in fact South Africa alone. Accordingly, the gross domestic product of South Africa per person is higher than that of nearly all other sub-Saharan African countries, and health expenditure is 10-20 times greater. PMID:11073053

  12. [Risk of contracting HIV].

    Science.gov (United States)

    Becerra, Valeria Peixoto; Gaspar, Maria Filomena M; Alves, Maria Do Socorro C F

    2009-04-01

    The authors identify social activities related to the risk of contracting HIV in nursing students, bearing in mind their influence while using bio-secure methods, by means of an exploratory and qualitative study; 168 Superior School of Nursing in Lisbon, Portugal students participated in this study. Data were gathered by means of a Free Association Word Test which includes social demographic variables related to the participants. 90% of the 168 students in this study were female and 10% male. The majority 79,2%, of the participants age fell between 21 and 25 years and 97,6% of these participants were Portuguese. In the free association word test when responding to the stimulus HIV/AIDS, participants expressed disease (which is contagious in a clinical setting), and death as the awaited outcome for it. For the test term "risk of contagion when dealing with an AIDS patient" the participants often mentioned the words protection against contagion, as well as fear to contact blood and gloves as the main prevention method. To the stimulus measures of bio-security the words most frequently cited were glove as a protective measure in the context of professional activity and preservative (condom) to avoid contagion in other social contexts experienced by the participants. PMID:19554898

  13. Impact of HIV-1, HIV-2, and HIV-1+2 dual infection on the outcome of tuberculosis

    OpenAIRE

    C. Wejse; C.B. Patsche; Kühle, A.; F.J.V. Bamba; Mendes, M. S.; G. Lemvik; V.F. Gomes; F. Rudolf

    2015-01-01

    Background: HIV-1 infection has been shown to impact the outcome of patients with tuberculosis (TB), but data regarding the impact of HIV-2 on TB outcomes are limited. The aim of this study was to assess the impact of HIV types on mortality among TB patients in Guinea-Bissau and to examine the predictive ability of the TBscoreII, a clinical score used to assess disease severity. Methods: In a prospective follow-up study, we examined the prevalence of HIV-1, HIV-2, and HIV-1+2 co-infection ...

  14. HIV among African American Gay and Bisexual Men

    Science.gov (United States)

    ... VIH En Español Get Tested Find an HIV testing site near you. Enter ZIP code or city Follow HIV/AIDS CDC HIV CDC HIV/AIDS See RSS | ... Email Updates on HIV Syndicated Content Website Feedback HIV Among African American Gay and Bisexual Men Format: ...

  15. EASY-HIT: HIV Full-Replication Technology for Broad Discovery of Multiple Classes of HIV Inhibitors▿ †

    OpenAIRE

    Kremb, Stephan; Helfer, Markus; Heller, Werner; Hoffmann, Dieter; Wolff, Horst; Kleinschmidt, Andrea; Cepok, Sabine; Hemmer, Bernhard; Durner, Jörg; Brack-Werner, Ruth

    2010-01-01

    HIV replication assays are important tools for HIV drug discovery efforts. Here, we present a full HIV replication system (EASY-HIT) for the identification and analysis of HIV inhibitors. This technology is based on adherently growing HIV-susceptible cells, with a stable fluorescent reporter gene activated by HIV Tat and Rev. A fluorescence-based assay was designed that measures HIV infection by two parameters relating to the early and the late phases of HIV replication, respectively. Validat...

  16. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... Nicotine Other Drugs Related Topics Addiction Science Adolescent Brain Comorbidity College-Age & Young Adults Criminal Justice Drugged Driving Drug Testing Drugs and the Brain Genetics Global Health Hepatitis (Viral) HIV/AIDS Medical ...

  17. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... is treatment, but no cure, at the present time. The virus (HIV) and the disease it causes ( ... en Español LATeen Viva La Fiesta! Trace Washington Times USA Today Companies: Washington Metropolitan Area Transit Authority ( ...

  18. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... Facebook Twitter 2005 –Ongoing Behaviors associated with drug abuse are among the main factors in the spread of HIV infection in the United States. Drugs can change the way the brain works, ...

  19. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... with HIV is a key predictor of the development of AIDS. Because of their compromised immune system, ... Children, Youth and Families The American Academy of Child & Adolescent Psychiatry (AACAP) The United Negro College Fund, ...

  20. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... Abuse, Dr. Nora D. Volkow. Message from the Director The Link Between HIV/AIDS and Drug Abuse ... Web site. Sincerely, Nora D. Volkow, M.D. Director National Institute on Drug Abuse Collaborators Thanks to ...

  1. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... Commonly Abused Drugs Charts Emerging Trends and Alerts Alcohol Club Drugs Cocaine Hallucinogens Heroin Inhalants Marijuana MDMA ( ... person at risk for getting HIV. Drug and alcohol intoxication affect judgment and can lead to unsafe ...

  2. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... patients who do not abuse drugs. In animal studies, methamphetamine has been shown to increase the amount ... behaviors. NIDA researchers have studied and continue to study the links between drug abuse and HIV/AIDS. ...

  3. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... are at risk for contracting HIV. In general, middle and late teen years are when young people ... Children, Youth and Families The American Academy of Child & Adolescent Psychiatry (AACAP) The United Negro College Fund, ...

  4. Answers about HIV Vaccine Research

    Science.gov (United States)

    ... trial participation by people of all races/ethnicities, genders and socioeconomic backgrounds. • Support vaccine volunteers and/or ... preventive HIV vaccines. These include leading universities, biotechnology companies, pharmaceutical firms and government agencies such as NIAID. • ...

  5. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... between drug abuse and HIV infection. It contains information for young people, parents and ... AIDS is a disease of the immune system for which there is treatment, but no cure, ...

  6. Maraviroc (Celsentri in HIV treatment

    Directory of Open Access Journals (Sweden)

    Viola Sacchi

    2008-12-01

    Full Text Available Since 1996, the prognosis of people living with immunodeficiency virus (HIV and acquired immunodeficiency syndrome (AIDS has improved significantly, due to highly active antiretroviral therapies (HAART based on a combination of 3-4 anti-HIV drugs; the use ofthese drugs can achieve a durable suppression of HIV viraemia, turning HIV infection into a chronic illness. The three first licensed classes of antiretroviral agents are nucleoside reverse transcriptase inhibitors (NRTIs, non-nucleoside reverse transcriptase inhibitors (NNRTIs and protease inhibitors (PIs. Until recently, treatment options for individuals developing resistanceto these drugs have been limited, but new drugs in existing classes (second generation NNRTIs and novel PIs and novel classes of drugs (integrase inhibitors, CCR5 antagonists and fusion inhibitors have become clinically available.

  7. Drugs That Fight HIV-1

    Science.gov (United States)

    ... program of the National Institutes of Health Nucleoside Reverse Transcriptase Inhibitors (NRTIs) NRTIs block reverse transcriptase, an enzyme HIV- ... these products are on last page.) Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) NNRTIs bind to and alter reverse transcriptase, ...

  8. FDA-Approved HIV Medicines

    Science.gov (United States)

    ... and acronyms) Brand Name FDA Approval Date Nucleoside Reverse Transcriptase Inhibitors (NRTIs) NRTIs block reverse transcriptase, an enzyme HIV ... AZT, ZDV) Retrovir March 19, 1987 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) NNRTIs bind to and later alter reverse ...

  9. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... with HIV is a key predictor of the development of AIDS. Because of their compromised immune system, ... their peers to prevent the spread of this disease. NIDA's public service announcements depict the devastating consequences ...

  10. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... Global Health Hepatitis (Viral) HIV/AIDS Medical Consequences Mental Health Military Pain Prevention Treatment Trends & Statistics Women ... After the Party" "Text Message" NIDA Home Site Map FAQs Accessibility Privacy FOIA(NIH) Working at NIDA ...

  11. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... chances of unsafe behavior by altering judgment and decision-making. To learn about HIV among youth, please visit: ... use and alcohol use can lead to poor decision making, which can result in risky sexual behaviors and ...

  12. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... is crucial to the normal function of the human immune system. Loss of these CD4+ cells in people with HIV is a key predictor of the development of AIDS. Because of their compromised immune system, ...

  13. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... Testing Drugs and the Brain Genetics Global Health Hepatitis (Viral) HIV/AIDS Medical Consequences Mental Health Military ... be transmitted between users. Other infections-such as hepatitis C-can also be spread this way. Hepatitis ...

  14. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... HIV patients who do not abuse drugs. In animal studies, methamphetamine has been shown to increase the ... a means of communication. The "Text Message" PSA features two young girls texting each other about a ...

  15. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... with HIV is a key predictor of the development of AIDS. Because of their compromised immune system, ... Foundation for Women Legislators (NFWL) Educational Institutions: Florida International University Montgomery College Center for the Advancement of ...

  16. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... of the brain that people use to weigh risks and benefits when making decisions. This page connects ... not just injection) can put a person at risk for getting HIV. Drug and alcohol intoxication affect ...

  17. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... greater injury to cells in the brain and cognitive impairment among methamphetamine abusers than among HIV patients ... After the Party" "Text Message" NIDA Home Site Map FAQs Accessibility Privacy FOIA(NIH) Working at NIDA ...

  18. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... Salts) Tobacco/Nicotine Related Topics Addiction Science Adolescent Brain Comorbidity College-Age & Young Adults Criminal Justice Drugged Driving Drug Testing Drugs and the Brain Genetics Global Health Hepatitis (Viral) HIV/AIDS Medical ...

  19. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... Charts Emerging Trends Alcohol Club Drugs Cocaine Hallucinogens Heroin Inhalants Marijuana MDMA (Ecstasy/Molly) Methamphetamine Opioids Prescription ... brain. Research has shown that HIV causes greater injury to cells in the brain and cognitive impairment ...

  20. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... Global Health Hepatitis (Viral) HIV/AIDS Medical Consequences Mental Health Military Pain Prevention Treatment Trends & Statistics Women ... AIDS (acquired immune deficiency syndrome). AIDS is a disease of the immune system for which there is ...

  1. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... HIV/AIDS : This site provides information both for health care providers and for Veterans and the public. Past Public Service Announcements Jack & Jill : Campaign launch, December 1, 2001. This page includes radio ...

  2. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... clinical trials, and other research information for health care providers, researchers, people affected by HIV/AIDS, and ... AIDS : This site provides information both for health care providers and for Veterans and the public. Past ...

  3. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... can suppress the virus and prevent or decrease symptoms of illness. To learn about current statistics of ... choices that ultimately led to an HIV-positive diagnosis. The "After the Party" PSA tells the story ...

  4. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... Drugs and HIV Email Facebook Twitter 2005 –Ongoing Behaviors associated with drug abuse are among the main ... lead people to engage in impulsive and unsafe behaviors. Injection drug use. People typically associate drug abuse ...

  5. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... providers and for Veterans and the public. Past Public Service Announcements Jack & Jill : Campaign launch, December 1, ... HIV. We have produced a set of multicultural public service announcements (PSAs) that use text messaging as ...

  6. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... system for which there is treatment, but no cure, at the present time. The virus (HIV) and ... dangerous weight loss, diarrhea, and a type of cancer called Kaposi's sarcoma. 1 Some hopeful news is ...

  7. Body Shape Changes with HIV

    Science.gov (United States)

    ... Z) Hepatitis HIV Mental Health Mental Health Home Suicide Prevention Substance Abuse Military Sexual Trauma PTSD Research (MIRECC) Military Exposures Polytrauma Rehabilitation Spinal Cord Injury Telehealth Womens Health Issues Wellness Programs MyHealtheVet Nutrition Quitting Smoking ...

  8. Sex and Sexuality and HIV

    Science.gov (United States)

    ... Z) Hepatitis HIV Mental Health Mental Health Home Suicide Prevention Substance Abuse Military Sexual Trauma PTSD Research (MIRECC) Military Exposures Polytrauma Rehabilitation Spinal Cord Injury Telehealth Womens Health Issues Wellness Programs MyHealtheVet Nutrition Quitting Smoking ...

  9. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... Global Health Hepatitis (Viral) HIV/AIDS Medical Consequences Mental ... virus) is the virus that causes AIDS (acquired immune deficiency syndrome). AIDS is a disease of the immune system for which there is ...

  10. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... Consequences Mental Health Military Pain Prevention Treatment Trends & Statistics Women and Drugs Publications Funding Funding Opportunities Clinical ... decrease symptoms of illness. To learn about current statistics of HIV in the United States, please visit: ...

  11. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... Statistics Women and Drugs Publications Funding Funding Opportunities Clinical Research Post-Award Concerns General Information Grant & Contract ... AIDS medical practice guidelines, HIV treatment and prevention clinical trials, and other research information for health care ...

  12. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... Criminal Justice Drugged Driving Drug Testing Drugs and the Brain Genetics Global Health Hepatitis (Viral) HIV/AIDS Medical ... the United States. Drugs can change the way the brain works, disrupting the parts of the brain that ...

  13. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... AIDS (acquired immune deficiency syndrome). AIDS is a disease of the immune system for which there is ... the present time. The virus (HIV) and the disease it causes (AIDS) are often linked and referred ...

  14. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... In animal studies, methamphetamine has been shown to increase the amount of HIV in brain cells 1 . ... services. Reference Marcondes, M.C. et al. “Methamphetamine increases brain viral load and activates natural killer cells ...

  15. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... Link between drug abuse and HIV and to help us Send the Message . Get the Facts What ... still be aired. Send the Message Overview Please help us send the message to young people and ...

  16. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... use to weigh risks and benefits when making decisions. This page connects you to information about the ... chances of unsafe behavior by altering judgment and decision-making. To learn about HIV among youth, please ...

  17. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... Web banner ads that you can download and add to your Web site. Please link these banners ... abuse and HIV. Post on Facebook or Twitter ; add photos to your Flickr , Pinterest , and Instagram pages; ...

  18. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... Tobacco/Nicotine Other Drugs Related Topics Addiction Science Adolescent Brain Comorbidity College-Age & Young Adults Criminal Justice ... public service ads (PSA) where an HIV-positive teenager recounts the night she went to a party ...

  19. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... teens and young adults have never known a world without it. NIDA’s "Learn the Link" campaign continues to raise awareness among this generation of the real risks of drug use for transmitting HIV, and ...

  20. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... June 2012 How are Drug Abuse and HIV Related? Drug abuse and addiction have been linked with ... treatment stop or reduce their drug use and related risk behaviors, including drug injection and unsafe sexual ...

  1. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... NIDA Contact Us Sharing Tools and Badges Other Resources Strategic Plan Search Share Print Home » News & Events » Public Education Projects » Learn the Link - Drugs and HIV Learn the Link - ...

  2. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... educational institutions, magazines, newspapers, companies, events, and radio stations for helping to raise awareness of the link ... Poets Sistahs Getting Real About HIV Conference Radio Stations: WTOP Radio WPFW Radio WOL Radio News & Events ...

  3. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... HIV patients who do not abuse drugs. In animal studies, methamphetamine has been shown to increase the ... of this virus. Although we currently have medical therapies that greatly extend the lives of people infected ...

  4. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... got high at a party and made risky choices that ultimately led to an HIV-positive diagnosis. ... Network TV Organizations: AIDS.gov AIDS Alliance for Children, Youth and Families The American Academy of Child & ...

  5. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... Festival Big Mini Film Festival Visual AIDS Bus Boys and Poets Sistahs Getting Real About HIV Conference Radio Stations: WTOP ... & Health Blog The NIDA Science Fair Award for Addiction Science USA Science & Engineering ...

  6. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... Pathol. 2010. 177(1):355-361. How are Teens Affected? Young people are at risk for contracting HIV. In general, middle and late teen years are when young people engage in risk- ...

  7. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... of Abuse Commonly Abused Drugs Charts Emerging Trends Alcohol Club Drugs Cocaine Hallucinogens Heroin Inhalants Marijuana MDMA ( ... person at risk for getting HIV. Drug and alcohol intoxication affect judgment and can lead to unsafe ...

  8. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... Age & Young Adults Criminal Justice Drugged Driving Drug Testing Drugs and the Brain Genetics Global Health Hepatitis ( ... on HIV/AIDS and related diseases, counseling and testing services, and referrals for medical and social services. ...

  9. HIV disclosure in the workplace

    OpenAIRE

    Degroote, S.; Vogelaers, D.; Koeck, R.; Borms, R.; De Meulemeester, L.; Vandijck, Dominique

    2014-01-01

    Objectives: As HIV is currently a chronic and manageable disease, an increasing amount of people living with HIV (PLHIV) are (again) active on the labour market. Since research on this topic is scarce, this study aimed to explore experiences of PLHIV in the workplace, especially concerning disclosure and adherence to antiretroviral therapy. Methods: A questionnaire was developed and validated in collaboration with Sensoa (Flemish expertise centre for sexual health) and participants were recru...

  10. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... Be sure to check out the NIDA Facebook page and tag us in your posts! Learn the link between drug abuse and HIV. http://1.usa.gov/1z20ww6 How many of us think about HIV/AIDS when we’re at parties or hanging out with friends? It’s a topic you can’t ignore. Learn the Link: http:// ...

  11. HIV-associated anal cancer

    OpenAIRE

    Newsom-Davis, Thomas; Bower, Mark

    2010-01-01

    HIV-associated anal carcinoma, a non-AIDS-defining cancer, is a human papillomavirus-associated malignancy with a spectrum of preinvasive changes. The standardized incidence ratio for anal cancer in patients with HIV/AIDS is 20-50. Algorithms for anal cancer screening include anal cytology followed by high-resolution anoscopy for those with abnormal findings. Outpatient topical treatments for anal intraepithelial neoplasia include infrared coagulation therapy, trichloroacetic acid, and imiqui...

  12. HIV Testing : Principles and Practice

    OpenAIRE

    Gersovitz, Mark

    2011-01-01

    Testing is a potentially important intervention to slow the HIV epidemic in Africa and elsewhere. Some countries in Africa have achieved high levels of testing but most have not. Cost, price, and questions of confidentiality have limited the expansion of testing. It looks possible, however, that there are choices as to the design of testing programs that would expand the number of people who could know their HIV status in ways that would be worthwhile.

  13. HIV-associated neurocognitive disorders.

    Science.gov (United States)

    Sanmarti, Montserrat; Ibáñez, Laura; Huertas, Sonia; Badenes, Dolors; Dalmau, David; Slevin, Mark; Krupinski, Jerzy; Popa-Wagner, Aurel; Jaen, Angeles

    2014-01-01

    Currently, neuropsychological impairment among HIV+ patients on antiretroviral therapy leads to a reduction in the quality of life and it is an important challenge due to the high prevalence of HIV-associated neurocognitive disorders and its concomitant consequences in relation to morbidity and mortality- including those HIV+ patients with adequate immunological and virological status. The fact that the virus is established in CNS in the early stages and its persistence within the CNS can help us to understand HIV-related brain injury even when highly active antiretroviral therapy is effective. The rising interest in HIV associated neurocognitive disorders has let to development new diagnostic tools, improvement of the neuropsychological tests, and the use of new biomarkers and new neuroimaging techniques that can help the diagnosis. Standardization and homogenization of neurocognitive tests as well as normalizing and simplification of easily accessible tools that can identify patients with increased risk of cognitive impairment represent an urgent requirement. Future efforts should also focus on diagnostic keys and searching for useful strategies in order to decrease HIV neurotoxicity within the CNS. PMID:25945248

  14. Controversies in HIV cure research

    Directory of Open Access Journals (Sweden)

    Johnston Rowena

    2012-03-01

    Full Text Available Abstract Background Antiretroviral therapy significantly reduces HIV viral burden and prolongs life, but does not cure HIV infection. The major scientific barrier to a cure is thought to be the persistence of the virus in cellular and/or anatomical reservoirs. Discussion Most efforts to date, including pharmaco, immuno or gene therapy, have failed to cure patients, with the notable exception of a stem cell transplant recipient commonly known as the Berlin patient. This case has revived interest in the potential to cure HIV infection and has highlighted the need to resolve critical questions in the basic, pre-clinical and clinical research spheres as they pertain specifically to efforts to eradicate HIV from the body of an infected person (a sterilizing cure or at least render the need for lifelong antiretroviral therapy obsolete (functional cure. This paper describes ongoing debates in each of these research spheres as they were presented and discussed at a satellite session that took place at the 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention in Rome in July 2011. Summary The resolution of these debates may have important implications for the search for a cure, the most efficient ways to identify and test promising interventions, and ultimately the availability of such a cure to diverse groups of HIV patients around the world.

  15. Jupiter - friend or foe? II: the Centaurs

    OpenAIRE

    Horner, J.; Jones, B. W.

    2009-01-01

    It has long been assumed that the planet Jupiter acts as a giant shield, signi?cantly lowering the impact rate of minor bodies upon the Earth, and thus enabling the development and evolution of life in a collisional environment which is not overly hostile. In other words, it is thought that thanks to Jupiter, mass extinctions have been sufficiently infrequent that the biosphere has been able to diversify and prosper. However, in the past, little work has been carried out to examine the validi...

  16. Possible ring material around centaur (2060) Chiron

    CERN Document Server

    Ortiz, J L; Pinilla-Alonso, N; Alvarez-Candal, A; Santos-Sanz, P; Morales, N; Fernández-Valenzuela, E; Licandro, J; Bagatin, A Campo; Thirouin, A

    2015-01-01

    We propose that several short duration events observed in past stellar occultations by Chiron were produced by rings material. From a reanalysis of the stellar occultation data in the literature we determined two possible orientations of the pole of Chiron's rings, with ecliptic coordinates l=(352+/-10) deg, b=(37+/-10) deg or l=(144+/-10) deg, b=(24+/-10) deg . The mean radius of the rings is (324 +/- 10) km. One can use the rotational lightcurve amplitude of Chiron at different epochs to distinguish between the two solutions for the pole. Both imply lower lightcurve amplitude in 2013 than in 1988, when the rotational lightcurve was first determined. We derived Chiron's rotational lightcurve in 2013 from observations at the 1.23-m CAHA telescope and indeed its amplitude is smaller than in 1988. We also present a rotational lightcurve in 2000 from images taken at CASLEO 2.15-m telescope that is consistent with our predictions. Out of the two poles the l=(144+/-10) deg, b=(24+/-10) deg solution provides a bett...

  17. Following an HIV Regimen: Steps to Take Before and After Starting HIV Medicines

    Science.gov (United States)

    HIV Treatment Following an HIV Regimen: Steps to Take Before and After Starting HIV Medicines (Last updated 3/1/2016; last reviewed 3/1/2016) ... maintain long-term medication adherence. Before starting an HIV regimen, talk to your health care provider about ...

  18. HIV Risk Behavior and Access to Services: What Predicts HIV Testing among Heterosexually Active Homeless Men?

    Science.gov (United States)

    Wenzel, Suzanne L.; Rhoades, Harmony; Tucker, Joan S.; Golinelli, Daniela; Kennedy, David P.; Zhou, Annie; Ewing, Brett

    2012-01-01

    HIV is a serious epidemic among homeless persons, where rates of infection are estimated to be three times higher than in the general population. HIV testing is an effective tool for reducing HIV transmission and for combating poor HIV/AIDS health outcomes that disproportionately affect homeless persons, however, little is known about the HIV…

  19. 42 CFR Appendix A to Part 130 - Definition of HIV Infection or HIV

    Science.gov (United States)

    2010-10-01

    ... 42 Public Health 1 2010-10-01 2010-10-01 false Definition of HIV Infection or HIV A Appendix A to... PAYMENTS RICKY RAY HEMOPHILIA RELIEF FUND PROGRAM Pt. 130, App. A Appendix A to Part 130—Definition of HIV Infection or HIV ER31MY00.000 ER31MY00.001...

  20. Occurence of pregnancies among HIV infected Indian women : Does knowledge about HIV status make a difference?

    NARCIS (Netherlands)

    Darak, Shrinivas; Hutter, Inge; Kulkarni, Sanjeevani; Kulkarni, Vinay; Janssen, Fanny

    2015-01-01

    This is the first study to examine the behavioural effect of HIV on fertility among HIV infected women in India. Retrospective calendar data from ever-married HIV infected women between 15 and 45 years of age, attending a specialized HIV clinic in Pune, Western India (N = 560), were analysed. Direct

  1. Occurrence of Pregnancies among HIV Infected Indian Women : Does Knowledge about HIV Status Make a Difference?

    NARCIS (Netherlands)

    S. Darak (Shrinivas); I. Hutter (Inge); S. Kulkarni (Sanjeevani); V. Kulkarni (Vinay); F. Janssen (Fanny)

    2015-01-01

    textabstractThis is the first study to examine the behavioural effect of HIV on fertility among HIV infected women in India. Retrospective calendar data from ever-married HIV infected women between 15 and 45 years of age, attending a specialized HIV clinic in Pune, Western India (N = 560), were anal

  2. Occurrence of pregnancies among HIV infected Indian women: Does knowledge about HIV status make a difference?

    NARCIS (Netherlands)

    Darak, S.; Hutter, I.; Kulkarni, S.; Kulkarni, V.; Janssen, F.

    2015-01-01

    This is the first study to examine the behavioural effect of HIV on fertility among HIV infected women in India. Retrospective calendar data from ever-married HIV infected women between 15 and 45 years of age, attending a specialized HIV clinic in Pune, Western India , were analysed. Directly standa

  3. Clinical profile of HIV infected patients attending a HIV referral clinic in Pune, India

    Directory of Open Access Journals (Sweden)

    Megha Antwal

    2014-01-01

    Interpretation & conclusions: Signs and symptoms associated with HIV positivity observed in this study can be used by health care providers to detect HIV infection early. Moreover, similar to HIV testing in patients with tuberculosis, strategies can be developed for considering Herpes zoster as a predictor of HIV infection.

  4. Diagnosis of Perinatal Transmission of HIV-1 Infection by HIV DNA PCR

    Directory of Open Access Journals (Sweden)

    Ira Shah

    2004-10-01

    Full Text Available To determine the sensitivity and specificity of HIV DNA PCR (Qualitative at various age groups todetect or rule out HIV infection in infants born to HIV infected mothers. Pediatric and perinatal HIVclinic in a tertiary pediatric hospital.Sixteen infants born to HIV positive mother enrolled in the preventionof mother to child transmission of HIV at our center were tested for HIV infection by HIV DNAPCR at 1.5 months, 3 months, 5.5 months and/or 7 months of age. Their HIV status was confirmedby an HIV ELISA test at 18 months of age by 2 different ELISA kits. Eight patients (50% had anegative HIV DNA PCR whereas 8 patients (50% had a positive DNA PCR of which 6 patients(75% had a false positive HIV DNA PCR and no false negative DNA PCR. Thus, the sensitivity ofHIV DNA PCR was 100% and specificity was 57.1% with a total efficiency of the test being62.5%. The efficiency of HIV DNA PCR at 1.5 months of age was 50%, at 3 months of age42.9%, at 5.5 months of age 60% and at 7 months of age was 100%. HIV DNA PCR has a highsensitivity but low specificity to diagnose HIV infection in infants less than 7 months of age. Hence,the results of the test have to be interpreted with caution in infants born to HIV positive mothers.

  5. HIV-1 Continues To Replicate and Evolve in Patients with Natural Control of HIV Infection

    DEFF Research Database (Denmark)

    Mens, Helene; Kearney, Mary; Wiegand, Ann;

    2010-01-01

    Elucidating mechanisms leading to the natural control of HIV-1 infection is of great importance for vaccine design and for understanding viral pathogenesis. Rare HIV-1-infected individuals, termed HIV-1 controllers, have plasma HIV-1 RNA levels below the limit of detection by standard clinical...

  6. A Small Dose of HIV? HIV Vaccine Mental Models and Risk Communication

    Science.gov (United States)

    Newman, Peter A.; Seiden, Danielle S.; Roberts, Kathleen J.; Kakinami, Lisa; Duan, Naihua

    2009-01-01

    Existing knowledge and beliefs related to HIV vaccines provide an important basis for the development of risk communication messages to support future HIV vaccine dissemination. This study explored HIV vaccine mental models among adults from segments of the population disproportionately affected by HIV/AIDS. Nine focus groups were conducted with…

  7. [Ergotism and HIV].

    Science.gov (United States)

    Finn, Bárbara C; Vadalá, Sabrina; Meraldi, Ana; Bruetman, Julio E; Martínez, Jorge V; Young, Pablo

    2013-01-01

    Ergotism is a complication of acute intoxication and/or chronic abuse of ergot derivatives. It expresses itself through a vasomotor syndrome with peripheral vascular disease which frequently involves extremities. We report four cases of HIV-1 infected patients treated with antiretroviral drugs including boosted-protease inhibitors who had self-treated themselves with ergotamine. They developed peripheral vascular disease symptoms and their pulses where diminished or absent in the physical examination. Arterial Doppler confirmed diffused arterial spasm in two of them. Ergotism following ergotamine-protease inhibitors association was diagnosed. Patients were treated through the discontinuity of involved drugs (protease inhibitors and ergotamine), calcium blockers; antithrombotic prophylaxis with enoxaparine, antiaggregant therapy with acetylsalicylic acid, and one of them received pentoxifylline and vasodilator prostaglandins infusion, with amelioration of the symptoms. We discuss the clinical presentation of this drug interaction, difficult to diagnose properly without a strong suspicion of its existence. PMID:23924536

  8. Perceived HIV-Associated Stigma among HIV-Seropositive Men: Psychometric Study of HIV Stigma Scale

    OpenAIRE

    Valle, Adrian; Treviño, Ana Cecilia; Zambrano, Farith Francisco; Urriola, Karla Elizabeth; Sánchez, Luis Antonio; Elizondo, Jesus Eduardo

    2015-01-01

    Objectives To assess the internal consistency and factor structure of the abridged Spanish version of the Berger HIV Stigma Scale (HSS-21), to provide evidence for its convergent and discriminant validity, and to describe perceived stigma in an urban population from northeast Mexico. Methods Seventy-five HIV-positive men who have sex with men (MSM) were recruited. Participants answered the Spanish versions of three Likert-type scales: HSS-21, Robsenberg’s self-esteem scale, and the abbreviate...

  9. Premature and accelerated aging: HIV or HAART?

    NARCIS (Netherlands)

    R.L. Smith; R. de Boer; S. Brul; Y. Budovskaya; H. van der Spek

    2013-01-01

    Highly active antiretroviral therapy (HAART) has significantly increased life expectancy of the human immunodeficiency virus (HIV)-positive population. Nevertheless, the average lifespan of HIV-patients remains shorter compared to uninfected individuals. Immunosenescence, a current explanation for t

  10. Emergency Preparedness for People Living with HIV

    Science.gov (United States)

    ... Hospitalization and Palliative Care Friends & Family Dating and Marriage Family Planning Mixed-Status Couples Discrimination Legal Issues ... National HIV/AIDS and Aging Awareness Day National Gay Men's HIV/AIDS Awareness Day National Latino AIDS ...

  11. Lower Your Sexual Risk of HIV

    Science.gov (United States)

    ... Hospitalization and Palliative Care Friends & Family Dating and Marriage Family Planning Mixed-Status Couples Discrimination Legal Issues ... National HIV/AIDS and Aging Awareness Day National Gay Men's HIV/AIDS Awareness Day National Latino AIDS ...

  12. How Do You Get HIV or AIDS?

    Science.gov (United States)

    ... Hospitalization and Palliative Care Friends & Family Dating and Marriage Family Planning Mixed-Status Couples Discrimination Legal Issues ... National HIV/AIDS and Aging Awareness Day National Gay Men's HIV/AIDS Awareness Day National Latino AIDS ...

  13. Toddler "Functionally Cured" of HIV Infection

    Science.gov (United States)

    ... Mississippi Medical Center led a team of laboratory investigators who provided HIV antiretroviral therapy for 18 months to a baby ... The landmark discovery was made by two pediatric HIV experts, Deborah ... findings at the Conference on Retroviruses and Opportunistic Infections ( ...

  14. HIV/AIDS Living Cases, 2012

    Data.gov (United States)

    U.S. Department of Health & Human Services — Living HIV and AIDS cases by gender, race/ethnicity, current age group, and exposure category in California, 2012. Table includes all persons living with HIV or...

  15. Research on HIV Co-Infections

    Science.gov (United States)

    ... this page Get email updates Order publications Featured Research The Path to a Cure for Hepatitis C ... Skip Content Marketing Share this: Main Content Area Research on HIV Co-Infections HIV-infected people are ...

  16. HIV Infection Seems to Affect Nervous System

    Science.gov (United States)

    ... fullstory_159344.html HIV Infection Seems to Affect Nervous System But symptoms tend to subside once antiretroviral drugs ... mild, it is clear that HIV affects the nervous system within days of infection," she said in a ...

  17. HIV / AIDS: Symptoms, Diagnosis, Prevention and Treatment

    Science.gov (United States)

    ... Navigation Bar Home Current Issue Past Issues HIV / AIDS HIV / AIDS: Symptoms , Diagnosis, Prevention and Treatment Past Issues / Summer ... and have resulted in a dramatic decrease in AIDS deaths in the U.S. NIH Research to Results ...

  18. Characteristics of HIV-2 and HIV-1/HIV-2 Dually Seropositive Adults in West Africa Presenting for Care and Antiretroviral Therapy

    DEFF Research Database (Denmark)

    Ekouevi, Didier K; Coffie, Patrick A; Messou, Eugene;

    2013-01-01

    HIV-2 is endemic in West Africa. There is a lack of evidence-based guidelines on the diagnosis, management and antiretroviral therapy (ART) for HIV-2 or HIV-1/HIV-2 dual infections. Because of these issues, we designed a West African collaborative cohort for HIV-2 infection within the framework o...

  19. HER-2 protein concentrations in breast cancer cells increase before immunohistochemical and fluorescence in situ hybridization analysis turn positive

    DEFF Research Database (Denmark)

    Olsen, Dorte A; Østergaard, Birthe; Bokmand, Susanne;

    2007-01-01

    . Paraffin-embedded tissue sections of the corresponding tumors were analyzed by IHC and FISH. RESULTS: Increased HER-2 concentrations in cancer tissue were found compared to autologous reference tissue (p<0.0001, Wilcoxon test) and normal breast tissue (p<0.0001, Mann-Whitney test). Good concordance rates...... measured using a quantitative method. METHODS: Tissue samples of malignant and adjacent benign breast tissue were collected from 118 consecutive women admitted for surgical treatment of breast cancer. The HER-2 protein concentration was determined by 2 HER-2 assays: ELISA and the Bayer ADVIA Centaur assay...

  20. Loneliness and HIV-related stigma explain depression among older HIV-positive adults

    OpenAIRE

    Grov, Christian; Golub, Sarit A.; Parsons, Jeffrey T.; Brennan, Mark; Karpiak, Stephen E.

    2010-01-01

    Advances in the treatment of HIV have resulted in a large growing population of older adults with HIV. These aging adults face added social, psychological, and physical challenges associated with the aging process. Correlations between depression, loneliness, health, and HIV/AIDS-related stigma have been studied, but there is little evaluation of these associations among HIV-positive adults over the age of 50. Data for these analyses were taken from the Research on Older Adults with HIV (ROAH...

  1. HIV Replication at Low Copy Number and its Correlation with the HIV Reservoir: A Clinical Perspective

    OpenAIRE

    Sarmati, Loredana; d'Ettorre, Gabriella; Parisi, Saverio Giuseppe; Andreoni, Massimo

    2015-01-01

    The efficacy of combination therapy (antiretroviral therapy - ARV) is demonstrated by the high rates of viral suppression achieved in most treated HIV patients. Whereas contemporary treatments may continuously suppress HIV replication, they do not eliminate the latent reservoir, which can reactivate HIV infection if ARV is discontinued. The persistence of HIV proviral DNA and infectious viruses in CD4+ T cells and others cells has long been considered a major obstacle in eradicating the HIV v...

  2. Prevalence and Change in Psychiatric Disorders Among Perinatally HIV-Infected and HIV-Exposed Youth

    OpenAIRE

    Mellins, Claude A.; Elkington, Katherine S.; Leu, Cheng-Shiun; Santamaria, E. Karina; Dolezal, Curtis; Wiznia, Andrew; Bamji, Mahrukh; McKay, Mary M.; Abrams, Elaine J

    2012-01-01

    As the pediatric HIV epidemic in resource-rich countries evolves into an adolescent epidemic, there is a substantive need for studies elucidating mental health needs of perinatally HIV-infected (PHIV+) youth as they transition through adolescence. This article examines the role of perinatal HIV infection in influencing mental health by comparing changes in psychiatric disorders and substance use disorders (SUD) in perinatally HIV-infected (PHIV+) and perinatally HIV-exposed, but uninfected (P...

  3. Risk Factors for HIV Transmission and Barriers to HIV Disclosure: Metropolitan Atlanta Youth Perspectives.

    Science.gov (United States)

    Camacho-Gonzalez, Andres F; Wallins, Amy; Toledo, Lauren; Murray, Ashley; Gaul, Zaneta; Sutton, Madeline Y; Gillespie, Scott; Leong, Traci; Graves, Chanda; Chakraborty, Rana

    2016-01-01

    Youth carry the highest incidence of HIV infection in the United States. Understanding adolescent and young adult (AYA) perspectives on HIV transmission risk is important for targeted HIV prevention. We conducted a mixed methods study with HIV-infected and uninfected youth, ages 18-24 years, from Atlanta, GA. We provided self-administered surveys to HIV-infected and HIV-uninfected AYAs to identify risk factors for HIV acquisition. By means of computer-assisted thematic analyses, we examined transcribed focus group responses on HIV education, contributors to HIV transmission, and pre-sex HIV status disclosure. The 68 participants had the following characteristics: mean age 21.5 years (standard deviation: 1.8 years), 85% male, 90% black, 68% HIV-infected. HIV risk behaviors included the perception of condomless sex (Likert scale mean: 8.0) and transactional sex (88% of participants); no differences were noted by HIV status. Qualitative analyses revealed two main themes: (1) HIV risk factors among AYAs, and (2) barriers to discussing HIV status before sex. Participants felt the use of social media, need for immediate gratification, and lack of concern about HIV disease were risk factors for AYAs. Discussing HIV status with sex partners was uncommon. Key reasons included: fear of rejection, lack of confidentiality, discussion was unnecessary in temporary relationships, and disclosure negatively affecting the mood. HIV prevention strategies for AYAs should include improving condom use frequency and HIV disclosure skills, responsible utilization of social media, and education addressing HIV prevention including the risks of transactional sex. PMID:26588663

  4. Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here?

    OpenAIRE

    Cohen, Myron S.; Smith, M. Kumi; Muessig, Kathryn E.; Hallett, Timothy B.; Powers, Kimberly A.; Kashuba, Angela D.

    2013-01-01

    Antiretroviral drugs that inhibit viral replication were expected to reduce transmission of HIV by lowering the concentration of HIV in the genital tract. In 11 of 13 observational studies, antiretroviral therapy (ART) provided to an HIV-infected index case led to greatly reduced transmission of HIV to a sexual partner. In the HPTN 052 randomised controlled trial, ART used in combination with condoms and counselling reduced HIV transmission by 96·4%. Evidence is growing that wider, earlier in...

  5. Grappling with HIV Transmission Risks: Narratives of Rural Women in Eastern Kenya Living with HIV

    OpenAIRE

    Kako, Peninnah M.; Stevens, Patricia E.; Karani, Anna K.; Mkandawire-Valhmu, Lucy; Banda, Anne

    2011-01-01

    As people live longer and more productively with HIV infection, issues of agency in reducing HIV risk are particularly important for HIV-infected women living in high prevalence, under-resourced countries such as Kenya. Because of their gendered lives, in that being masculine is associated with dominance, while being feminine is associated with passiveness, women in rural Kenya must cope with continued HIV transmission risk even after knowing they are infected with HIV. In this narrative inte...

  6. HIV shedding from male circumcision wounds in HIV-infected men: a prospective cohort study.

    OpenAIRE

    Tobian, Aaron A. R.; Godfrey Kigozi; Jordyn Manucci; Grabowski, Mary K.; David Serwadda; Richard Musoke; Redd, Andrew D.; Fred Nalugoda; Steven J Reynolds; Nehemiah Kighoma; Oliver Laeyendecker; Justin Lessler; Gray, Ronald H.; Thomas C Quinn; Wawer, Maria J.

    2015-01-01

    Editors' Summary Background About 35 million people are currently infected with HIV, the virus that causes AIDS by destroying immune system cells, and every year, 2 million more people become HIV-positive. Antiretroviral therapy (ART) can keep HIV in check, but there is no cure for AIDS. Consequently, prevention of HIV acquisition and transmission is an important component of efforts to control the AIDS epidemic. Because HIV is most often spread through unprotected sex with an infected partne...

  7. HIV/AIDS, Comorbidity, and Alcohol

    OpenAIRE

    Justice, Amy; Sullivan, Lynn; Fiellin, David; ,

    2010-01-01

    Alcohol use is common among people infected with HIV and plays an important role in their health outcomes. Because alcohol use complicates HIV infection and contributes to comorbid diseases, it is important for researchers and practitioners to understand these interactions and to integrate alcohol treatment with medical management of long-term HIV infection and associated comorbidity. The Veterans Aging Cohort Study (VACS) is a large, multisite study of the effects of alcohol use on HIV outco...

  8. HIV treatment cascade in tuberculosis patients

    OpenAIRE

    Lessells, Richard J; Swaminathan, Soumya; Godfrey-Faussett, Peter

    2016-01-01

    Purpose of review Globally, the number of deaths associated with tuberculosis (TB) and HIV coinfection remains unacceptably high. We review the evidence around the impact of strengthening the HIV treatment cascade in TB patients and explore recent findings about how best to deliver integrated TB/HIV services. Recent findings There is clear evidence that the timely provision of antiretroviral therapy (ART) reduces mortality in TB/HIV coinfected adults. Despite this, globally in 2013, only arou...

  9. Children of HIV positive haemophilic men.

    OpenAIRE

    Goldman, E; LEE, C.; Miller, R.; Kernoff, P; Morris-Smith, J; Taylor, B

    1993-01-01

    All 14 children who were conceived at the time their 12 haemophilic fathers were anti-HIV positive were shown to be HIV negative and to be healthy physically and mentally. Eleven of the 12 female partners have remained anti-HIV negative and one has seroconverted. Despite counselling it is likely that children will continue to be conceived by anti-HIV positive haemophiliacs.

  10. Update on HIV in Western Europe

    OpenAIRE

    Nakagawa, F.; Phillips, A N; Lundgren, J. D.

    2014-01-01

    HIV infection in Western Europe is mainly concentrated among men who have sex with men, heterosexuals who acquired HIV from sub-Saharan African countries, and in people who inject drugs. The rate of newly diagnosed cases of HIV has remained roughly stable since 2004 whereas the number of people living with HIV has slowly increased due to new infections and the success of antiretroviral therapy in prolonging life. An ageing population is gradually emerging that will require additional care. Th...

  11. HIV-related neuropathy: current perspectives

    OpenAIRE

    Schütz SG; Robinson-Papp J

    2013-01-01

    Sonja G Schütz, Jessica Robinson-Papp Department of Neurology, Mount Sinai School of Medicine, New York, NY, USA Abstract: Distal symmetric polyneuropathy (DSP) related to human immunodeficiency virus (HIV) is one of the most common neurologic complications of HIV, possibly affecting as many as 50% of all individuals infected with HIV. Two potentially neurotoxic mechanisms have been proposed to play a crucial role in the pathogenesis of HIV DSP: neurotoxicity resulting from the viru...

  12. Inflammation in HIV-Infected Patients

    DEFF Research Database (Denmark)

    Langkilde, Anne; Petersen, Janne; Klausen, Henrik Hedegaard;

    2012-01-01

    To examine mechanisms underlying the increased inflammatory state of HIV-infected patients, by investigating the association of HIV-related factors, demography, lifestyle, and body composition with the inflammatory marker soluble urokinase plasminogen activator receptor (suPAR).......To examine mechanisms underlying the increased inflammatory state of HIV-infected patients, by investigating the association of HIV-related factors, demography, lifestyle, and body composition with the inflammatory marker soluble urokinase plasminogen activator receptor (suPAR)....

  13. Helminth-HIV Coinfection: Should We Deworm?

    OpenAIRE

    Walson, Judd L; John-Stewart, Grace

    2007-01-01

    Background and Objectives The HIV-1 pandemic has disproportionately affected individuals in resource-constrained settings. It is important to determine if other prevalent infections affect the progression of HIV-1 in co-infected individuals in these settings. Some observational studies suggest that helminth infection may adversely affect HIV-1 progression. We sought to evaluate existing evidence on whether treatment of helminth infection impacts HIV-1 progression. Review Methods This review w...

  14. Recent update in HIV vaccine development

    OpenAIRE

    Shin, So Youn

    2016-01-01

    Despite the tremendous efforts to develop a successful human immunodeficiency virus (HIV) vaccine, the quest for a safe and effective HIV vaccine seems to be remarkably long and winding. Disappointing results from previous clinical trials of VaxGen's AIDSVAXgp120 vaccine and MRKAd5 HIV-1 Gag/Pol/Nef vaccine emphasize that understanding the correlates of immune protection in HIV infection is the key to solve the puzzle. The modest vaccine efficacy from RV144 trial and the successive results ob...

  15. The impact of HIV on children's welfare

    OpenAIRE

    Harttgen, Kenneth

    2007-01-01

    Children living in HIV/AIDS affected households bear the heaviest burden of the epidemic. Besides direct vertical transmission, HIV/ AIDS potentially worsens the children’s welfare indirectly through its socio-economic impact. This paper uses household survey data including information about individual HIV infection status to analyze the direct and indirect effects of HIV-infected household members on child mortality, undernutrition and educational attainment for Burkina Faso, Cameroon, Ghana...

  16. HIV Vaccine-Challenges and Opportunities

    Institute of Scientific and Technical Information of China (English)

    2007-01-01

    The need for an efficacious HIV/AIDS vaccine remains the highest priority of the world HIV/AIDS agenda. The generation of an efficacious HIV/AIDS vaccine proves an enormous scientific challenge. This article reviews the neutralizing antibody problem, elusive immune protection, immunogen design, pre-existing anti-vector immunity and design of phase 3 vaccine trials and the challenges and opportunities in development of HIV/AIDS vaccine are discussed.

  17. Adolescent HIV/AIDS: Issues and challenges

    OpenAIRE

    Naswa Smriti; Marfatia Y

    2010-01-01

    Adolescence (10- 19 years) is a phase of physical growth and development accompanied by sexual maturation, often leading to intimate relationships. Adolescent HIV/AIDS is a separate epidemic and needs to be handled and managed separately from adult HIV. The adolescents can be subdivided into student, slum and street youth; street adolescents being most vulnerable to HIV/AIDS. Among various risk factors and situations for adolescents contracting HIV virus are adolescent sex workers, child traf...

  18. Tuberculosis Facts - TB and HIV/AIDS

    Science.gov (United States)

    Tuberculosis (TB) Facts TB and HIV/AIDS What is TB? “TB” is short for a disease called tuberculosis. TB is spread through the air from one person to another. ... HIV) infection affect TB? The HIV, or the AIDS virus, helps TB germs make you sick because ...

  19. HIV genetic information and clonal growth

    Science.gov (United States)

    Based on an analysis of blood cells from five HIV-infected individuals, NCI researchers have identified more than 2,400 HIV DNA insertion sites. Analysis of these sites showed that there is extensive clonal expansion (growth) of HIV infected cells.

  20. HIV control in vivo: Dynamical analysis

    Science.gov (United States)

    Gumel, A. B.; Moghadas, S. M.

    2004-10-01

    A deterministic model for the immunological and therapeutic control of human immunodeficiency virus (HIV) in vivo is studied qualitatively. In addition to analyzing the local stability of the equilibria, the global stability of the infection-free equilibrium is established. The optimal efficacy level of anti-retroviral therapy needed to eradicate HIV from the body of an HIV-infected individual is obtained.

  1. The Global HIV Epidemics among Sex Workers

    OpenAIRE

    Kerrigan, Deanna; Wirtz, Andrea; Baral, Stefan; Decker, Michele; Murray, Laura; Poteat, Tonia; Pretorius, Carel; Sherman, Susan; Sweat, Mike; Semini, Iris; N'Jie, N'Della; Stanciole, Anderson; Butler, Jenny; Osornprasop, Sutayut; Oelrichs, Robert

    2013-01-01

    Since the beginning of the epidemic sex workers have experienced a heightened burden of HIV across settings, despite their higher levels of HIV protective behaviors (UNAIDS, 2009). Unfairly, sex workers have often been framed as 'vectors of disease' and 'core transmitters' rather than workers and human beings with rights in terms of HIV prevention and beyond. By gaining a deeper understand...

  2. Curcumin derivatives as HIV-1 protease inhibitors

    Energy Technology Data Exchange (ETDEWEB)

    Sui, Z.; Li, J.; Craik, C.S.; Ortiz de Montellano, P.R. [Univ. of California, San Francisco, CA (United States)

    1993-12-31

    Curcumin, a non-toxic natural compound from Curcuma longa, has been found to be an HIV-1 protease inhibitor. Some of its derivatives were synthesized and their inhibitory activity against the HIV-1 protease was tested. Curcumin analogues containing boron enhanced the inhibitory activity. At least of the the synthesized compounds irreversibly inhibits the HIV-1 protease.

  3. Methylation: a regulator of HIV-1 replication?

    OpenAIRE

    Jeang Kuan-Teh; Yedavalli Venkat RK

    2007-01-01

    Abstract Recent characterizations of methyl transferases as regulators of cellular processes have spurred investigations into how methylation events might influence the HIV-1 life cycle. Emerging evidence suggests that protein-methylation can positively and negatively regulate HIV-1 replication. How DNA- and RNA- methylation might impact HIV-1 is also discussed.

  4. Impact of Chromatin on HIV Replication

    OpenAIRE

    Agosto, Luis M.; Matthew Gagne; Henderson, Andrew J.

    2015-01-01

    Chromatin influences Human Immunodeficiency Virus (HIV) integration and replication. This review highlights critical host factors that influence chromatin structure and organization and that also impact HIV integration, transcriptional regulation and latency. Furthermore, recent attempts to target chromatin associated factors to reduce the HIV proviral load are discussed.

  5. HIV/AIDS and Mental Health

    OpenAIRE

    Baingana, Florence; Thomas, Rachel; Comblain, Christine

    2005-01-01

    Mental and neurological disorders have an intertwined relationship with HIV, yet are often overlooked when AIDS interventions are planned and implemented. Cognitive disorders, substance abuse, and disorders of personality can influence behavior in ways that lead to greater risk of HIV infection. Conversely, HIV/AIDS itself can lead to psychological conditions due to circumstances surroundi...

  6. HIV Prevention Readiness in Undergraduates and Inmates.

    Science.gov (United States)

    Antonio, Michael E.; And Others

    Prevention of Human Immunodeficiency Virus (HIV) transmission is increasingly an international priority. Education of high-risk populations, such as incarcerated individuals, is particularly important in thwarting the spread of HIV. To address this concern, the attitudes, beliefs, and knowledge of inmates concerning HIV and AIDS related issues are…

  7. HIV Testing on Campus: The Next Step.

    Science.gov (United States)

    Hayden, Joanna

    1994-01-01

    Sees first phase in human immunodeficiency virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) prevention on many campuses to be focused on education. Calls second phase HIV testing for early diagnosis. Explains steps taken to implement HIV testing program on suburban campus and discusses student program evaluation. (Author/NB)

  8. HIV diagnosis, linkage to HIV care, and HIV risk behaviors among newly diagnosed HIV-positive female sex workers in Kigali, Rwanda

    NARCIS (Netherlands)

    S.L. Braunstein; M.M. Umulisa; N.J. Veldhuijzen; E. Kestelyn; C.M. Ingabire; J. Nyinawabega; J.H.H.M. van de Wijgert; D. Nash

    2011-01-01

    To evaluate linkage-to-care, sexual behavior change, and psychosocial experiences among newly HIV-diagnosed female sex workers (FSWs) in Rwanda. FSWs (n = 800) with unknown serostatus were screened for HIV during 2007/2008. Women testing HIV positive (n = 192) were referred to care and asked to retu

  9. Voices of Experience: Living with HIV. Pamela.

    Centers for Disease Control (CDC) Podcasts

    2009-06-07

    This podcast showcases Pamela, a woman living with HIV, as she tells her story.  Created: 6/7/2009 by Division of HIV and AIDS Prevention (DHAP), National Center for HIV, Hepatitis, STD, and Tuberculosis Prevention ( NCHHSTP).   Date Released: 6/7/2009.

  10. Voices of Experience: Living with HIV. Doug.

    Centers for Disease Control (CDC) Podcasts

    2009-06-07

    This podcast showcases Doug, a man living with HIV, as he tells his story.  Created: 6/7/2009 by Division of HIV and AIDS Prevention (DHAP), National Center for HIV, Hepatitis, STD, and Tuberculosis Prevention ( NCHHSTP).   Date Released: 6/7/2009.

  11. Voices of Experience: Living with HIV. Denise.

    Centers for Disease Control (CDC) Podcasts

    2009-06-07

    This podcast showcases Denise, a woman living with HIV, as she tells her story.  Created: 6/7/2009 by Division of HIV and AIDS Prevention (DHAP), National Center for HIV, Hepatitis, STD, and Tuberculosis Prevention ( NCHHSTP).   Date Released: 6/7/2009.

  12. Differences in HIV vaccine acceptability between genders.

    Science.gov (United States)

    Kakinami, Lisa; Newman, Peter A; Lee, Sung-Jae; Duan, Naihua

    2008-05-01

    The development of safe and efficacious preventive HIV vaccines offers the best long-term hope of controlling the AIDS pandemic. Nevertheless, suboptimal uptake of safe and efficacious vaccines that already exist suggest that HIV vaccine acceptability cannot be assumed, particularly among communities most vulnerable to HIV. The present study aimed to identify barriers and motivators to future HIV vaccine acceptability among low socioeconomic, ethnically diverse men and women in Los Angeles County. Participants completed a cross-sectional survey assessing their attitudes and beliefs regarding future HIV vaccines. Hypothetical HIV vaccine scenarios were administered to determine HIV vaccine acceptability. Two-sided t-tests were performed, stratified by gender, to examine the association between vaccine acceptability and potential barriers and motivators. Barriers to HIV vaccine acceptability differed between men and women. For women, barriers to HIV vaccine acceptability were related to their intimate relationships (pnegative experiences with health care providers (pGender-specific interventions may increase vaccine acceptability among men and women at elevated risk for HIV infection. Among women, interventions need to focus on addressing barriers due to gendered power dynamics in relationships and discrimination in health care. Among men, education that addresses fears and misconceptions about adverse effects of HIV vaccination on health and the importance of vaccination as one component of integrated HIV prevention may increase vaccine acceptability. PMID:18484322

  13. Get the Facts, Talk about HIV

    Centers for Disease Control (CDC) Podcasts

    2012-02-01

    Dr. Kevin Fenton, Director of CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, urges members of the black community to talk about HIV.  Created: 2/1/2012 by National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP).   Date Released: 2/1/2012.

  14. Changes in US HIV Treatment Guidelines

    Centers for Disease Control (CDC) Podcasts

    2012-10-03

    Following the 2012 HIV Treatment Guidelines, which include early diagnosis and treatment with ART, can increase longevity and improve the quality of life for patients living with HIV.  Created: 10/3/2012 by National Center for HIV/AIDS, Hepatitis, STD and TB Prevention (NCHHSTP).   Date Released: 10/3/2012.

  15. Update on HIV in Western Europe

    DEFF Research Database (Denmark)

    Nakagawa, Fumiyo; Phillips, Andrew N; Lundgren, Jens D

    2014-01-01

    HIV infection in Western Europe is mainly concentrated among men who have sex with men, heterosexuals who acquired HIV from sub-Saharan African countries, and in people who inject drugs. The rate of newly diagnosed cases of HIV has remained roughly stable since 2004 whereas the number of people l...

  16. HIV and incarceration: prisons and detention

    Directory of Open Access Journals (Sweden)

    Jürgens Ralf

    2011-05-01

    Full Text Available Abstract The high prevalence of HIV infection among prisoners and pre-trial detainees, combined with overcrowding and sub-standard living conditions sometimes amounting to inhuman or degrading treatment in violation of international law, make prisons and other detention centres a high risk environment for the transmission of HIV. Ultimately, this contributes to HIV epidemics in the communities to which prisoners return upon their release. We reviewed the evidence regarding HIV prevalence, risk behaviours and transmission in prisons. We also reviewed evidence of the effectiveness of interventions and approaches to reduce the risk behaviours and, consequently, HIV transmission in prisons. A large number of studies report high levels of risk behaviour in prisons, and HIV transmission has been documented. There is a large body of evidence from countries around the world of what prison systems can do to prevent HIV transmission. In particular, condom distribution programmes, accompanied by measures to prevent the occurrence of rape and other forms of non-consensual sex, needle and syringe programmes and opioid substitution therapies, have proven effective at reducing HIV risk behaviours in a wide range of prison environments without resulting in negative consequences for the health of prison staff or prisoners. The introduction of these programmes in prisons is therefore warranted as part of comprehensive programmes to address HIV in prisons, including HIV education, voluntary HIV testing and counselling, and provision of antiretroviral treatment for HIV-positive prisoners. In addition, however, action to reduce overcrowding and improve conditions in detention is urgently needed.

  17. HIV and schistosomiasis in rural Zimbabwe

    DEFF Research Database (Denmark)

    Kotze, Sebastian Ranzi; Zinyama-Gutsire, Rutendo; Kallestrup, Per; Benn, Christine Stabell; Gomo, Exnevia; Gerstoft, Jan; van Dam, Govert; Mortensen, Ole Hartvig; Ullum, Henrik; Erikstrup, Christian

    2015-01-01

    with schistosomiasis, inflammatory cytokines, and mortality. METHODS: The study included 192 HIV-infected and 177 HIV-uninfected individuals from Mupfure in rural Zimbabwe. Of these, 208 were infected with Schistosoma haematobium, 27 with S. mansoni and 48 with both. Plasma RBP, HIV-RNA, CD4 cell count...

  18. Voices of Experience: Living with HIV. ODell.

    Centers for Disease Control (CDC) Podcasts

    2009-06-07

    This podcast showcases ODell, a man living with HIV, as he tells his story.  Created: 6/7/2009 by Division of HIV and AIDS Prevention (DHAP), National Center for HIV, Hepatitis, STD, and Tuberculosis Prevention ( NCHHSTP).   Date Released: 6/7/2009.

  19. Leukocyte telomere length in HIV-infected and HIV-exposed uninfected children: shorter telomeres with uncontrolled HIV viremia.

    Directory of Open Access Journals (Sweden)

    Hélène C F Côté

    Full Text Available OBJECTIVES: Nucleoside reverse transcriptase inhibitors (NRTIs used in HIV antiretroviral therapy can inhibit human telomerase reverse transcriptase. We therefore investigated whether in utero or childhood exposure to NRTIs affects leukocyte telomere length (LTL, a marker of cellular aging. METHODS: In this cross-sectional CARMA cohort study, we investigated factors associated with LTL in HIV-1-infected (HIV(+ children (n = 94, HIV-1-exposed uninfected (HEU children who were exposed to antiretroviral therapy (ART perinatally (n = 177, and HIV-unexposed uninfected (HIV(- control children (n = 104 aged 0-19 years. Univariate followed by multivariate linear regression models were used to examine relationships of explanatory variables with LTL for: a all subjects, b HIV(+/HEU children only, and c HIV(+ children only. RESULTS: After adjusting for age and gender, there was no difference in LTL between the 3 groups, when considering children of all ages together. In multivariate models, older age and male gender were associated with shorter LTL. For the HIV(+ group alone, having a detectable HIV viral load was also strongly associated with shorter LTL (p = 0.007. CONCLUSIONS: In this large study, group rates of LTL attrition were similar for HIV(+, HEU and HIV(- children. No associations between children's LTL and their perinatal ART exposure or HIV status were seen in linear regression models. However, the association between having a detectable HIV viral load and shorter LTL suggests that uncontrolled HIV viremia rather than duration of ART exposure may be associated with acceleration of blood telomere attrition.

  20. Recent developments in HIV-related kidney disease

    OpenAIRE

    Estrella, Michelle M.; Fine, Derek M.; Atta, Mohamed G.

    2010-01-01

    Although kidney disease has been a recognized complication of HIV infection since the beginning of the HIV epidemic, its epidemiology, underlying causes and treatment have evolved in developed countries where HAART has been widely available. HIV-associated nephropathy and HIV immune complex-mediated kidney disease were the prominent renal diagnoses in the earlier period of the HIV epidemic. While HIV immune complex-mediated kidney disease remains a common finding among HIV-infected individual...

  1. HIV protease inhibitors in gut barrier dysfunction and liver injury

    OpenAIRE

    Wu, Xudong; Li, Yunzhou; Peng, Kesong; Zhou, Huiping

    2014-01-01

    The development of HIV protease inhibitors (HIV PIs) has been one of the most significant advances of the past two decades in controlling HIV infection. HIV PIs have been used successfully in highly active anti-retroviral therapy (HAART) for HIV infection, which is currently the most effective treatment available. Incorporation of HIV PIs in HAART causes profound and sustained suppression of viral replication, significantly reduces the morbidity and mortality of HIV infection, and prolongs th...

  2. Potential Anti-HIV Agents from Marine Resources: An Overview

    OpenAIRE

    Thanh-Sang Vo; Se-Kwon Kim

    2010-01-01

    Human immunodeficiency virus (HIV) infection causes acquired immune deficiency syndrome (AIDS) and is a global public health issue. Anti-HIV therapy involving chemical drugs has improved the life quality of HIV/AIDS patients. However, emergence of HIV drug resistance, side effects and the necessity for long-term anti-HIV treatment are the main reasons for failure of anti-HIV therapy. Therefore, it is essential to isolate novel anti-HIV therapeutics from natural resources. Recently, a great de...

  3. The effects of an HIV project on HIV and non-HIV services at local government clinics in urban Kampala

    OpenAIRE

    Kyegombe Nambusi; Etonu Allan; Manabe Yukari C; Matsubayashi Toru; Muganzi Alex; Coutinho Alex; Peters David H

    2011-01-01

    Abstract Background HIV/AIDS is a major public health concern in Uganda. There is widespread consensus that weak health systems hamper the effective provision of HIV/AIDS services. In recent years, the ways in which HIV/AIDS-focused programs interact with the delivery of other health services is often discussed, but the evidence as to whether HIV/AIDS programs strengthen or distort overall health services is limited. The aim of this study was to examine the effect of a PEPFAR-funded HIV/AIDS ...

  4. Clinical presentation and opportunistic infections in HIV-1, HIV-2 and HIV-1/2 dual seropositive patients in Guinea-Bissau

    DEFF Research Database (Denmark)

    Sørensen, Allan; Jespersen, Sanne; Katzenstein, Terese L;

    2016-01-01

    BACKGROUND: Better understanding of HIV-2 infection is likely to affect the patient care in areas where HIV-2 is prevalent. In this study, we aimed to characterize the clinical presentations among HIV-1, HIV-2 and HIV-1/2 dual seropositive patients. METHODS: In a cross-sectional study, newly...... diagnosed HIV patients attending the HIV outpatient clinic at Hospital Nacional Simão Mendes in Guinea-Bissau were enrolled. Demographical and clinical data were collected and compared between HIV-1, HIV-2 and HIV-1/2 dual seropositive patients. RESULTS: A total of 169 patients (76% HIV-1, 17% HIV-2 and 6......% HIV 1/2) were included in the study between 21 March 2012 and 14 December 2012. HIV-1 seropositive patients were younger than HIV-2 and HIV-1/2 seropositive patients, but no difference in sex was observed. Patients with HIV-1 and HIV-1/2 had a lower baseline CD4 cell count than HIV-2 seropositive...

  5. Effects of HIV status notification on reducing the risk of sexual transmission of HIV in China

    Institute of Scientific and Technical Information of China (English)

    Bao Yugang; Jing Jun; Zhang Yanhui; Li Huasheng; Feng Liangui; Ning Zhen; Tan Hongzhuan

    2014-01-01

    Background The risk of HIV sexual transmission is much higher among people unaware of their HIV status than among those aware.Only a few studies have indicated that the incidence of unsafe sex can be reduced when people know their HIV status.This study was to investigate this effect in China.Methods A cohort study consisting of two surveys was conducted at two different times among a group of people living with HIV/AIDS,whose status was newly diagnosed with HIV via sexual contact,in Shanghai,Chongqing,and Kunming.The first survey was conducted among 823 people tested positive for HIV before notifying them of the HIV status.The second survey was conducted among 650 HIV-positive people at six months following the first survey (after notification of HIV status).The scope of survey covered unsafe sex practices,number of unsafe sexual partners,and frequency of unsafe sexual behaviors over the prior six months.Unsafe sex is defined as unprotected anal or vaginal sex with partners who are HIV positive or whose HIV status is unknown.Results The proportion of unsafe sex was reduced by about 85% after HIV status notification.The risk of HIV sexual transmission was 15 times higher among persons unaware of their HIV status than among those aware.Approximately 95% of new sexually transmitted HIV infections stemmed from 56% of the infected persons unaware of their HIV status in China.Conclusion Timely HIV status notification has the potential to significantly reduce unsafe sex among HIV-infected persons and reduce the risk for HIV transmission via unsafe sex.

  6. HIV and tuberculosis in India

    Indian Academy of Sciences (India)

    Soumya Swaminathan; G Narendran

    2008-11-01

    The global impact of the converging dual epidemics of tuberculosis (TB) and human immunodeficiency virus (HIV) is one of the major public health challenges of our time. The World Health Organization (WHO) reports 9.2 million new cases of TB in 2006 of whom 7.7% were HIV-infected. Tuberculosis is the most common opportunistic infection in HIV-infected patients as well as the leading cause of death. Further, there has been an increase in rates of drug resistant tuberculosis, including multi-drug (MDRTB) and extensively drug resistant TB (XDRTB), which are difficult to treat and contribute to increased mortality. The diagnosis of TB is based on sputum smear microscopy, a 100-year old technique and chest radiography, which has problems of specificity. Extra-pulmonary, disseminated and sputum smear negative manifestations are more common in patients with advanced immunosuppression. Newer diagnostic tests are urgently required that are not only sensitive and specific but easy to use in remote and resource-poor settings. Treatment of HIV-TB co-infection is complex and associated with high pill burden, overlapping drug toxicities, risk of immune reconstitution inflammatory syndrome (IRIS) and challenges related to adherence. From a programmatic point of view, screening of all HIV-infected persons for tuberculosis and vice-versa will help identify co-infected patients who require treatment for both infections. This requires good coordination and communication between the TB and AIDS control programs, in India.

  7. HIV Prevention in Care and Treatment Settings: Baseline Risk Behaviors among HIV Patients in Kenya, Namibia, and Tanzania.

    OpenAIRE

    Kidder, Daniel P; Bachanas, Pam; Medley, Amy; Pals, Sherri; Nuwagaba-Biribonwoha, Harriet; Ackers, Marta; Howard, Andrea; DeLuca, Nick; Mbatia, Redempta; Sheriff, Muhsin; Arthur, Gilly; Katuta, Frieda; Cherutich, Peter; Somi, Geoffrey

    2013-01-01

    HIV care and treatment settings provide an opportunity to reach people living with HIV/AIDS (PLHIV) with prevention messages and services. Population-based surveys in sub-Saharan Africa have identified HIV risk behaviors among PLHIV, yet data are limited regarding HIV risk behaviors of PLHIV in clinical care. This paper describes the baseline sociodemographic, HIV transmission risk behaviors, and clinical data of a study evaluating an HIV prevention intervention package for HIV care and treat...

  8. Neurologic Complications in Treated HIV-1 Infection.

    Science.gov (United States)

    Bhatia, Nisha S; Chow, Felicia C

    2016-07-01

    Effective combination antiretroviral therapy has transformed HIV infection into a chronic disease, with HIV-infected individuals living longer and reaching older age. Neurological disease remains common in treated HIV, however, due in part to ongoing inflammation and immune activation that persist in chronic infection. In this review, we highlight recent developments in our understanding of several clinically relevant neurologic complications that can occur in HIV infection despite treatment, including HIV-associated neurocognitive disorders, symptomatic CSF escape, cerebrovascular disease, and peripheral neuropathy. PMID:27170369

  9. Nursing Care of HIV-Positive Women

    DEFF Research Database (Denmark)

    Nielsen, Ben; Martinsen, Bente

    2015-01-01

    to improve quality of life after being diagnosed with HIV, a sharp distinction between HIV and AIDS and a religious and spiritually coping. Identifying the emotional challenges women living with HIV face in their daily lives may help nurses obtain a clearer understanding and greater knowledge of how...... to provide HIV-positive women with effective care that empower and support these women in managing their chronic disease. However to ensure that nurses have the proper tools for effective care for women living with HIV European studies are essentials in relation to what emotional challenges these women...

  10. HIV Prevention by Oral Preexposure Prophylaxis

    OpenAIRE

    Heneine, Walid; Kashuba, Angela

    2012-01-01

    The impressive advances in antiretroviral (ARV) therapy of chronic human immunodeficiency virus (HIV) infections during the last decade and the availability of potent ARV drugs have fueled interest in using chemoprophylaxis as a novel HIV prevention strategy. Preexposure prophylaxis (PrEP) refers to the use of ARV drugs in HIV-negative persons to prevent HIV infection. The rationale for PrEP builds on the success of ARV prophylaxis in preventing mother-to-child transmission of HIV and on a la...

  11. Clinical significance of HIV-1 coreceptor usage

    Directory of Open Access Journals (Sweden)

    Lusso Paolo

    2010-01-01

    Full Text Available Abstract The identification of phenotypically distinct HIV-1 variants with different prevalence during the progression of the disease has been one of the earliest discoveries in HIV-1 biology, but its relevance to AIDS pathogenesis remains only partially understood. The physiological basis for the phenotypic variability of HIV-1 was elucidated with the discovery of distinct coreceptors employed by the virus to infect susceptible cells. The role of the viral phenotype in the variable clinical course and treatment outcome of HIV-1 infection has been extensively investigated over the past two decades. In this review, we summarize the major findings on the clinical significance of the HIV-1 coreceptor usage.

  12. Grappling with HIV transmission risks: narratives of rural women in eastern Kenya living with HIV.

    Science.gov (United States)

    Kako, Peninnah M; Stevens, Patricia E; Karani, Anna K; Mkandawire-Valhmu, Lucy; Banda, Anne

    2012-01-01

    As people live longer and more productively with HIV infection, issues of agency in reducing HIV risk are particularly important for HIV-infected women living in high prevalence, underresourced countries such as Kenya. Because of their gendered lives, in that being masculine is associated with dominance and being feminine is associated with passiveness, women in rural Kenya must cope with continued HIV transmission risk even after knowing they are infected with HIV. In this narrative interview study, informed by theories of gender and postcolonial feminism, we examined personal accounts of HIV risk and risk reduction of 20 rural women in eastern Kenya who were living with HIV. From our analysis of the women's narratives, two major themes emerged: gender-based obstacles even in the context of a known HIV diagnosis, and struggles with economic pressures amid HIV risks. Implications for policy, programs, and research are discussed. PMID:22137546

  13. HIV or HIV-Therapy? Causal attributions of symptoms and their impact on treatment decisions among women and men with HIV

    OpenAIRE

    Kremer H; Sonnenberg-Schwan U; Arendt G; Brockmeyer NH; Potthoff A; Ulmer A; Graefe K; Lorenzen T; Starke W; Walker UA

    2009-01-01

    Abstract Objectives Among people with HIV, we examined symptom attribution to HIV or HIV-therapy, awareness of potential side effects and discontinuation of treatment, as well as sex/gender differences. Methods HIV-patients (N = 168, 46% female) completed a comprehensive symptom checklist (attributing each endorsed symptom to HIV, HIV-therapy, or other causes), reported reasons for treatment discontinuations and potential ART-related laboratory abnormalities. Results Main symptom areas were f...

  14. HIV and pet ownership.

    Science.gov (United States)

    Downing, D

    1995-01-01

    The Centers for Disease Control and Prevention (CDC) states that there is no evidence that dogs, cats or non-primate animals can contract the human immunodeficiency virus (HIV) or transmit it to human beings. When the immune system is suppressed through disease, age, or medical treatments, a person becomes more vulnerable to infections. Pets Are Wonderful Support (PAWS) has developed guidelines for having pets. Proper pet selection, proper pet care and good personal hygiene of the owner can eliminate almost any possible risk a pet poses. New pets pose more of a health risk because health history and vaccination records are usually not known. Adult pets are often safer, and are less likely to be involved in playful activities that include biting and scratching. There is a slim chance of contracting toxoplasmosis from cats, but certain precautions can minimize risk. Annual veterinarian examinations are recommended to keep vaccinations current. The CDC does not recommend keeping a cat with feline leukemia virus or feline immunodeficiency virus since these diseases can make the cat more susceptible to other illnesses which can be passed on to a person with a compromised immune system. Turtles and birds are not recommended since they may harbor diseases. Several services are available to pet owners and are listed in the article. PMID:11362398

  15. Hiv og kontaktopsporing i Danmark

    DEFF Research Database (Denmark)

    Rodkjær, Lotte Ørneborg; Østergaard, Lars; Frydenberg, Morten

    2008-01-01

    INTRODUCTION: Counselling and partner notification play significant roles in the prevention of HIV. In Denmark, there is no overall strategy or monitoring concerning partner notification and the results of partner notification are unknown. The primary purposes of the study were to describe the...... present organisation and conditions concerning partner notification in Denmark. MATERIALS AND METHODS: Information about organizational factors was collected through a questionnaire and supplementary interviews. The study population was all consecutive, newly-diagnosed HIV positive persons in the period...... from 1 May 2005 to 1 June 2006. During this period 254 were diagnosed with HIV. RESULTS: The study showed significant differences in the organisation of partner notification. A total of 123 index cases were offered partner notification. The stated number of partners per index case was 2.4, and 1...

  16. [Pneumocystis pneumonia in HIV-negative adults].

    Science.gov (United States)

    Rouyer, M; Stoclin, A; Blanc, F-X

    2015-12-01

    In HIV-negative adults, Pneumocystis jirovecii pneumonia can be observed when immunodeficiency is present, especially in case of drug-induced immune suppression (steroids, chemotherapy, transplantation). Clinical, radiological, and biological presentations are different in HIV-positive and HIV-negative individuals with different immunodeficiency profiles. In HIV-negative patients, dyspnea occurs more quickly (median duration of 5 days to get a diagnosis), diagnosis is more difficult because of less Pneumocystis in bronchoalveolar lavage, and mortality is higher than in HIV-positive individuals. Lung CT-scan typically shows diffuse ground glass opacities, but peri-bronchovascular condensations or ground glass opacities clearly limited by interlobular septa can also be observed. Lymphopenia is common but CD4+ T-cells count is rarely performed. HIV-negative patients with Pneumocystis pneumonia are co-infected with bacteria, viruses or fungi in about 30% cases. Bronchoalveolar lavage is often more neutrophilic than in HIV-positive individuals. PCR and β-D-glucan have good sensitivity but poor specificity to diagnose Pneumocystis pneumonia. Trimethoprim-sulfamethoxazole remains the first choice of treatment. Duration is 14 days in HIV-negative patients whereas it is typically of 21 days in HIV-positive individuals. Adjunctive corticosteroids are of beneficial effect in HIV-positive adult patients with substantial hypoxaemia but are not recommended in HIV-negative patients, as they could be deleterious in some individuals. PMID:26572261

  17. Opportunity Knocks: HIV Prevention in Primary Care.

    Science.gov (United States)

    Thrun, Mark W

    2014-06-01

    Expansions in health care coverage, a comprehensive framework for HIV prevention and care, electronic medical records, and novel HIV prevention modalities create a current opportunity to change the trajectory of the HIV epidemic in the United States. HIV is increasingly disproportionately found in populations historically at higher risk, including gay men and other men who have sex with men, transgender women, injection drug users, and persons of color. This underscores the need for providers to identify persons at higher risk for HIV and assure the provision of screening and prevention services. In turn, universal screening for HIV-testing every adolescent and adult at least once in their lifetime-will increasingly be necessary to find the infrequent cases of HIV in lower risk populations. In both these domains, primary care providers will play a unique role in complementing traditional providers of HIV prevention and care services by increasing the proportion of their patients who have been screened for HIV, opening dialogues around sexual health, including asking about sexual orientation and gender identity, and prescribing antivirals as pre- and postexposure prophylaxis for their non-HIV-infected patients. Primary care providers must understand and embrace their importance along the HIV prevention and care continuum. PMID:26789615

  18. Pathogenesis of HIV-associated pulmonary hypertension: potential role of HIV-1 Nef.

    Science.gov (United States)

    Almodovar, Sharilyn; Hsue, Priscilla Y; Morelli, Julie; Huang, Laurence; Flores, Sonia C

    2011-06-01

    Infection with HIV increases the risk for lung diseases, including noninfectious pulmonary hypertension (PH). HIV-associated PH (HIV-PH) is an important lung disease in HIV-infected persons who live longer with antiretrovirals. The early stages of HIV-PH may be overlooked by healthcare providers due to nonspecific symptoms, including progressive dyspnea and nonproductive cough. HIV-PH may be detected via chest radiographs, CT scans, or electrocardiograms, but Doppler echocardiography is the most useful screening test to identify candidates for right heart catheterization. HIV-PH has a poor prognosis with high mortality; improved biomarkers to identify earlier stages of PH would benefit clinical care. The HIV-PH mechanism remains unknown, but HIV proteins such as Tat and Nef may play a role. HIV-1 Nef is a broad-spectrum adaptor protein that may affect HIV-infected and uninfected pulmonary vascular cells. Studies in macaques suggest that Nef is important in HIV-PH pathogenesis because monkeys infected with a chimeric simian immunodeficiency virus (SIV) expressing HIV-nef (SHIVnef) alleles, but not monkeys infected with the native SIV, develop pulmonary vascular remodeling. Four consistent amino acid mutations arose spontaneously in Nef passaged in the monkeys. To translate these findings to humans, one research endeavor of the Lung HIV Study focuses on the identification of HIV nef mutations in HIV-infected individuals with PH compared with HIV-infected normotensive patients. We present some of the preliminary evidence. Ongoing longitudinal studies will establish the connection between Nef mutations and the propensity for HIV-PH. PMID:21653533

  19. Non-infectious Pulmonary Diseases and HIV.

    Science.gov (United States)

    Triplette, M; Crothers, K; Attia, E F

    2016-06-01

    Pulmonary complications remain among the most frequent causes of morbidity and mortality for individuals with HIV despite the advent of antiretroviral therapy (ART) and improvement in its efficacy and availability. The prevalence of non-infectious pulmonary diseases is rising in this population, reflecting both an increase in smoking and the independent risk associated with HIV. The unique mechanisms of pulmonary disease in these patients remain poorly understood, and direct effects of HIV, genetic predisposition, inflammatory pathways, and co-infections have all been implicated. Lung cancer, chronic obstructive pulmonary disease (COPD), and pulmonary hypertension are the most prevalent non-infectious pulmonary diseases in persons with HIV, and the risk of each of these diseases is higher among HIV-infected (HIV+) persons than in the general population. This review discusses the latest advances in the literature on these important complications of HIV infection. PMID:27121734

  20. The value of reducing HIV stigma.

    Science.gov (United States)

    Brent, Robert J

    2016-02-01

    HIV-stigma is a major reason why HIV continues to be a global epidemic. Interventions targeting HIV-stigma are therefore necessary. To find an intervention that is worthwhile, a Cost-Benefit Analysis is needed which compares costs and benefits. There are many documented costs of HIV-stigma. What is missing is a valuation of the benefits of reducing HIV-stigma. The purpose of this paper is to present a general method that can be used to value the benefits of stigma reduction programs. The method involves estimating the marginal rate of substitution (MRS) between stigma and income in the utility function of older people with HIV. To illustrate how our framework can be used, we applied it to a sample of just over 900 people coming from the 2005-06 ROAH study (Research on Older Adults with HIV) in New York City. PMID:26820574

  1. [HIV in elderly women after travelling abroad].

    Science.gov (United States)

    Jespersen, Sanne; Thorsteinsson, Kristina; David, Kim Peter; Lebech, Anne-Mette; Storgaard, Merete

    2016-05-01

    We report two cases of HIV infection among female travellers of older age. A Danish woman in her eighties was diagnosed with acute HIV infection after travelling to West Africa. A sexual history was not recorded before her third hospital visit. A West African woman in her seventies who had been living in Denmark for 40 years was diagnosed with advanced HIV after having been to West Africa for family visits. We want to emphasize that women of older age also have sex that may put them at risk of HIV, that febrile returning travellers should be tested for HIV, and that presence of HIV indicator diseases should lead to HIV testing. PMID:27137117

  2. Snapshot of HIV pathogenesis in China

    Institute of Scientific and Technical Information of China (English)

    Nitin K SAKSENA; Bin WANG; Megan STEAIN; Rong Ge YANG; Lin Qi ZHANG

    2005-01-01

    Several reviews have focused on the nature of HIV infection and its spread in various geographical regions of China.In contrast, this review provides a comprehensive update on the prevalence of multiple HIV-1 subtypes, consequent emergence of recombinant and novel forms of HIV-1 in China, and the implications this may have on HIV diversity and the development of effective vaccines. In addition it also examines the dissemination of primary drug resistance in therapy na(i)ve patients, as well as co-infections with two other important viruses-hepatitis B and C. The main purpose of this review is to provide a current snapshot of HIV-1 pathogenesis in China and possibly shed some light on the future of HIV evolution, and potential challenges for future vaccine and anti-retroviral therapeutics against HIV strains in this area.

  3. Initiation of HIV Reverse Transcription

    Directory of Open Access Journals (Sweden)

    Roland Marquet

    2010-01-01

    Full Text Available Reverse transcription of retroviral genomes into double stranded DNA is a key event for viral replication. The very first stage of HIV reverse transcription, the initiation step, involves viral and cellular partners that are selectively packaged into the viral particle, leading to an RNA/protein complex with very specific structural and functional features, some of which being, in the case of HIV-1, linked to particular isolates. Recent understanding of the tight spatio-temporal regulation of reverse transcription and its importance for viral infectivity further points toward reverse transcription and potentially its initiation step as an important drug target.

  4. Humanes Immundefizienz-Virus (HIV)

    OpenAIRE

    Neye, Niko

    2010-01-01

    Since the first reports of an unusual cluster of severe pneumonia in June 1981, HIV/AIDS has become a huge pandemia that claimed more than 25 million casualties by the year 2006. At present, it is estimated that 33 million people have been infected with HIV world-wide. The overwhelming majority of which (96%) live in the low- and middle-income countries with the region of Sub-Saharan Africa being particularly badly affected. In this work, a comprehensive investigation of scientific publica...

  5. HIV-Associated Pathogenesis: The Role of HIV-1 Nef Gene

    Institute of Scientific and Technical Information of China (English)

    Xiaoning Xu; Hao Wu

    2006-01-01

    Since the discovery of HIV more than two decades ago, scientific progress has been impressive and has dramatically advanced our understanding of HIV infection, from molecular through cellular and then on to systemic pathogenesis,such as the functions of HIV-1 nef gene. However, there is still much to be learned before we fully understand how the host interacts with the virus at molecular level and how immune responses correlate with protection from disease. This review describes our current knowledge of HIV/AIDS with the reference of HIV nef functions and its role in HIV-1 mediated pathogenesis.

  6. Performance of 3 Rapid Tests for Discrimination Between HIV-1 and HIV-2 in Guinea-Bissau, West Africa

    DEFF Research Database (Denmark)

    Hønge, Bo Langhoff; Bjarnason Obinah, Magnús Pétur; Jespersen, Sanne;

    2014-01-01

    As HIV-2 is intrinsically resistant to nonnucleoside reverse transcriptase inhibitors, it is mandatory to discriminate between HIV types before initiating antiretroviral treatment. Guinea-Bissau has the world's highest prevalence of HIV-2 and HIV-1/HIV-2 dually infected individuals. We evaluated 3...

  7. Ergotismo y HIV

    Directory of Open Access Journals (Sweden)

    Bárbara C. Finn

    2013-08-01

    Full Text Available El ergotismo es una complicación de la intoxicación aguda y/o el abuso crónico de los derivados del ergot. Se manifiesta por síndrome vasomotor con enfermedad vascular periférica que frecuentemente compromete extremidades. Presentamos cuatro casos de pacientes infectados con el virus de la inmunodeficiencia humana 1 (HIV-1, en tratamiento con antirretrovirales que incluyen inhibidores de la proteasa reforzados con ritonavir, y que habían recibido ergotamina como automedicación. Ellos desarrollaron síntomas de enfermedad vascular periférica y al examen físico sus pulsos estaban disminuidos o ausentes. El Doppler arterial confirmó signos de espasmo arterial difuso en dos de ellos. Se hizo diagnóstico de ergotismo secundario a la asociación de ergotamina-inhibidores de la proteasa. Los pacientes fueron tratados con la discontinuación de las drogas involucradas (inhibidores de la proteasa y ergotamina, bloqueantes cálcicos, profilaxis antitrombótica con enoxaparina, antiagregación con ácido acetil salicílico y uno ellos recibió pentoxifilina e infusión de prostaglandinas vasodilatadoras con mejoría de los síntomas. Discutimos la presentación clínica de esta interacción medicamentosa, difícil de diagnosticar correctamente sin una fuerte sospecha de su existencia.

  8. Human defensins 5 and 6 enhance HIV-1 infectivity through promoting HIV attachment

    Directory of Open Access Journals (Sweden)

    Lu Wuyuan

    2011-06-01

    Full Text Available Abstract Background Concurrent sexually transmitted infections (STIs increase the likelihood of HIV transmission. The levels of defensins are frequently elevated in genital fluids from individuals with STIs. We have previously shown that human defensins 5 and 6 (HD5 and HD6 promote HIV entry and contribute to Neisseria gonorrhoeae-mediated enhancement of HIV infectivity in vitro. In this study, we dissect the molecular mechanism of the HIV enhancing effect of defensins. Results HD5 and HD6 primarily acted on the virion to promote HIV infection. Both HD5 and HD6 antagonized the anti-HIV activities of inhibitors of HIV entry (TAK 779 and fusion (T-20 when the inhibitors were present only during viral attachment; however, when these inhibitors were added back during viral infection they overrode the HIV enhancing effect of defensins. HD5 and HD6 enhanced HIV infectivity by promoting HIV attachment to target cells. Studies using fluorescent HIV containing Vpr-GFP indicated that these defensins enhanced HIV attachment by concentrating virus particles on the target cells. HD5 and HD6 blocked anti-HIV activities of soluble glycosaminoglycans including heparin, chondroitin sulfate, and dextran sulfate. However, heparin, at a high concentration, diminished the HIV enhancing effect of HD5, but not HD6. Additionally, the degree of the HIV enhancing effect of HD5, but not HD6, was increased in heparinase-treated cells. These results suggest that HD5 and haparin/heparan sulfate compete for binding to HIV. Conclusions HD5 and HD6 increased HIV infectivity by concentrating virus on the target cells. These defensins may have a negative effect on the efficacy of microbicides, especially in the setting of STIs.

  9. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... About NIDA Director's Page Organization Legislative Activities Advisory Boards & Groups Working at NIDA Donating to NIDA Contact Us Sharing Tools and Badges Other Resources Strategic Plan Search Share Print Home » News & Events » Public Education Projects » Learn the Link - Drugs and HIV Learn ...

  10. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... with HIV is a key predictor of the development of AIDS. Because of their compromised immune system, ... what to do to counter these trends. Online ... Department of Health and Human Services (HHS), offers access to the latest, federally ...

  11. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... News NIDA Notes Podcasts E-Newsletters Public Education Projects Contact the Press Office Meetings & Events Media Guide ... Search Share Print Home » News & Events » Public Education Projects » Learn the Link - Drugs and HIV Learn the ...

  12. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... projects/learn-link-drugs-hiv . 120x90 460x80 486x60 Social Media Send the message to young people and ... the discussion between friends, and the importance of family. For more information, read a message from the ...

  13. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... projects/learn-link-drugs-hiv . 120x90 460x80 486x60 Social Media Send the message to young people and to ... available for your use to share on your social media accounts. About the Campaign Overview The Learn the ...

  14. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... associated with drug abuse are among the main factors in the spread of HIV infection in the United States. Drugs can change the way the brain works, disrupting the parts of the brain that people use to weigh risks and benefits when making decisions. This page connects ...

  15. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... spread this way. Hepatitis C can cause liver disease and permanent liver damage. Poor judgment and risky behavior. Drug abuse by any route (not just injection) can put a person at risk for getting HIV. Drug and alcohol intoxication affect judgment and can lead to unsafe sexual practices, ...

  16. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... the News NIDA Notes Podcasts E-Newsletters Public Education Projects Contact the Press Office Meetings & Events Media ... Plan Search Share Print Home » News & Events » Public Education Projects » Learn the Link - Drugs and HIV Learn ...

  17. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... projects/learn-link-drugs-hiv . 120x90 460x80 486x60 Social Media Send the message to young people and ... Center (NWHRC) Mujeres Unidas Contra el SIDA New Mexico AIDS Services African Advocates Against AIDS The Women’s ...

  18. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... HIV or transmitting it to someone else. Biological effects of drugs. Drug abuse and addiction can affect a person's ... the discussion between friends, and the importance of family. For more information, read a ... Drug Abuse, Dr. Nora D. Volkow. Message from the ...

  19. HIV Infection and Cancer Risk

    Science.gov (United States)

    ... the roles of HIV, hepatitis C infection, and alcohol abuse. Journal of Clinical Oncology 2006; 24(31):5005–5009. [PubMed Abstract] Massad LS, Seaberg EC, Wright RL, et al. Squamous cervical lesions in women with human immunodeficiency virus: long-term follow-up. ...

  20. Libya, HIV, and open communication

    OpenAIRE

    Jeang Kuan-Teh

    2006-01-01

    Abstract This year-end editorial discusses several points including the recent Libyan verdict sentencing five Bulgarian nurses and a Palestinian doctor to death for allegedly infecting 426 children with HIV. It also comments on the role played by open communication for bridging cultural misunderstandings and summarizes briefly Retrovirology's progress in 2006.

  1. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... shown to increase the amount of HIV in brain cells 1 . Drug abuse treatment. Since the late 1980s, ... Reference Marcondes, M.C. et al. “Methamphetamine increases brain viral load and activates natural killer cells in simian immunodeficiency virus-infected monkeys. Am. J. ...

  2. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... send the message to young people and to parents, teachers, and the media about the link between drug abuse and HIV. We have produced a set of multicultural public service announcements (PSAs) that use text messaging as a means of communication. The "Text Message" PSA features two young girls ...

  3. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... Plan Search Share ... Behaviors associated with drug abuse are among the main factors in the spread of HIV infection in the United States. Drugs can change the way the brain works, disrupting the parts of the brain that ...

  4. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... includes radio announcements that can still be aired. Send the Message Overview Please help us send the message to young people and to parents, ... risks and benefits when making decisions. Watch the "Send the Message About Drugs and HIV" Video How ...

  5. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available Researchers Medical & Health Professionals Patients & Families Parents & Educators Children & Teens Search Connect with NIDA : Google Plus Facebook LinkedIn Twitter ... Brain Genetics Global Health Hepatitis (Viral) HIV/AIDS Medical Consequences Mental Health Military Pain Prevention Treatment Trends & ...

  6. Treatment of primary HIV infection

    NARCIS (Netherlands)

    M.L. Grijsen

    2013-01-01

    In this thesis we studied the treatment of PHI. Early cART transiently lowered the viral setpoint and deferred the need for restart of cART during chronic HIV infection, which was most likely caused by the effects of the CD4 gain during treatment and the transient lowering of the viral setpoint. Eve

  7. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... parties or hanging out with friends? In the “d’cisions” Webisode series, Kim and her friends never ... always will be associated with HIV/AIDS. The “d’cisions” Webisode series is part of the Drugs + ...

  8. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... Adolescent Brain Comorbidity College-Age & Young Adults Criminal Justice Drugged Driving Drug Testing Drugs and the Brain ... projects/learn-link-drugs-hiv . 120x90 460x80 486x60 Social Media Send the message to young people and ...

  9. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... projects/learn-link-drugs-hiv . 120x90 460x80 486x60 Social Media Send the message to young people and ... available for your use to share on your social media accounts. About the Campaign Overview The Learn ...

  10. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... young people engage in risk-taking and sensation-seeking behaviors. Unsafe sexual practices increase a person's risk of ... HIV, and it encourages them to share this information with their peers to prevent ... behaviors. NIDA researchers have studied and continue to study ...

  11. Drugs + HIV, Learn the Link

    Medline Plus

    Full Text Available ... young people and to parents, teachers, and the media about the link between drug abuse and HIV. We have produced a set of multicultural public service announcements (PSAs) that use text messaging as a means of communication. The "Text Message" PSA features two young girls ...

  12. Screening and diagnosis for HIV

    Science.gov (United States)

    ... also called immunoassay) checks for antibodies to the HIV virus. Your health care provider may order the test for you to have done at a lab. Or, you may have it done at a testing center or use a home kit. These tests can detect antibodies starting a few ...

  13. Impacts to HIV/AIDS of gender

    Directory of Open Access Journals (Sweden)

    Emel Taşçı

    2007-03-01

    Full Text Available The impact of gender on HIV/AIDS is an important dimension in understanding the evolution of the epidemic. HIV/AIDS is one of the vital problems of our century. HIV/AIDS is not merely a medical disease but also is a problem, which possesses economical, cultural, psychological and social dimensions. Women are more vulnerable to HIV than men because of biological and cultural factors. Besides women who carry HIV virus experience difficulty in taking care of their own health, they also carry the burden of possibility that their children and other members of the family might catch HIV virus. Most often, social support is insufficient and the conditions brought by treatment cannot be utilized appropriately due to external interventions. Most of the problems that women under the risk of HIV run into are largely social rather than medical. Many women infected with HIV were isolated because they didn’t get of sufficient social support or didn’t equal time for their care and it is thought that this inequality still continues. An analysis of the impact of gender on HIV/AIDS demonstrates the importance of integrating gender into HIV programming and finding ways to strengthen women by implementing policies and programs that increase their access to education and information. Women's empowerment is vital to reversing the epidemic.

  14. The crying need for an HIV statute.

    Science.gov (United States)

    Grover, A

    1996-01-01

    By 2000, India will have the largest number of reported HIV cases in the world. 22,520 HIV cases and 2528 AIDS cases were reported in India during May 1986 to April 1996. However, the numbers of cases are greatly underestimated and the National AIDS Control Organization and the Indian Health Organization estimate more like 1.78 and 4.4 million HIV cases, respectively, in the country. Goa is the only state in India with a law on HIV. The 1988 Goa Public Health Amendment Act legislated the mandatory testing of people suspected to be infected with HIV and the forced isolation of people who test HIV-seropositive. The provision of mandatory isolation was later made discretionary. The government at the federal level has decided that the provision of relevant education is the best way to prevent the spread of HIV. Some people believe that education is enough and law reform does not help. The author, however, argues that an integrationist strategy based upon education as the central component of HIV prevention must be backed up by legislation to prevent the spread of HIV infection and strengthen the rights of HIV positive persons against forced testing, isolation, breach of confidentiality, and discrimination. India's current legal regime cannot protect these rights. PMID:12347627

  15. HIV Infection Accelerates Hepatitis C-Related Liver Fibrosis

    Science.gov (United States)

    ... HIV Infection Accelerates Hepatitis C–Related Liver Fibrosis HIV Infection Accelerates Hepatitis C–Related Liver Fibrosis Email ... the progression of other chronic diseases as well. HIV and Fibrosis Dr. Kirk and his team tapped ...

  16. Sexual Risk Behavior: HIV, STD, & Teen Pregnancy Prevention

    Science.gov (United States)

    ... Health STDs Home Page Teen Pregnancy Sexual Risk Behaviors: HIV, STD, & Teen Pregnancy Prevention Recommend on Facebook Tweet Share Compartir ... tested for human immunodeficiency virus (HIV).* Sexual risk behaviors place adolescents at risk for HIV infection, other sexually transmitted ...

  17. Analysis of Sequence Based Classifier Prediction for HIV Subtypes

    Directory of Open Access Journals (Sweden)

    S. Santhosh Kumar

    2012-10-01

    Full Text Available Human immunodeficiency virus (HIV is a lent virus that causes acquired immunodeficiency syndrome (AIDS. The main drawback in HIV treatment process is its sub type prediction. The sub type and group classification of HIV is based on its genetic variability and location. HIV can be divided into two major types, HIV type 1 (HIV-1 and HIV type 2 (HIV-2. Many classifier approaches have been used to classify HIV subtypes based on their group, but some of cases are having two groups in one; in such cases the classification becomes more complex. The methodology used is this paper based on the HIV sequences. For this work several classifier approaches are used to classify the HIV1 and HIV2. For implementation of the work a real time patient database is taken and the patient records are experimented and the final best classifier is identified with quick response time and least error rate.

  18. Aging with HIV: Responding to an Emerging Challenge

    Science.gov (United States)

    ... Us FAQs Stay Connected You are here Home Aging with HIV: Responding to an emerging challenge September ... immune status in people infected with HIV. Cognitive aging HIV and its treatment can have profound effects ...

  19. HIV Patients Now Living Long Enough to Develop Alzheimer's

    Science.gov (United States)

    ... nlm.nih.gov/medlineplus/news/fullstory_158394.html HIV Patients Now Living Long Enough to Develop Alzheimer's ... of Alzheimer's disease diagnosed in a person with HIV highlights the fact that long-time HIV survivors ...

  20. HIV infection is associated with diffusing capacity impairment in women

    OpenAIRE

    FITZPATRICK, Meghan E.; Gingo, Matthew R.; Kessinger, Cathy; Lucht, Lorrie; Kleerup, Eric; Greenblatt, Ruth M.; Claman, David; Ponath, Claudia; Fong, Serena; Huang, Laurence; Morris, Alison

    2013-01-01

    Respiratory dysfunction is common in HIV, but few studies have directly assessed whether HIV remains an independent risk factor for pulmonary function abnormalities in the antiretroviral therapy era. Additionally, few studies have focused on pulmonary outcomes in HIV+ women.

  1. Brief Report: Macrophage Activation in HIV-2-Infected Patients Is Less Affected by Antiretroviral Treatment-sCD163 in HIV-1, HIV-2, and HIV-1/2 Dually Infected Patients.

    Science.gov (United States)

    Hønge, Bo L; Andersen, Morten N; Jespersen, Sanne; Medina, Candida; Correira, Faustino G; Jakobsen, Martin R; Laursen, Alex; Erikstrup, Christian; Møller, Holger J; Wejse, Christian

    2016-07-01

    The course of disease among HIV-2, HIV-1, and HIV-1/2 dually infected patients is different. We investigated the macrophage activation marker soluble CD163 (sCD163) dynamics in 212 HIV-1, HIV-2, and HIV-1/2 dually infected patients. There were no differences in sCD163 levels at baseline or during follow-up without antiretroviral therapy (ART). At follow-up on ART, median sCD163 levels were decreased for HIV-1-infected patients (P < 0.001), but not among HIV-2 (P = 0.093) or HIV-1/2 dually infected patients (P = 0.145). The larger decrease in sCD163 levels among HIV-1-infected patients during ART may indicate an HIV type-dependent differential effect of ART on macrophage activation during HIV infection. PMID:26825178

  2. Compromiso renal en pacientes HIV+

    Directory of Open Access Journals (Sweden)

    María Marta Pernasetti

    2010-06-01

    Full Text Available Varias complicaciones nefrológicas pueden ocurrir durante la infección por el virus de la inmunodeficiencia humana (HIV especialmente en estadios avanzados de la enfermedad o relacionadas con otras infecciones o drogas. Poco conocida es la prevalencia de alteraciones renales subclínicas de pacientes HIV+ surgidas como complicación o relacionadas a la infección y/o tratamiento. Realizamos un corte transversal de pacientes asintomáticos HIV+ referidos en forma consecutiva al consultorio de nefrología para la detección de alteraciones nefrológicas. Se estudiaron 52 pacientes adultos mediante exámenes de sangre y orina, ultrasonido y biopsia renal. Edad media 39.9 ± 10.6 años, 88% varones, tiempo de diagnóstico de la infección: 53.2 ± 41.2 (2-127 meses. El 71% tenían síndrome de inmunodeficiencia adquirida (HIV-sida y el 77% recibían con antirretrovirales. La carga viral al momento del estudio fue 7043 ± 3322 copias y el recuento de CD4+ 484 ± 39 cel/mm³. El 30.7% presentó alteraciones del sedimento urinario: albuminuria: 16.6%, hematuria microscópica: 11.5%, hipercalciuria: 10.8% y cristaluria 6%. La media del filtrado glomerular fue 102.2 ± 22.9 ml/min (rango: 34-149. El 41% presentó anormalidades que corresponderían a enfermedad renal crónica (estadios 1 a 3. Los pacientes con alteraciones tenían mayor edad, con duración más prolongada de la infección. Las anomalías renales no se asociaron con mayor prevalencia de HIV-sida. Dos pacientes fueron biopsiados, con hallazgos de nefritis túbulo-intersticial crónica con cristales y glomerulonefritis por IgA. No hubo hallazgos de nefropatía por HIV. El amplio espectro y la alta prevalencia de anormalidades nefrológicas subclínicas encontradas sugieren que los pacientes asintomáticos HIV+ deberían realizar evaluaciones nefrológicas de rutina.

  3. HIV classification using coalescent theory

    Energy Technology Data Exchange (ETDEWEB)

    Zhang, Ming [Los Alamos National Laboratory; Letiner, Thomas K [Los Alamos National Laboratory; Korber, Bette T [Los Alamos National Laboratory

    2008-01-01

    Algorithms for subtype classification and breakpoint detection of HIV-I sequences are based on a classification system of HIV-l. Hence, their quality highly depend on this system. Due to the history of creation of the current HIV-I nomenclature, the current one contains inconsistencies like: The phylogenetic distance between the subtype B and D is remarkably small compared with other pairs of subtypes. In fact, it is more like the distance of a pair of subsubtypes Robertson et al. (2000); Subtypes E and I do not exist any more since they were discovered to be composed of recombinants Robertson et al. (2000); It is currently discussed whether -- instead of CRF02 being a recombinant of subtype A and G -- subtype G should be designated as a circulating recombination form (CRF) nd CRF02 as a subtype Abecasis et al. (2007); There are 8 complete and over 400 partial HIV genomes in the LANL-database which belong neither to a subtype nor to a CRF (denoted by U). Moreover, the current classification system is somehow arbitrary like all complex classification systems that were created manually. To this end, it is desirable to deduce the classification system of HIV systematically by an algorithm. Of course, this problem is not restricted to HIV, but applies to all fast mutating and recombining viruses. Our work addresses the simpler subproblem to score classifications of given input sequences of some virus species (classification denotes a partition of the input sequences in several subtypes and CRFs). To this end, we reconstruct ancestral recombination graphs (ARG) of the input sequences under restrictions determined by the given classification. These restritions are imposed in order to ensure that the reconstructed ARGs do not contradict the classification under consideration. Then, we find the ARG with maximal probability by means of Markov Chain Monte Carlo methods. The probability of the most probable ARG is interpreted as a score for the classification. To our

  4. The HIV/AIDS epidemic in Cuba: description and tentative explanation of its low HIV prevalence

    Directory of Open Access Journals (Sweden)

    Clémençon Stéphan

    2007-11-01

    Full Text Available Abstract Background The Cuban HIV/AIDS epidemic has the lowest prevalence rate of the Caribbean region. The objective of this paper is to give an overview of the HIV/AIDS epidemic in Cuba and to explore the reasons for this low prevalence. Methods Data were obtained from the Cuban HIV/AIDS programme established in 1983. This programme has an extensive adult HIV testing policy, including testing of all pregnant women. HIV and AIDS cases have been recorded since 1986. Persons found to be HIV-positive are interviewed on their sexual behaviour and partners. Tracing and voluntary testing of these partners are organised. Epidemiological description of this epidemic was obtained from analysis of this data set. Using elementary mathematical analyses, we estimated the coverage of the detection system (percentage of HIV-positive adults detected and the average period between HIV infection and detection. Estimated HIV prevalence rates were corrected to account for the coverage. Results HIV prevalence has increased since 1996. In 2005, the prevalence among pregnant women was 1.2 per 10,000 (16/137000. Estimated HIV prevalence among 15- to 49-year-olds was 8.1 per 10,000 (4913/6065000; 95%CI: 7.9 per 10,000 – 8.3 per 10,000. Most (77% of the HIV-positive adults were men, most (85.1% of the detected HIV-positive men were reported as having sex with men (MSM, and most of the HIV-positive women reported having had sex with MSM. The average period between HIV infection and detection was estimated to be 2.1 years (IQR = 1.7 – 2.2 years. We estimated that, for the year 2005, 79.6% (IQR: 77.3 – 81.4% of the HIV-positive persons were detected. Conclusion MSM drive the HIV epidemic in Cuba. The extensive HIV testing policy may be an important factor in explaining the low HIV prevalence. To reduce the HIV epidemic in Cuba, the epidemic among MSM should be addressed. To understand this epidemic further, data on sexual behaviour should be collected. Now that

  5. Knowledge of HIV Transmission and Associated Factors among HIV-Positive and HIV-Negative Patients in Rural Kenya

    OpenAIRE

    Hong, Steven Y.; Thompson, Daria; Wanke, Christine; Omosa, Gloria; Jordan, Michael R.; Tang, Alice M; Patta, Shem; Mwero, Ben; Mjomba, Innocent; Mwamburi, Mkaya

    2012-01-01

    Knowledge of HIV transmission is a prerequisite to practicing safer behaviors to prevent HIV infections and may be expected to vary by region because of cultural and socioeconomic determinants. A cross-sectional study was conducted in rural Kenya using a standardized questionnaire assessing HIV transmission knowledge, socio-demographic and other characteristics. Participants were recruited from the voluntary counseling and testing clinic and the general hospital population of Moi District Hos...

  6. HIV-1 Tat and HIV-associated Dementia%HIV-1Tat蛋白与艾滋病脑病

    Institute of Scientific and Technical Information of China (English)

    周勤华; 姚鑫; 惠斌

    2012-01-01

    HIV-1 gene expression requires the transcriptional activator protein Tal of human immunodeficiency virus-1 ( HIV-1) , which stimulates viral transcript elongation. A significant number of people infected with the HIV develop neurologic complications. HIV-1-associated dementia( HAD) is a severe central nervous system(CNS) disorder neurologically induced by HIV-1. HAD represents the most severe form of HIV-related neuropsychiatric impairment and is characterized by motor dysfunction and impaired cognitions and behaviors. HIV-1 trans-activator of transcription( Tat) is an important factor in viral pathogenesis. The Tat protein not only drives the regulatory regions of the virus, but also might be actively released from the cells and then interacts with the cell surface receptors of other uninfected cells in the brain leading to cellular dysfunction. Growing evidence indicates that HIV-1 Tat protein play a major role in pathogenesis of HAD. This article reviewed the pleomorphic actions of Tat protein and the evidence supporting its central role in the neuropathogenesis of HAD.%Tat蛋白是HIV-1编码的反式转录激活因子,其主要功能是反式激活HIV-1病毒基因组转录的起始和延伸,启动病毒复制,近年来研究发现,Tat蛋白在HIV-1感染所引起的严重中枢神经系统(CNS)并发症——艾滋病脑病中起重要作用,是艾滋病脑病发生与发展的重要致病因子.本文就HIV-1 Tat蛋白在艾滋病脑病中的研究进展作一综述.

  7. Pregnancy loss and role of infant HIV status on perinatal mortality among HIV-infected women

    OpenAIRE

    Kim Hae-Young; Kasonde Prisca; Mwiya Mwiya; Thea Donald M; Kankasa Chipepo; Sinkala Moses; Aldrovandi Grace; Kuhn Louise

    2012-01-01

    Abstract Background HIV-infected women, particularly those with advanced disease, may have higher rates of pregnancy loss (miscarriage and stillbirth) and neonatal mortality than uninfected women. Here we examine risk factors for these adverse pregnancy outcomes in a cohort of HIV-infected women in Zambia considering the impact of infant HIV status. Methods A total of 1229 HIV-infected pregnant women were enrolled (2001–2004) in Lusaka, Zambia and followed to pregnancy outcome. Live-born infa...

  8. HIV Status Awareness, Partnership Dissolution and HIV Transmission in Generalized Epidemics.

    OpenAIRE

    Reniers, G; Armbruster, B.

    2012-01-01

    OBJECTIVES: HIV status aware couples with at least one HIV positive partner are characterized by high separation and divorce rates. This phenomenon is often described as a corollary of couples HIV Testing and Counseling (HTC) that ought to be minimized. In this contribution, we demonstrate the implications of partnership dissolution in serodiscordant couples for the propagation of HIV. METHODS: We develop a compartmental model to study epidemic outcomes of elevated partnership dissoluti...

  9. Clinical profile of HIV infected patients attending a HIV referral clinic in Pune, India

    OpenAIRE

    Megha Antwal; Rohan Gurjar; Shweta Chidrawar; Jyoti Pawar; Sunil Gaikwad; Narayan Panchal; Varsha Kale; Madhuri Thakar; Arun Risbud; Srikanth Tripathy

    2014-01-01

    Background & objectives: Human immunodeficiency virus (HIV) has infected several million individuals in India. Various interventions have been implemented for early detection and prevention of transmission of HIV infection. This has progressively changed the clinical profile of HIV infected individuals and this study documents the clinical presentation of individuals positive for HIV in 2010, in Pune, Maharashtra, India. Methods: This cross-sectional study included subjects who had come ...

  10. Strategies and Outcomes of HIV Status Disclosure in HIV-Positive Young Women with Abuse Histories

    OpenAIRE

    Clum, Gretchen A.; Czaplicki, Lauren; Andrinopoulos, Katherine; Muessig, Kathryn; Hamvas, L.; Ellen, Jonathan M.

    2013-01-01

    Young women with HIV and histories of physical and/or sexual abuse in childhood may be vulnerable to difficulties with disclosure to sexual partners. Abuse in childhood is highly prevalent in HIV-positive women, and has been associated with poorer communication, low assertiveness, low self worth, and increased risk for sexual and other risk behaviors that increase the risk of secondary transmission of HIV. HIV disclosure may be an important link between abuse and sexual risk behaviors. Qualit...

  11. HIV Disclosure and Transmission Risks to Sex Partners Among HIV-Positive Men.

    Science.gov (United States)

    Kalichman, Seth C; Kalichman, Moira O; Cherry, Chauncey; Grebler, Tamar

    2016-05-01

    Disclosure of HIV-positive status to sex partners is critical to protecting uninfected partners. In addition, people living with HIV often risk criminal prosecution when they do not inform sex partners of their HIV status. The current study examined factors associated with nondisclosure of HIV status by men living with HIV in Atlanta, GA (92% African African, mean age = 43.8), who engage in condomless sex with uninfected sex partners. Sexually active HIV-positive men (N = 538) completed daily electronic sexual behavior assessments over the course of 28 days and completed computerized interviews, drug testing, medication adherence assessments, and HIV viral load retrieved from medical records. Results showed that 166 (30%) men had engaged in condomless vaginal or anal intercourse with an HIV-uninfected or unknown HIV status sex partner to whom they had not disclosed their HIV status. Men who engaged in nondisclosed condomless sex were less adherent to their HIV treatment, more likely to have unsuppressed HIV, demonstrated poorer disclosure self-efficacy, enacted fewer risk reduction communication skills, and held more beliefs that people with HIV are less infectious when treated with antiretroviral therapy. We conclude that undisclosed HIV status is common and related to condomless sex with uninfected partners. Men who engage in nondisclosed condomless sex may also be more infectious given their nonadherence and viral load. Interventions are needed in HIV treatment as prevention contexts that attend to disclosure laws and enhance disclosure self-efficacy, improve risk reduction communication skills, and increase understanding of HIV infectiousness. PMID:27158850

  12. CD25 Preselective Anti-HIV Vectors for Improved HIV Gene Therapy

    OpenAIRE

    Kalomoiris, Stefanos; Lawson, Je'Tai; Chen, Rachel X.; Bauer, Gerhard; Nolta, Jan A.; Anderson, Joseph S.

    2012-01-01

    As HIV continues to be a global public health problem with no effective vaccine available, new and innovative therapies, including HIV gene therapies, need to be developed. Due to low transduction efficiencies that lead to low in vivo gene marking, therapeutically relevant efficacy of HIV gene therapy has been difficult to achieve in a clinical setting. Methods to improve the transplantation of enriched populations of anti-HIV vector-transduced cells may greatly increase the in vivo efficacy ...

  13. Assessment of linkages from HIV testing to enrolment and retention in HIV care in Central Mozambique

    OpenAIRE

    Celso Azarias Inguane; Stephen Gloyd; João Luis Manuel; Charlene Brown; Vincent Wong; Orvalho Augusto; Wisal Mustafa Hassan; Lúcia Vieira; Pires Afonso; Mehol Jamnadás; Jama Joy Bernard; James Cowan; Samuel Kalibala; James Pfeiffer

    2016-01-01

    Introduction: Effectiveness of the rapid expansion of antiretroviral therapy (ART) throughout sub-Saharan Africa is highly dependent on adequate enrolment and retention in HIV care. However, the measurement of both has been challenging in these settings. This study aimed to assess enrolment and retention in HIV care (pre-ART and ART) among HIV-positive adults in Central Mozambique, including identification of barriers and facilitators. Methods: We assessed linkages to and retention in HIV car...

  14. Mental Health in Youth Infected with and Affected by HIV: The Role of Caregiver HIV

    OpenAIRE

    Elkington, Katherine S.; Robbins, Reuben N.; Bauermeister, José A.; Abrams, Elaine J.; McKay, Mary; Mellins, Claude A.

    2010-01-01

    Objective To examine the association of youth and caregiver HIV status, and other contextual and social regulation factors with youth mental health. Method Data were from two longitudinal studies of urban youth perinatally infected, affected, and unaffected by HIV (N = 545; 36% PHIV+ youth; 45.7% HIV+ caregivers). Youth mental health was measured using the Child Behavior Checklist, the Child Depression Inventory, and the State–Trait Anxiety Inventory for Children. Results HIV+ youth reported ...

  15. The virus stops with me: HIV-infected Ugandans' motivations in preventing HIV transmission.

    Science.gov (United States)

    King, Rachel; Lifshay, Julie; Nakayiwa, Sylvia; Katuntu, David; Lindkvist, Pille; Bunnell, Rebecca

    2009-02-01

    Few Positive Prevention interventions have been implemented in Africa; however, greater attention is now being paid to interventions that include messages of personal responsibility or altruism that may motivate HIV-infected individuals towards HIV prevention behaviors in Africa. We conducted 47 in-depth interviews in 2004 with HIV-infected men and women purposefully sampled to represent a range of sexual activities among clients of an AIDS support organization in Uganda. Qualitative interviews were selected from a cross-sectional survey of 1092 HIV-infected men and women. Clients were interviewed about their concerns around sexual HIV transmission, feelings of responsibility and reasons for these feelings, as well as about the challenges and consequences of actions to prevent HIV transmission. The reasons they provided for their sense of prevention responsibility revolved around ethical and practical themes. Responsibility toward sexual partners was linked to the belief that conscious transmission of HIV equals murder, would cause physical and emotional harm, and would leave children orphaned. The primary reason specific to preventing HIV transmission to unborn children was the perception that they are 'innocent'. Most participants felt that HIV-infected individuals held a greater responsibility for preventing HIV transmission than did HIV-uninfected individuals. Respondents reported that their sense of responsibility lead them to reduce HIV transmission risk, encourage partner testing, disclose HIV test results, and assume an HIV/AIDS educator role. Challenges to HIV preventive behavior and altruistic intentions included: sexual desire; inconsistent condom use, especially in long term relationships; myths around condom use; fear of disclosure; gender-power dynamics; and social and financial pressure. Our finding that altruism played an important role in motivating preventive behaviors among HIV-infected persons in Uganda supports the inclusion of altruistic

  16. Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples

    OpenAIRE

    Anglemyer, Andrew; Rutherford, George W.; Horvath, Tara; Baggaley, Rachel C; Egger, Matthias; Siegfried, Nandi

    2013-01-01

    BACKGROUND Antiretroviral drugs have been shown to reduce risk of mother-to-child transmission of human immunodeficiency virus (HIV) and are also widely used for post-exposure prophylaxis for parenteral and sexual exposures. Sexual transmission may be lower in couples in which one partner is infected with HIV and the other is not and the infected partner is on antiretroviral therapy (ART). OBJECTIVES To determine if ART use in an HIV-infected member of an HIV-discordant couple is ...

  17. HIV/AIDS, Globalizacao e Seguranca Ontológica

    DEFF Research Database (Denmark)

    Tufte, Thomas

    2004-01-01

    HIV/AIDS, Entertainment-Education, Communication for Development, Migration, Ontological Security......HIV/AIDS, Entertainment-Education, Communication for Development, Migration, Ontological Security...

  18. Increasing rates of obesity among HIV-infected persons during the HIV epidemic.

    Directory of Open Access Journals (Sweden)

    Nancy Crum-Cianflone

    Full Text Available BACKGROUND: The prevalence and factors associated with overweight/obesity among human immunodeficiency virus (HIV-infected persons are unknown. METHODS: We evaluated prospective data from a U.S. Military HIV Natural History Study (1985-2004 consisting of early diagnosed patients. Statistics included multivariate linear regression and longitudinal linear mixed effects models. RESULTS: Of 1682 patients, 2% were underweight, 37% were overweight, and 9% were obese at HIV diagnosis. Multivariate predictors of a higher body mass index (BMI at diagnosis included more recent year of HIV diagnosis, older age, African American race, and earlier HIV stage (all p<0.05. The majority of patients (62% gained weight during HIV infection. Multivariate factors associated with a greater increase in BMI during HIV infection included more recent year of diagnosis, lower BMI at diagnosis, higher CD4 count, lower HIV RNA level, lack of AIDS diagnosis, and longer HIV duration (all p<0.05. Nucleoside agents were associated with less weight gain; other drug classes had no significant impact on weight change in the HAART era. CONCLUSIONS: HIV-infected patients are increasingly overweight/obese at diagnosis and during HIV infection. Weight gain appears to reflect improved health status and mirror trends in the general population. Weight management programs may be important components of HIV care.

  19. HIV Care in the Swedish-Danish HIV Cohort 1995-2010

    DEFF Research Database (Denmark)

    Helleberg, Marie; Häggblom, Amanda; Sönnerborg, Anders;

    2013-01-01

    Successful treatment reduces morbidity, mortality and transmission of HIV. We evaluated trends in the treatment status of HIV infected individuals enrolled in care in Sweden and Denmark during the years 1995-2010. Our aim was to assess the proportion of HIV-infected individuals who received...

  20. Group Intervention to Reduce HIV Transmission Risk Behavior Among Persons Living With HIV/AIDS

    Science.gov (United States)

    Kalichman, Seth C.; Rompa, David; Cage, Marjorie

    2005-01-01

    Results of a randomized controlled trial show that a behavioral intervention grounded in social cognitive theory reduces unprotected sexual behaviors among men and women living with HIV infection, with the greatest reductions in HIV transmission risk behaviors occurring with non-HIV-positive sex partners. In this article, the authors describe the…